# EDGAR Filing Document

**Accession Number:** 0001085921
**File Stem:** 0001062993-23-004754
**Filing Date:** 2023-2
**Character Count:** 281839
**Document Hash:** 02177c4cabeb6cf3bb8b016a2ddfd747
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-004754.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001062993-23-004754

**CONFORMED SUBMISSION TYPE**: 20-F

**PUBLIC DOCUMENT COUNT**: 100

**CONFORMED PERIOD OF REPORT**: 20221031

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MICROMEM TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0001085921
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 20-F
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26005
- **FILM NUMBER:** 23666388

**BUSINESS ADDRESS:**
- **STREET 1:** 121 RICHMOND ST W
- **STREET 2:** SUITE 602
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5H 2K1
- **BUSINESS PHONE:** 416-364-6513

**MAIL ADDRESS:**
- **STREET 1:** 121 RICHMOND ST W
- **STREET 2:** SUITE 602
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5H 2K1

?xml version="1.0" encoding="UTF-8"? Micromem Technologies Inc.: Form 20-F - Filed by newsfilecorp.com

------

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 20-F** 

**[ ]** REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

or

**[X]** ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For The Fiscal Year Ended <u>**October 31, 2022**</u>

Or

**[ ]** TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

or

**[ ]** SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. <u>**0-26005**</u>

**<u>MICROMEM TECHNOLOGIES INC.</u>**

(Exact name of Registrant as specified in its charter)

<u>**Ontario, Canada**</u>

(Jurisdiction of incorporation or organization)

**121 Richmond Street West, Suite 602** 

**Toronto, Ontario M5H 2K1, Canada** 

**Tel: (416) 364-6513** 

<u>**Fax: (416) 360-4034**</u>

(Address of principal executive offices)

<u>**Joseph Fuda; 416-364-6513, jfuda@micromeminc.com, 121 Richmond Street West, Suite 602 Toronto, ON M5H 2K1**</u> 

(Name, Telephone, E-Mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

<u>**None**</u>

Securities registered or to be registered pursuant to Section 12(g) of the Act:

<u>**Common Shares without par value**</u>

------

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

<u>**None**</u>

Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: <u>**467,607,678 Common Shares**</u>

Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act:

Yes [ ] No [X]

If this report is an annual or transition report, indicate by check mark if the registration is not required to file a report pursuant to section 13 or 15 of the Securities Exchange Act of 1934:

Yes [ ] No [X]

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:

Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [ X ] No [ ]

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of "large, accelerated filer," accelerator filer," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer [ ] Accelerated Filer [ ] Non-Accelerated Filer [X] Emerging growth company [ ]

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act (15 U.S.C. 7262(b) by the registered public accounting firm that prepared or issued its audit report. [ ]

If securities are registered pursuant to Section 12(b) of the Act, indicated by check mark whether financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.<sup>1</sup> [ ]

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).<sup>2</sup>[ ]

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP [ ] International Financial Reporting Standards as issued Other [ ] <br> by the International Accounting Standards Board [X]

____________________________

<sup>1</sup> Not Applicable

<sup>2</sup> Not Applicable

------

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the Registrant has elected to follow:

Item 17 [ ] Item 18 [ ]

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):

Yes [ ] No [X]

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange of 1934 subsequent to the distribution of securities under a plan confirmed by the court [ ]

------

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | Page |
| [**Part I**](#page5_integixAnchor) |  | [5](#page5_integixAnchor) |
| [Item 1.](#page5_integixAnchor) | [Identity of Directors, Senior Management and Advisors](#page5_integixAnchor) | [5](#page5_integixAnchor) |
| [Item 2.](#page5_integixAnchor) | [Offer Statistics and Expected Timetable](#page5_integixAnchor) | [5](#page5_integixAnchor) |
| [Item 3.](#page5_integixAnchor) | [Key Information](#page5_integixAnchor) | [5](#page5_integixAnchor) |
| [Item 4.](#page15_integixAnchor) | [Information on the Company](#page15_integixAnchor) | [15](#page15_integixAnchor) |
| [Item 4A.](#page22_integixAnchor) | [Unresolved Staff Comments](#page22_integixAnchor) | [22](#page22_integixAnchor) |
| [Item 5.](#page22_integixAnchor) | [Operating and Financial Review and Prospects](#page22_integixAnchor) | [22](#page22_integixAnchor) |
| [Item 6.](#page29_integixAnchor) | [Directors, Senior Management and Employees](#page29_integixAnchor) | [29](#page29_integixAnchor) |
| [Item 7.](#page32_integixAnchor) | [Major Shareholders and Related Party Transactions](#page32_integixAnchor) | [32](#page32_integixAnchor) |
| [Item 8.](#page33_integixAnchor) | [Financial Information](#page33_integixAnchor) | [33](#page33_integixAnchor) |
| [Item 9.](#page33_integixAnchor) | [The Offer and Listing](#page33_integixAnchor) | [33](#page33_integixAnchor) |
| [Item 10.](#page34_integixAnchor) | [Additional Information](#page34_integixAnchor) | [34](#page34_integixAnchor) |
| [Item 11.](#page45_integixAnchor) | [Quantitative and Qualitative Disclosures about Market Risk](#page45_integixAnchor) | [45](#page45_integixAnchor) |
| [Item 12.](#page45_integixAnchor) | [Description of Securities Other Than Equity Securities](#page45_integixAnchor) | [45](#page45_integixAnchor) |
| [**Part II**](#page45_integixAnchor) |  | [45](#page45_integixAnchor) |
| [Item 13.](#page45_integixAnchor) | [Defaults, Dividend Arrearages and Delinquencies](#page45_integixAnchor) | [45](#page45_integixAnchor) |
| [Item 14.](#page45_integixAnchor) | [Material Modifications to the Rights of Security Holders and Use of Proceeds](#page45_integixAnchor) | [45](#page45_integixAnchor) |
| [Item 15.](#page45_integixAnchor) | [Controls and Procedures](#page45_integixAnchor) | [45](#page45_integixAnchor) |
| [Item 16.](#page46_integixAnchor) | [\[Reserved\]](#page46_integixAnchor) | [46](#page46_integixAnchor) |
| [Item 16A](#page46_integixAnchor) | [Audit Committee Financial Expert](#page46_integixAnchor) | [46](#page46_integixAnchor) |
| [Item 16B](#page46_integixAnchor) | [Code of Ethics](#page46_integixAnchor) | [46](#page46_integixAnchor) |
| [Item 16C](#page46_integixAnchor) | [Principal Accountant Fees and Services](#page46_integixAnchor) | [46](#page46_integixAnchor) |
| [Item 16D](#page47_integixAnchor) | [Exemptions from the Listing Standards for Audit Committees](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [Item 16E](#page47_integixAnchor) | [Purchases of Equity by the Issuer and Affiliated Purchasers](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [Item 16F](#page47_integixAnchor) | [Changes in Registrant's Certifying Accountant](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [Item 16G](#page47_integixAnchor) | [Corporate Governance](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [Item 16H](#page47_integixAnchor) | [Mine Safety Disclosure](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [Item 16I](#page47_integixAnchor) | [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#page47_integixAnchor) | [47](#page47_integixAnchor) |
| [**Part III**](#page48_integixAnchor) |  | [48](#page48_integixAnchor) |
| [Item 17.](#page48_integixAnchor) | [Financial Statements](#page48_integixAnchor) | [48](#page48_integixAnchor) |
| [Item 18](#page48_integixAnchor) | [Financial Statements](#page48_integixAnchor) | [48](#page48_integixAnchor) |
| [Item 19.](#page48_integixAnchor) | [Exhibits](#page48_integixAnchor) | [48](#page48_integixAnchor) |
| [Signatures](#page49_integixAnchor) |  | [49](#page49_integixAnchor) |

---

------

**PART I**

**INTRODUCTION**

**Abbreviations** 

Throughout this document, Micromem Technologies Inc. and/or its affiliates are referred to as "Micromem", the "Company", "we", "us" or "our".

**Forward Looking and Cautionary Statements** 

This Form 20-F contains certain forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the business of our Company and the industry in which we operate, our management's beliefs, and assumptions made by our management. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks" and "estimates," variations on such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions which are difficult to predict. Our actual results could differ materially from those expressed or forecasted in these forward-looking statements as a result of certain factors, including those set forth under Item 3-Key Information - Risk Factors and elsewhere in this Form 20-F.

**ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS** 

Not applicable.

**ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE** 

Not applicable.

**ITEM 3. KEY INFORMATION**

**A. Selected Financial Data** 

***Fiscal Years 2022, 2021, 2020, 2019 and 2018***

The following table sets forth our selected consolidated financial data in United States dollars as of and for each of the fiscal years ended October 31, 2022, October 31, 2021, October 31, 2020, October 31, 2019 and October 31, 2018. The selected consolidated financial data has been derived from our audited consolidated financial statements. All information contained in the following table should be read in conjunction with our audited consolidated financial statements and the notes thereto in "Item 18-Financial Statements" and "Item 5 - Operating and Financial Review and Prospects" included elsewhere in this Annual Report on Form 20-F.

Our consolidated financial statements for the years ended October 31, 2022, 2021, 2020, 2019 and 2018 have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board.

------

**International Financial Reporting Standards**

**Selected balance sheet information**

**(all amounts in U.S. dollars)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** | **2019** | **2018** |
| Working Capital (deficiency) | (4722878) | (3452924) | (4202571) | (4301324) | (3828503) |
| Capital Assets | 48092 | 26012 | 49249 | 2677 | 9228 |
| Total Assets | 99519 | 225293 | 278026 | 83484 | 710737 |
| Capital Stock | 87784725 | 86815836 | 85463642 | 84153696 | 82282903 |
| Shareholders' equity (deficiency) | (4748000) | (3471278) | (4187342) | (4278647) | (3423170) |

---

**Selected statement of operations and deficit information** 

**(all amounts in U.S. dollars)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | 2022 | 2021 | 2020 | 2019 | 2018 |
| Interest and other income | $- | $- | $- | $- | $- |
| Research and development expenses (recovery) |  |  |  | (41546) | (130069) |
| General and administrative and other expenses (6) | 1228516 | 1020783 | 948420 | 1599137 | 1742463 |
| (Gain) on revaluation of derivative liabilities (1) | (409607) | (2547192) | (771920) | (343436) | (1094718) |
| (Gain) Loss on conversion of debt (2) | 46449 | (9506) | 96484 | 101919 | 63852 |
| Loss (Gain) on extinguishment of debt (5) | 200650 | 1018928 | (127409) | (646) | (399191) |
| Accretion Expense (3) | 1179603 | 1169921 | 1099818 | 1517436 | 2039344 |
| Stock compensation expense (4) | 41484 | 360044 |  |  | 140612 |
| Loss before income taxes | (2287095) | (1012978) | (1245393) | (2832864) | (2362239) |
| Net Loss | (2287095) | (1012978) | (1245393) | (2832864) | (2362239) |

---

1) Gain on revaluation of derivative liabilities for 2022, 2021, 2020, 2019 and 2018 above relates to the measurement of the derivative liabilities relating to the outstanding convertible bridge loans. The gain as reported is a non-cash charge which is calculated in accordance with IFRS.

2) Loss on conversion of debt relates to the inducement of additional common shares issued to the bridge loan lenders who converted their bridge loans to common shares and any loss recorded on the repayment of convertible debentures.

3) Accretion expense is a non-cash expense calculated in accordance with IFRS and relates to increasing the carrying value of the debt to the contracted amount over the term of the loan.

4) Stock compensation expense is a non-cash expense calculated in accordance with IFRS using the Black Scholes option pricing model.

5) Loss (Gain) on extinguishment of debt relates to the replacement of an existing debt instrument at maturity date with a new debt instrument reflecting revised renewal terms at maturity date.

6) Includes general and administrative expenses, professional fees, other fees, salaries, travel and entertainment expenses, amortization expense, foreign exchange loss, interest expense and financing costs. In 2020 we also report the recovery of a reserve of $205,788 for litigation costs which was recorded in 2018-19. In 2021 we report a recovery of stale dated accounts payable of $422,982.

------

**Currency and Exchange Rates** 

Our financial statements are all expressed in United States dollars. All other financial data appearing in this Form 20-F are expressed in United States dollars with the exception of certain limited cases when reference is made to instruments denominated in Canadian dollars ("CDN $").

Transactions that were conducted in Canadian dollars or other foreign currencies have been converted into United States dollars using the 3 month average rate of exchange per quarter which rate approximates the rate of exchange prevailing at the date of such transactions. Monetary assets and liabilities denominated in Canadian dollars or other foreign currencies but expressed in this Form 20-F in United States dollars have been converted into United States dollars at the rate of exchange prevailing on the date of the applicable financial statement. Non-monetary assets and liabilities denominated in Canadian dollars but expressed in this Form 20-F in United States dollars have been converted into US dollars at the historical exchange rate at the date of the transaction.

The following table sets forth, for the periods indicated, the high, low, end of period and average for period based on the Noon Buying Rates as published by the Bank of Canada, as expressed in the amount of U.S. Dollars equal to one Canadian dollar.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** | **2019** | **2018** |
| High for period | 0.8031 | 0.8111 | 0.7863 | 0.7699 | 0.7513 |
| Low for period | 0.7217 | 0.7903 | 0.6898 | 0.7353 | 0.8138 |
| End of period | 0.7383 | 0.8075 | 0.7854 | 0.7699 | 0.7609 |
| Average for period | 0.7692 | 0.0841 | 0.7461 | 0.7529 | 0.7767 |

---

The following table sets forth, for each period indicated, the high and low exchange rates for United States dollars expressed in Canadian dollars on the last day of each month during such period, based on the Noon Buying Rate.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **February** | **March** | **April** | **May** | **June** | **July** |
|  | **2022** | **2022** | **2022** | **2022** | **2022** | **2022** |
| High | 1.2832 | &nbsp;&nbsp;&nbsp;&nbsp;1.2867 | 1.2895 | &nbsp;&nbsp;&nbsp;&nbsp;1.3039 | &nbsp;&nbsp;&nbsp;&nbsp;1.3035 | &nbsp;&nbsp;&nbsp;&nbsp;1.3138 |
| Low | 1.2677 | &nbsp;&nbsp;&nbsp;&nbsp;1.2470 | 1.2451 | &nbsp;&nbsp;&nbsp;&nbsp;1.2648 | &nbsp;&nbsp;&nbsp;&nbsp;1.2540 | &nbsp;&nbsp;&nbsp;&nbsp;1.2824 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **August** | **September** | **October** | **November** | **December** | **January** |
|  | **2022** | **2022** | **2022** | **2022** | **2022** | **2023** |
| High | 1.3111 | 1.3726 | 1.3856 | 1.3749 | 1.3687 | 1.3658 |
| Low | 1.2753 | 1.2980 | 1.3547 | 1.3288 | 1.3433 | 1.3305 |

---

On February 17, 2023 the noon buying rate for one Canadian dollar, as quoted by the Bank of Canada, was CDN $1.3487= U.S. $1.00.

**B. Capitalization and Indebtedness**

Not applicable.

**C. Reasons for the Offer and Use of Proceeds**

Not applicable.

**D. Risk Factors** 

We and our investors face a number of risks, which are described below.

------

**Risk Factors Related to Our Business**

***The financial statements of our Company have been prepared on a going concern basis.***

We have prepared our financial statements on a "going concern" basis which presumes that we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future.

Our ability to continue as a going concern is dependent upon the successful commercialization of our sensor technology platforms that we currently have under development with our industry partners. Ultimately, we must achieve a profitable level of operation through licensing fees, royalties and the commercial sale of our products. We will require additional financing in the interim to fund our activity.

At October 31, 2022 we had $33,227 of cash on hand. Our working capital deficiency is $4,722,878 at October 31, 2022. Subsequent to October 31, 2022, through to the date of the filing of this Annual Report on Form 20-F, we have raised an additional $143,000 through the issuance of convertible debentures and $36,635 through private placements of equity.

Our consolidated financial statements, which have been prepared on a going concern basis, do not include any adjustments to the amounts and classifications of the assets and liabilities that might be necessary should we be unable to continue in business. If the going concern assumption was not appropriate for our financial statements then adjustments would be necessary in the carrying value of assets and liabilities, the reported expenses and the balance sheet classifications used. Such adjustments could be material.

The COVID-19 pandemic creates additional risk for the Company if there is a prolonged industry slowdown in those sectors where the Company currently operates, including the oil and gas sectors in particular. The Company has encountered delays in the commercialization plans for its technology with its primary customers. There remains considerable uncertainty as of this date as to the duration of the pandemic. If the pandemic continues for an extended period of time in 2023, there could be repercussions to the Company's ongoing business which could be significant.

***We currently have no operating revenue.***

We have not yet reported commercial revenues from licensing fees, royalties or product sales. If we fail to enter into license agreements or if we do not obtain purchase orders from potential customers, we will have no revenues. If we enter into such agreements the amount of the revenues we receive will depend on the terms we are able to secure from each licensee and the ability of licensees to compete in their particular market.

***There are market risks relating to the sale of our sensor technology platforms.***

We continued to develop applications of our sensor technology in 2022 working with our technical advisors and our strategic development partners. We are pursuing joint development agreements with potential strategic partners with the expectation that we will jointly develop sensor applications for use by these potential strategic partners. We believe that these current initiatives will result in revenues and cash flow to the Company in the future but there can be no assurance when and if such revenues will be achieved.

We may face competition from larger corporations which also sell sensor technology and who have greater financial resources than the Company.

Our success will in part be determined by the following factors which have not yet been fully and completely tested nor measured: the ability of manufacturers to incorporate the technology into existing manufacturing capabilities without significant retooling and material costs, price competitiveness and the differential performance advantages of our technology.

Additionally, our ability to compete successfully will depend on elements outside of our control, including the rate at which customers incorporate our technology into their products, the success of such customers in selling those products, our protection of our intellectual property, the number, nature and success of our competitors and their product introductions and general market and economic conditions. Our success will depend on our ability to protect our intellectual property, to develop, introduce, and license or sell in a timely manner our technology or products incorporating our technology and to compete effectively on the basis of factors such as speed, density, die size and power consumption.

------

***Failure to secure continued financing will cause our business to suffer.***

Since there is no assurance that commercial revenues will be realized in future, we will need additional financing to continue our development and to successfully market our technology to potential licensees and strategic partners.

There can be no assurance that we will be able to continue to raise sufficient financing in the future and the failure to do so would affect our ability to further develop our technology platforms and to market our products to existing and new potential customers.

***Because our success and value depends in part on our ownership and use of intellectual property, our failure to protect our property could adversely affect our future growth and success.***

Our success will depend, in part, on our ability to protect our intellectual property. We rely primarily on patent, copyright, trademark and trade secret laws, as well as nondisclosure agreements and other methods to protect our proprietary technology and processes. Despite our efforts to do so, unauthorized parties may attempt to copy or otherwise obtain and use our products or technology, develop similar technology independently or design around our patents. Policing unauthorized use of our products is expensive and difficult, and we cannot be certain that all required steps we have taken will prevent misappropriation or infringement of our intellectual property.

***Intellectual property claims against us, no matter how groundless, could cause our business to suffer.***

Our future success and competitive position depend in part on our ability to retain rights to our technology, including any improvements that may be made on that technology from time to time by us or on our behalf. Certain of our technology is patented or is subject to pending patent applications in the United States and abroad and we know of no challenge that has been made either against our technology or our rights to it. We have no reason to believe that any such challenge might be made or that the grounds for any such challenge exist. If any intellectual property litigation were to be commenced against us, no matter how groundless, the result could be a significant expense to us, adversely affecting further development, licensing and sales, diverting the efforts of our technical and management personnel and, in the event of an adverse outcome, damages and possible restrictions on the further development, licensing and use of our technology. There can be no assurance that any of our outstanding pending patent applications will be issued as patents or that any issued patent will not be determined to be invalid at a later date.

***We have a history of losses, and we may continue to generate losses in future.***

To date, we have operated as a product development company and have not been profitable. Unless and until we are able to successfully commercialize our technology applications, we may not be able to generate sufficient revenues in future periods and we may not be able to attain profitability.

The further development of our sensor technology may require significant additional capital which we may have to fund directly if we are unable to secure financing from development partners. Therefore, we may incur expenses without receiving equal and offsetting revenues at least until we are able to license our technology to third parties. This may result in net operating losses until we can generate an acceptable level of revenues. Further, even if we achieve operating revenues, there can be no assurance that such revenues will be sufficient to fund continuing operations.

The likelihood of the success of our business plan must be considered in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with developing and expanding early stage businesses and the competitive environment in which we operate.

------

***We will be dependent upon the success of a limited range of products.***

The range of products we intend to commercialize is currently limited to applications of our sensor technology. If we are not successful in commercializing our technology platforms, or if there is not adequate demand for such technology or the market for such technology develops less rapidly than we anticipate, we may not have the capability to shift our resources to the development of alternative products on a timely basis. This could limit future revenues and profitability.

***We may not realize income from the licensing of our technologies if our licensees fail to commercialize the products that incorporate these technologies.***

In order to generate revenues from our sensor technology platforms, we will need to enter into licensing arrangements with third parties who can integrate our technology into products that will gain acceptance in the market. We have not yet entered into any licensing agreements, and there is no assurance that we will be able to do so on acceptable terms in future. To the extent we are successful in licensing our technology; in general we will seek upfront payments plus ongoing royalties based on anticipated commercial sales of the products into which our technology is incorporated. Our ability to realize royalties will thus depend upon the successful manufacture and commercialization of such products, which will be primarily within the control of the licensee. There is no assurance that such licensees will be successful in marketing and selling such products. In addition, licensees could decide to delay or discontinue the commercialization of products for financial or other business reasons. Even if our licensees succeed in developing products that incorporate our technology, in all likelihood a significant amount of development and testing will be required before such products can be introduced to market. Therefore we may not receive royalty income for a substantial period following the commencement of any licensing arrangements. If our licensees are unable to commercialize products on a timely basis, they may lose market share to competing or alternative technologies. Any failure by the companies to which we license our technologies to successfully develop marketable products would have an adverse effect on our future royalty payments and financial condition.

***In order to commercialize our future products, we will need to establish a sales and marketing capability.***

At present, we have limited sales and marketing capability and our financial resources have been limited. We will need to add marketing and sales expertise and must also develop the necessary supporting distribution channels. Although we believe we can build the required infrastructure either in-house or through strategic relationships, we may not be successful in doing so. Failure to establish a sales force and distribution network would have an adverse effect on our ability to grow our business.

***We depend on key personnel.***

Our senior managers and employees are Joseph Fuda, who serves as our Chief Executive Officer, and Dan Amadori, who serves as our Chief Financial Officer. We have engaged the services of several engineering/technical consulting firms to assist in converting our development efforts to commercialization. Our success depends on our ability to retain certain of our senior management and key technical personnel, our ability to attract and retain additional highly skilled personnel in the future and to maintain our working relationships with our engineering and technical consulting firms to whom we have historically subcontracted our development work.

Steven Van Fleet resigned as President of our wholly-owned subsidiary, Micromem Applied Sensor Technologies, Inc. (MAST) in August 2018. Micromem has engaged other consultants since September 2018 to assist the Company after Mr. Van Fleet's departure. There can be no assurances that such efforts will be successful.

***A depressed oil and gas sector could place our development projects at risk.***

Certain of our development partners are engaged primarily in the oil and gas sector. If market conditions are depressed for this sector, there is a risk that such companies could defer or cancel previously established capital expenditure programs or product development initiatives. If these situations arose with our development partners in this sector, our related development projects could be at risk of delays or cancellation.

------

***Risks associated with the COVID-19 pandemic:***

The impact on the Company of the COVID-19 pandemic during the 2022 and 2021 fiscal years has been significant. Management has taken a number of remedial steps including (i) closing the office in mid-March 2020, and it reopened in 2022 (ii) utilized the Canada Employment Wage Subsidy program from the Canadian Federal Government to support our payroll obligations in 2020, (iii) utilized the Canadian Federal Government small business loan program and secured a $40,000 CDN ($30,629 USD) term loan which is as described in our consolidated financial statements. An additional $20,000 CDN ($15,135 USD) of term loan financing under this program was secured in January 2021, (iv) regular phone and electronic contact with our key service providers, subcontractors, and customers, and (v) business-related travel was curtailed after March 2020; it resumed in 2022.

There remains uncertainty as to the duration of the pandemic. If the pandemic continues for an extended period of time in 2023, there may be repercussions to the Company's ongoing business which could be significant.

***We may be materially affected by global economic, political and other conditions beyond our control.***

Our ability to generate revenue may be adversely affected by uncertainty in the global economy and could also be affected by unstable global political conditions. Health epidemics, terrorist attacks or acts of war could significantly disrupt our operations and the operations of our future customers, suppliers, distributors, or resellers. We cannot predict the potential impact on our financial condition or our results of operations should such events occur.

We are pursuing a significant business opportunity in Romania, working with Romgaz, the state-controlled gas company. To date, the war in the Ukraine with Russia, has not impacted our go forward plans in Romania. If the Ukraine war expands into other eastern European countries in future, there could be repercussions to our ongoing business which could be significant.

***We may be materially affected by rapid technological change and evolving industry standards.***

Short product life cycles are inherent in high-technology companies due to rapid technological change and evolving industry standards. Our future financial condition and results of operations depend on our ability to respond effectively to these changes. There can be no assurance that we will be able to successfully do so or adapt our current products to new technologies or new industry standards. In addition, our customers may be reluctant to adopt new technologies and standards or they may prefer competing technologies and standards. Because the technology market changes so rapidly, it is difficult for us to predict the rate of adoption of our technology.

***We may be materially affected by risks associated with new product development.***

Our new product development is complex and requires us to investigate and evaluate multiple alternatives, as well as plan the design and manufacture of those alternatives selected for further development. Our development efforts could be adversely affected by hardware and software design flaws, product development delays, changes in operating systems and changes in industry standards. The manufacturing of new products involves integrating complex designs and processes, coordinating with suppliers for parts and components and managing manufacturing capacities to accommodate forecasted demand. If we are not successful in meeting these requirements, this could adversely affect our ability to introduce new products on a timely basis.

***Our operations may be materially affected by the risks associated with the continued developments and protection of our intellectual property.***

There can be no assurance that we will be able to continue to develop new intellectual property or that we will continue to have it developed for us. We rely on a combination of U.S. patent, copyright, trademark, and trade secret laws to protect our intellectual property rights. We previously filed patent and trademark registration applications with certain foreign governments; in 2019 we abandoned certain of these foreign applications. We may not have appropriate coverage in all jurisdictions where we may sell or license our product in future.

We enter into confidentiality and non-disclosure agreements relating to our intellectual property with our employees and consultants. Despite our efforts to protect our intellectual property rights, unauthorized parties may attempt to copy or otherwise obtain or use our intellectual property. Monitoring the unauthorized use of our intellectual property is difficult and we cannot be certain that we will be able to adequately protect our intellectual property in the future.

------

***There are foreign exchange risks associated with our Company.***

Because we have historically raised funds in both U.S. and Canadian markets and a portion of our costs are denominated in Canadian dollars, our funding is subject to foreign exchange risks. A decrease in the value of the U.S. dollar relative to the Canadian dollar could affect our costs and potential future profitability. We do not currently hold forward exchange contracts or other hedging instruments to exchange foreign currencies for U.S. dollars so as to offset potential currency rate fluctuations.

**Risk Factors Related to Our Common Shares**

***Our stock is subject to the penny stock regulations, which may discourage brokers from effecting transactions in the stock and adversely affect the stock's market price and liquidity.***

Our common shares constitute "penny stock" under applicable regulations of the Securities and Exchange Commission. The penny stock regulations impose significant restrictions on brokers who sell penny stock to persons other than established customers and institutional accredited investors. Broker-dealers participating in sales of our stock will be subject to the so called "penny stock" regulations covered by Rule 15g-9 under the Exchange Act. Under the rule, broker-dealers must furnish to all investors in penny stocks a risk disclosure document required by the rule, make a special suitability determination of the purchaser and have received the purchaser's written agreement to the transaction prior to the sale. The penny stock regulations may discourage brokers from effecting transactions in the common shares. This would decrease market liquidity, adversely affect market price and make it difficult for you to use the common shares as collateral.

***The rights of our shareholders may differ from the rights typically afforded to shareholders of a U.S. corporation.***

We are incorporated under the Business Corporations Act (Ontario), also referred to herein as the "OBCA". The rights of holders of our common shares are governed by the laws of the Province of Ontario, including the OBCA, by the applicable laws of Canada, and by our Articles of Incorporation and all amendments thereto, also referred to herein as the Articles, and our By-laws. These rights differ in certain respects from the rights of shareholders in typical U.S. corporations. The principal differences include without limitation the following:

Under the OBCA, we have a lien on any common share registered in the name of a shareholder or the shareholder's legal representative for any debt owed by the shareholder to us. Under some U.S. state laws, corporations generally are not entitled to any such statutory liens in respect of debts owed by shareholders.

With regard to certain matters, we must obtain approval of our shareholders by way of at least 66 2/3% of the votes cast at a meeting of shareholders duly called for such purpose being cast in favor of the proposed matter. Such matters include without limitation: (a) the sale, lease or exchange of all or substantially all of our assets out of the ordinary course of our business; and (b) any amendments to our Articles including, but not limited to, amendments affecting our capital structure such as the creation of new classes of shares, changing any rights, privileges, restrictions or conditions in respect of our shares, or changing the number of issued or authorized shares, as well as amendments changing the minimum or maximum number of directors set forth in the Articles. Under some U.S. state laws, the sale, lease, exchange or other disposition of all or substantially all of the assets of a corporation generally requires approval by a majority of the outstanding shares, although in some cases approval by a higher percentage of the outstanding shares may be required. In addition, under some U.S. state laws, the vote of a majority of the shares is generally sufficient to amend a company's certificate of incorporation, including amendments affecting capital structure or the number of directors. Under certain circumstances the board of directors may also have the ability to change the number of directors under some U.S. state laws.

Pursuant to our By-laws, two persons present in person or represented by proxy and each entitled to vote thereat shall constitute a quorum for the transaction of business at any meeting of shareholders. Under some U.S. state laws, a quorum generally requires the presence in person or by proxy of a specified percentage of the shares entitled to vote at a meeting, and such percentage is generally not less than one-third of the number of shares entitled to vote.

------

Under rules of the Ontario Securities Commission, a meeting of shareholders must be called for consideration and approval of certain transactions between a corporation and any "related party" (as defined in such rules). A "related party" is defined to include, among other parties, directors and senior officers of a corporation, holders of more than 10% of the voting securities of a corporation, persons owning a block of securities that is otherwise sufficient to affect materially the control of the corporation, and other persons that manage or direct, to a substantial degree, the affairs or operations of the corporation. At such shareholders' meeting, votes cast by any related party who holds common shares and who has an interest in the transaction may not be counted for the purposes of determining whether the minimum number of required votes have been cast in favor of the transaction. Under some U.S. state laws, a transaction between a corporation and one or more of its officers or directors can generally be approved either by the shareholders or a by majority of the directors who do not have an interest in the transaction. Corporations that are listed on a U.S. securities exchange or are quoted on Nasdaq may also be required to have transactions with officers and directors and other related party transactions reviewed by an audit committee comprised of independent directors.

There is no limitation imposed by our Articles or other charter documents on the right of a non-resident to hold or vote our common shares. However, the Investment Canada Act , also referred to herein as the Investment Act, as amended by the World Trade Organization Agreement Implementation Act, also referred to herein as the WTOA Act, generally prohibits implementation of a reviewable investment by an individual, government or agency thereof, corporation, partnership, trust or joint venture that is not a "Canadian," as defined in the Investment Act, unless, after review, the minister responsible for the Investment Act is satisfied that the investment is likely to be a net benefit to Canada. An investment in our common shares by a non-Canadian would be reviewable under the Investment Act if it were an investment to acquire direct control of Micromem, and the value of our assets were CDN $5.0 million or more. However, an investment in our shares by a national of a country (other than Canada) that is a member of the World Trade Organization or has a right of permanent residence in such a country (or by a corporation or other entity that is a "WTO Investor-controlled entity" pursuant to detailed rules set out in the Investment Act) would be reviewable at a higher threshold of CDN $344 million in assets, except for certain economic sectors with respect to which the lower threshold would apply. A non-Canadian, whether a national of a WTO member or otherwise, would acquire control of Micromem for purposes of the Investment Act if he or she acquired a majority of our common shares. The acquisition of less than a majority, but at least one-third of our common shares, would also be presumed to be an acquisition of control of Micromem, unless it could be established that Micromem was not controlled in fact by the acquirer through the ownership of voting shares. The United States is a WTO Member for purposes of the Investment Act. Certain transactions involving our common shares would be exempt from the Investment Act, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an acquisition of our common shares if the acquisition were made in connection with the person's business as a trader or dealer in securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an acquisition of control of Micromem in connection with the realization of a security interest granted for a loan or other financial assistance and not for any purpose related to the provisions of the Investment Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an acquisition of control of Micromem by reason of an amalgamation, merger, consolidation or corporate reorganization, following which the ultimate direct or indirect control of Micromem, through the ownership of voting interests, remains unchanged. Under U.S. law, except in limited circumstances, restrictions generally are not imposed on the ability of non- residents to hold a controlling interest in a U.S. corporation.

***U.S. shareholders may not be able to enforce civil liabilities against us.***

Micromem is incorporated under the laws of the Province of Ontario. Additionally, a number of our directors and executive officers are non-residents of the U.S., and all or a substantial portion of the assets of such persons are located outside the U.S. As a result, should any investor commence an action in the U.S. against Micromem or its directors or executive officers, Micromem or its directors or officers, as the case may be, may be able to insist that any action against them take place in the jurisdiction of the Province of Ontario. Accordingly, it may be difficult for investors to effect service of process on Micromem or these non-United States resident persons within the United States or to rely in the United States upon judgments obtained in the United States based on the civil liability provisions of the U.S. federal securities laws against Micromem or its executive officers and non-United States resident directors. In addition, if an investor were to obtain a U.S. judgment against Micromem or its directors or executive officers, there is doubt as to the enforceability of such U.S. judgment in Canada.

------

***As a foreign private issuer, we are permitted to file less information with the SEC than a company that is not a foreign private issuer or that files as a domestic issuer.***

As a foreign private issuer, we are exempt from certain rules under the Securities Exchange Act of 1934, as amended ("the Exchange Act") that impose disclosure requirements as well as procedural requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions of Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as a company that files as a domestic issuer whose securities are registered under the Exchange Act, nor are we generally required to comply with the SEC's Regulation FD, which restricts the selective disclosure of material non-public information. For as long as we are a "foreign private issuer" we intend to file our annual financial statements on Form 20-F and furnish our quarterly financial statements on Form 6-K to the SEC for so long as we are subject to the reporting requirements of Section 13(g) or 15(d) of the Exchange Act. However, the information we file or furnish is not the same as the information that is required in annual and quarterly reports on Form 10-K or Form 10-Q for U.S. domestic issuers. Accordingly, there may be less information publicly available concerning us than there is for a company that files as a domestic issuer.

***We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act***'***s domestic reporting regime and cause us to incur additional legal, accounting and other expenses.***

We are required to determine our status as a foreign private issuer on an annual basis at the end of our second fiscal quarter. In order to maintain our current status as a foreign private issuer, either (1) a majority of our shares must be either directly or indirectly owned of record by non-residents of the United States or (2) (a) a majority of our executive officers or directors must not be U.S. citizens or residents, (b) more than 50 percent of our assets cannot be located in the United States and (c) our business must be administered principally outside the United States. If we lost this status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We would also be subject to additional restrictions on offers and sales of securities outside the United States and would have to comply with the generally more restrictive Regulation S requirements under the Securities Act of 1933, as amended, that apply to U.S. domestic issuers, which could limit our ability to access capital markets in the future. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs.

***We do not anticipate paying dividends.*** We have never paid a dividend on our securities and we do not anticipate paying dividends in the foreseeable future.

***We are likely a ''passive foreign investment company'' ("PFIC"), which may have adverse U.S. federal income tax consequences for U.S. investors.***

We believe that we were classified as a PFIC for our most recently completed tax year, and based on current business plans and financial expectations, we expect that we may be a PFIC for our current tax year and subsequent tax years. If we are a PFIC for any year during a U.S. taxpayer's holding period of common shares, then such U.S. taxpayer generally will be required to treat any gain realized upon a disposition of the common shares or any so-called ''excess distribution'' received on its common shares as ordinary income, and to pay an interest charge on a portion of such gain or distribution. In certain circumstances, the sum of the tax and the interest charge may exceed the total amount of proceeds realized on the disposition, or the amount of excess distribution received, by the U.S. taxpayer. Subject to certain limitations, these tax consequences may be mitigated if a U.S. taxpayer makes a timely and effective QEF Election (as defined below) or a Mark-to-Market Election (as defined below). Subject to certain limitations, such elections may be made with respect to the common shares. A U.S. taxpayer who makes a timely and effective QEF Election generally must report on a current basis its share of our net capital gain and ordinary earnings for any year in which we are a PFIC, whether or not we distribute any amounts to our shareholders. However, U.S. taxpayers should be aware that there can be no assurance that we will satisfy the record keeping requirements that apply to a qualified electing fund, or that we will supply U.S. taxpayers with information that such U.S. taxpayers require to report under the QEF Election rules, in the event that we are a PFIC and a U.S. taxpayer wishes to make a QEF Election. Thus, U.S. taxpayers may not be able to make a QEF Election with respect to their common shares. A U.S. taxpayer who makes the Mark-to-Market Election generally must include as ordinary income each year the excess of the fair market value of the common shares over the taxpayer's basis therein. This paragraph is qualified in its entirety by the discussion below under the heading "*Certain United States Federal Income Tax Consequences - Passive Foreign Investment Company Rules*." Each potential investor who is a U.S. taxpayer should consult its own tax advisor regarding the tax consequences of the PFIC rules and the acquisition, ownership, and disposition of the common shares.

------

***We may need to issue additional securities which may cause our shareholders to experience dilution.***

Our Board of Directors has the authority to issue additional common shares, without par value, or other of our securities without the prior consent or vote of our shareholders. The issuance of additional common shares would dilute the proportionate equity interest and voting power of our shareholders.

***The price of our common shares and volume of our common shares may be volatile.***

Our shareholders may be unable to sell a significant number of our common shares on the OTCQB without a significant reduction in the market price of the shares.

Furthermore, there can be no assurance that we will be able to meet the listing requirements of, or achieve listing on, any other stock exchange. The market price of the common shares may be affected significantly by factors such as fluctuations in our operating results, announcements of technological innovations or new products by us or our competitors, action by governmental agencies against us or the industry in general, developments with respect to patents or proprietary rights, public concern as to the safety of products developed by us or others, the interest of investors, traders and others in public companies such as ours and general market conditions. In recent years, the securities markets in the United States and Canada have experienced a high level of price and volume volatility, and the market price of securities of many companies, particularly small capitalization companies, have experienced fluctuations which have not necessarily been related to the operating performance, underlying asset values or business prospects of such companies.

**ITEM 4. INFORMATION ON THE COMPANY** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**A. History and Development of Our Company** 

Micromem is a corporation formed under the laws of the Province of Ontario, Canada, with principal executive offices at 121 Richmond Street West, Suite 602, Toronto, Ontario M5H 2K1 (416.364.6513). Micromem was incorporated on October 21, 1985 as Mine Lake Minerals Inc. We subsequently changed our name to Avanti Capital Corp. on June 23, 1988, to Avanti Corp International Inc. on April 30, 1992 and to Micromem Technologies Inc. on January 11, 1999 in connection with our acquisition of Pageant Technologies Incorporated, also referred to herein as Pageant International. Our website address is www.micromeminc.com. The information on our website is not part of this Annual Report on Form 20-F. We have included our website address in this document as an inactive textual reference only.

**The Evolution of Micromem from Memory to Sensor Based Client Solutions** 

Micromem Applied Sensors Technologies, Inc., our wholly-owned subsidiary ("MAST") was incorporated in 2008 in the State of Delaware. MAST was formed in connection with a contract with BAE Systems in Nashua, New Hampshire. BAE Systems is a Department of Defense trusted facility, which can only do business with U.S. entities (ITAR regulations). BAE Systems' interest was in the potential to utilize our MRAM technology in a radiation-hardened environment for military applications. During this work it was determined that the Hall sensor, which was integral to the MRAM design, had several performance characteristics that by itself, as a product, would potentially create value for MAST.

------

Frost & Sullivan was contracted by MAST in 2009 to assess the market opportunities for a late entry into the Hall sensor market. The Hall sensor market in 2009 was robust at an estimated $1.9 billion USD. The market barriers were mature market, declining margins and heavy competition. A decision was taken to not enter the Hall sensor component market for the above reasons. A decision was taken to explore the market opportunities associated with creating unique sensor based solutions that revolved around our Hall sensor technology.

A decision was taken to internally develop, at our own cost, proof of concepts for products that we had gleaned, through our marketing efforts, to have potential market value. These included a magnetic gold sensor for drilling plug analysis, an oil condition sensor for automotive use and an oil/gas aerial exploration platform.

In 2010, MAST was engaged to develop a sensor platform for detecting four nanometer magnetic particles in a flowing oil stream at a concentration less than 1 ppb. Another revenue generating opportunity came in 2011 from a supplier for high speed air bearing motors. MAST replaced the incumbent Hall sensor supplier and delivered a unique circuit board form factor that incorporated the smallest Hall sensor in the world.

In 2011 MAST became aware of the NineSigma Open Innovation model. Nine Sigma's core services connect innovation-seeking companies to the best solutions, capabilities, and partners around the world. MAST's relationship with NineSigma provided us access to the Global Fortune 1000 companies and resulted in a future sales proposal pipeline.

In 2011, a decision was taken to stop research and development effort in the MRAM market space. This decision was taken, in part, due to the high capital demand for staying current in the rapidly changing technology and, equally important, the MRAM market had not grown at the anticipated growth rates. Micromem had amassed multiple memory patents and in 2013 began efforts to value the patent portfolio and attempt to arrange for a sale of these assets.

Until 2014, Micromem funded virtually all of its research and development initiatives. Our main priority was to provide customers with sensor based platform solutions that address their difficult business problems. By 2015 we had advanced a number of our product development initiatives under joint product development agreements with our clients Chevron, Castrol, Flextronics, and Eversource Energy. Our pipeline of development projects expanded.

In 2016 and 2017, we attempted to advance our projects towards field trials. The Flextronics and Eversource projects were ultimately discontinued. We continued with the Chevron and Castrol development projects and began discussions with Repsol SA.

In 2018 the Castrol project was discontinued. We continued to advance our Chevron and Repsol S.A. projects.

In October 2018, Steve Van Fleet filed a lawsuit again the Company and MAST seeking payment of alleged remuneration and expense reimbursements due to him totaling $214,574. The Company denied the allegations and, in turn, interposed counterclaims again Mr. Van Fleet seeking, among other things, damages of not less than $3.0 million. In 2021 the litigation with Mr. Van Fleet was resolved in our favor. See Item 5 - Contingencies in this Annual Report.

**Recent Developments Prior to Fiscal Year 2022:**

**Chevron:** In 2019 we continued to engage with Chevron personnel and with our engineering subcontractor, Entanglement Technologies Inc. ("Entanglement"). We met with the Chevron team members in their Houston offices on seven occasions to continue our dialogue and measure our go forward path. We also met directly with Entanglement on three occasions for these purposes. The field testing of the onsite pilot program was coordinated between Chevron, Entanglement and the Company and commenced in March 2019 at a California based oil well site operated by Chevron. The initial on site testing was conducted over a period of approximately six weeks. Thereafter sample testing from the onsite well continued in both the Entanglement and Chevron laboratories. Chevron advised that the results of the testing that has been completed to date has met with their expectations and requirements and that the performance of the technology in the onsite pilot and subsequent lab sample testing has been validated.

------

**Romgaz**: Romgaz is the state-controlled gas company in Romania. We initiated a dialogue with the senior management team at Romgaz in May 2019. The opportunity developed as a result of the progress that we had experienced with our Chevron initiative which, by that point, has advanced to the onsite pilot program referenced above.

We continued our initial discussions with Romgaz thereafter and, in October 2019, we announced that the Company had executed a letter of intent ("Romgaz LOI") which afforded the Company the opportunity to sell the ARTRA technology units to Romgaz and to develop a robust analytics solution for the technology. The key conditions to progressing the Romgaz LOI were twofold - that Romgaz would continue with their due diligence on the ARTRA technology, and that manufacturing of the commercial units in the future would be completed, with the Company's input, in Romania.

Discussions and negotiations with Romgaz continued after the execution of the Romgaz LOI in October 2019. These discussions involved Chevron whom the Company introduced to Romgaz as part of the Romgaz due diligence process.

In December 2019 Romgaz put forward a series of questions to Chevron relating to the Chevron experience with the ARTRA technology and the testing that Chevron had conducted in 2019. The dialogue that the Company coordinated between Romgaz and Chevron was positive, and the specifics of these discussions were approved by both parties and posted to the Micromem website on December 20, 2019.

As of October 31, 2022, the Company has been negotiating with Romgaz with respect to initial purchase orders that Romgaz would be issuing to Micromem : (a) for the purchase of initial units of the existing ARTRA technology for training and education purposes, (b) for a proposal by Micromem to deliver a comprehensive analytics solution to Romgaz for the technology, and, (c) pending satisfactory completion of (b), a purchase order for commercial orders for the technology which is to be manufactured in Romania, although there can be no assurances that such purchase order will be made.

**Repsol:** In Q1 2019 we submitted a proposed letter of intent (" Repsol LOI") to the Repsol engineering team with whom we engaged in September 2018 after the resignation of Mr. Van Fleet .The Repsol LOI was intended to reset the go forward product development parameters, marketing efforts and cost sharing arrangements for this project. The original Repsol purchase order submitted in 2017 was suspended as part of these discussions with Repsol.

The underlying technology for the Repsol initiative has been referenced in our 2018 Annual Report as the RT Lube Analyzer. The initial development completed on this technology between 2016-2018 was undertaken by the Company and its engineering subcontract, SBM Microsystems. In 2019 we moved the project to an engineering and manufacturing entity in Toronto Canada. In mid-2019, we began negotiations with the Repsol team towards a final development contract.

**Capital Expenditures**

Micromem reports no capital expenditures in 2022. It incurred $5,271 of capital expenditures in 2021 which related to the purchase of computer equipment. It reported no capital expenditures in 2020.

**Available Information**

The SEC maintains an Internet site at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Information is also available under the Company's profile on SEDAR (www.sedar.com) or on www.micromeminc.com.

------

**B. Business Overview** 

**Update of Product Development Activity at October 31, 2022**

The current status of our active development projects is as reported below. In general, the COVID-19 pandemic has resulted in delays encountered on the continued progress of our product development initiatives after February 2020.

(a) *Romgaz*:

The COVID-19 pandemic has resulted in delays in the execution of our commercial activity with Romgaz during the 2022 fiscal year.

We have referenced in our 2022 interim quarterly MD&A commentaries that we were awaiting initial purchase orders for the interwell tracer technology application during fiscal 2022.

Our discussions with Romgaz have been continuous on a weekly basis throughout fiscal 2022 and have continued to progress since our fiscal year end. The key go-forward points in these discussions, at the current date are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) We are anticipating an initial purchase order for several interwell tracer devices, similar to the technology that Chevron deployed in the California field trials referenced above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Micromem will be commissioned to conduct/lead a development program to enhance and expand the analytics capabilities of the existing technology with the end goal of delivering a comprehensive analytics solution to Romgaz for its specific performance requirements in its gas wells.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Micromem and has pursued discussions whereby the technology application developed in (ii) above will be manufactured on a commercial scale in Romania. It is expected that the technology that will be manufactured in Romania will be suitable for both oil and gas well applications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) A joint venture agreement between Micromem and Romgaz is contemplated. The working relationship between Micromem and Romgaz is expected to expand to include the development of other technology applications where Micromem has been active over the past five years. We expect to finalize these working arrangements and move forward with these initiatives in 2023. It is expected that Romgaz will provide the initial capital to launch this expanded working relationship.

In anticipation of these developments with Romgaz in 2023, Micromem is planning for its business activity to include the following components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Continuance of its working relationship with the developer of the interwell tracer device (ARTRA 171) technology which Chevron has successfully tested in on site testing of operating oil wells and for which we anticipate Romgaz purchase orders in 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) We plan to maintain our dialogue with Chevron and may pursue certain licensing opportunities with Chevron relating to their proprietary technology in our continued work with Romgaz.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) We have established a Toronto - based engineering/product presence in cooperation with an established manufacturing and engineering group with whom we expect to have a role as a strategic partner to Micromem.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Between June 2021-August 2022, Micromem hired two engineering staff persons through the University of Toronto coop program, each for a 16-month term. The engineering staff were responsible for supporting all of Micromem's current initiatives with Chevron, Romgaz and other potential customers. We may continue this program of coop hires, as appropriate, in future.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) We will plan to add additional senior management to the Micromem team in the project management, engineering, and financial reporting areas of discipline .We will also look to recruit additional corporate directors to our Board .

(b) *Chevron:*

As previously reported, successful field testing of the interwall tracer device was conducted on-site at a California-based Chevron well site in 2019. Sample testing was conducted for a 12-month period thereafter through March 2020.

We attended the Houston- based OTC oil and gas conference in August 2021 and have maintained a current dialogue with Chevron and with other industry participants.

While Chevron has curtailed further development activity on this project after the onset of the COVID-19 pandemic; we believe it continues to have interest in our interwell tracer technology.

Once our initiative with Romgaz is launched, we plan to attempt to reengage with Chevron to assess potential current opportunities to collaborate upon with Chevron.

Senior management at Chevron has, in the past, been very supportive of Micromem's engagement with Romgaz.

(c) *Repsol S.A. ("Repsol"):*

With our additional staff resources in Toronto, we began to reconfigure the RT Lube Analyzer technology in which Repsol has previously expressed interest and for which we negotiated a letter of intent with Repsol in 2019. Since then, we have not had interaction with Repsol during the Covid 19 pandemic; this project may be restarted in future.

**Deferred development costs / development expenses**

Until October 31, 2016, we capitalized as deferred development costs the expenditures that we incurred on these projects, net of the recoveries of such costs from our development partners. Since November 2016, we have expensed net costs as such costs did not meet the criteria for capitalization based on our impairment analysis.

We have previously reported on the chronology, by customer, of our investment in development costs relating to our various projects which we undertook with our strategic partners. A summary of these costs and recoveries between 2012 and 2021 is provided as below:

*Net Costs absorbed by the Company:*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **(1)** | **(2)** | **(3)** | **(4)** | **(5)** | **(6)** | **(7)** | **Total** |
| Cost incurred | 4499466 | 225000 | 2035676 | 939458 | 2470329 | 1129168 | 522720 | 11821817 |
| Recoveries from development partners | (3442050) | (100000) | (838500) | (300000) | (200000) |  | (46000) | (4926550) |
| Net costs absorbed by the Company | 1057416 | 125000 | 1197176 | 639458 | 2270329 | 1129168 | 476720 | 6895267 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Chevron (2013-2019)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Repsol (2018-2019)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Castrol (2014-2018)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Saudi Aramco (2012-2013)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Northeast Utilities (2013-2015)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. GM/Flextronics (2012-2015)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Other (various) (2011-2014)

The Chevron development project was self-funding after 2016. The Castrol project was suspended in 2018 given that Castrol was not prepared to commit additional funding to the project. The Saudi Aramco contract was completed in 2014. The Northeast Utilities contract was terminated in 2015 given that Northeast Utilities was not prepared to commit additional funding to the project other than in kind consideration. The GM/Flextronics work commenced in 2012; the Company was absorbing all of the costs associated with the development of the prototype product being developed in conjunction with GM/Flextronics. The prototype work was suspended due to the turnover of the GM project team by 2016-2017 and the Company's decision to stop committing additional funding to the project after 2016. The Company has been awarded several patents relating to the work completed on the GM/Flextronics project.

------

In 2019 the Company incurred $36,051 of expenses with respect to the ongoing costs associated with the Chevron project and recovered $77,597 from Chevron including payments received for certain milestones achieved in 2018.

The Company remains as a pre revenue entity at October 31, 2022. It did not incur any further development expenses on any project in 2020 ,2021 or 2022 and it did not submit any invoices to any of its development partners in 2022.

Given the progress and momentum achieved to date with Chevron and with Romgaz, the Company believes it will have commercial orders and revenues in 2023, although there can be no assurances such purchase orders will be made or that revenues will be achieved.

**Intellectual Property**

Our intellectual property consists of two components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) A series of patents and provisional patents relating to the smart oil pan plug technology (the formal reference is the "multimodal conditional sensor platform and system thereof") originally developed from the work completed on the GM/Flextronics project.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) A series of older patents relating to the Hall sensor application for magnetic random access memory (MRAM). These patents and the market for MRAM applications have not been pursued by the Company since 2009 and all of the costs associated with these patents were written off by 2013 after unsuccessful attempts to sell or license this intellectual property to other parties.

Beginning in 2018, we began to abandon provisional patent filings in a number of international jurisdictions as a cost cutting initiative. We continued that process in 2019, 2020, 2021 and 2022.

We believe that the U.S. patents that have been granted for MRAM have sustaining value to be realized in the future. If the Company's financial position improves, it may pursue the exploitation of its patents in this field of endeavors.

Our patent costs are summarized below for the fiscal years ending October 31, 2019-2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | 2022 | 2021 | 2020 | 2019 |
|  | $| $| $| $|
| &nbsp;&nbsp;Patent expenditures: |  |  |  |  |
| &nbsp;&nbsp;Patent costs capitalized: |  |  |  |  |
| &nbsp;&nbsp;Amortization expense: |  |  | 8123 | 152962 |
| &nbsp;&nbsp;Impairment Reserve: |  |  |  | 223143 |

---

**Share Capital**

At October 31, 2022, the Company had 467,607,678 common shares outstanding (2021: 435,737,734 common shares outstanding). Additionally, the Company has 11,725,000 stock options outstanding with a weighted average exercise price of $0.06 per share (2021: 11,700,000 options outstanding with a weighted average exercise price of $0.06 per share).

**Changes to Our Board of Directors and Management:** 

The Company held its most recent Annual General and Special Meeting of the shareholders for the fiscal years ending 2017, 2018, and 2019 on September 8, 2020. At the meeting Joseph Fuda, Alex Dey and Oliver Nepomuceno were re-elected as directors. Brian Von Herzen, who had served as a director of the Company since 2014 was not a candidate for the Board of Directors at the annual meeting. Joseph Fuda and Dan Amadori continue in their respective roles of CEO and CFO respectively.

------

We plan to schedule the next Annual General Meeting of shareholders to cover the 2020, 2021 and 2022 fiscal years prior to June 30, 2023. We will evaluate the opportunities to expand our Board of Directors at this upcoming Annual General Meeting.

**Equity Financing Transactions:** 

In the fiscal year ended October 31, 2022 the Company completed the following transactions:

(a) Pursuant to prospectus and registration exemptions set forth in applicable securities law, the Company completed private placements consisting of common shares, received net proceeds of $207,588 and issued a total of 5,012,450 common shares.

(b) The Company continued its bridge loan financing activities in 2022, specifically:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) It issued 26,443,820 common shares for the conversion of bridge loans totaling $764,432.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) It realized net proceeds of $765,671 from the issuance of convertible debentures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) It repaid $63,490 of bridge loans previously secured.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Certain of the bridge loans that matured in 2022 were extended at maturity date, ultimately through October 31, 2022 and thereafter.

In the fiscal year ended October 31, 2021 the Company completed the following transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Pursuant to prospectus and registration exemptions set forth in applicable securities law, the Company completed private placements consisting of common shares, received net proceeds of $840,564 and issued a total of 17,573,429 common shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company continued its bridge loan financing activities in 2021, specifically:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) It issued 15,611,852 common shares for the conversion of bridge loans totaling $511,630.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) It realized net proceeds of $510,000 from the issuance of convertible debentures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) It repaid $593,301 of bridge loans previously secured.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Certain of the bridge loans that matured in 2021 were extended at maturity date, ultimately through October 31, 2022 and thereafter.

**Environmental Matters:**

We are subject to various environmental protection regulations imposed by the government in the jurisdiction where we conduct our development work. We are not aware of any current or pending environmental protection laws or regulations that would have a material impact on our capital expenditure requirements or competitive position.

**C. Organizational Structure** 

In November 2007, the Company incorporated Micromem Applied Sensors Technology, Inc. ("MAST") as a Delaware-based wholly-owned subsidiary. MAST had an office in New York City and was being managed by Steven Van Fleet, its then President and a Director of Micromem. We have utilized the services of other consultants to continue the work of MAST since the departure of Mr. Van Fleet in August 2018.

In October 2008, the Company incorporated 7070179 Canada Inc. as a wholly-owned subsidiary. On October 31, 2008, the Company assigned its rights, title, and interest in certain of its intellectual property which it previously held directly to 707179 Canada Inc. in exchange for common shares of this wholly-owned subsidiary.

We have a wholly-owned subsidiary, Pageant International, which was incorporated under the laws of the Turks & Caicos Islands and continued to Barbados on May 25, 2001. Pageant International has a wholly-owned subsidiary, Pageant Technologies (USA) Inc., a corporation incorporated in the State of Utah. Pageant Technologies USA has been inactive since 2002.

------

We have a wholly-owned subsidiary, Memtech International Inc., incorporated under the laws of the Bahamas, which in turn has a wholly-owned subsidiary, Memtech International (USA) Inc., a corporation incorporated in the State of Delaware. We also have a wholly-owned subsidiary Micromem Holdings (Barbados) Inc. These subsidiaries have been inactive since inception.

**D. Property, Plant and Equipment** 

We maintain our corporate headquarters in Toronto, Ontario, Canada. We occupied 2,500 square feet of commercial office space pursuant to a lease that was extended in February 2017 for five years through July 2022. In August 2022 we moved to a smaller unit in the same commercial building occupying 1,154 square feet pursuant to a lease from August 1, 2022 to July 31, 2025. The Company sublets a portion of its rental space on a month to month basis and realized sublet income of $17,652 (2021: $24,809; 2020: $17,692)

In 2022, the Company capitalized $48,408 of right of use assets under IFRS 16 pertaining to its lease for office premises and recorded an equivalent liability in its accounts. The Company recorded amortization of $25,878 in 2022 (2021: $28,033; 2020: $27,735).

**ITEM 4A. UNRESOLVED STAFF COMMENTS** 

None.

**ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS**

This section of the Form 20-F has been prepared to provide a more substantive discussion of our business and to assist the reader in analyzing the audited consolidated financial statements for the years ended October 31, 2022, October 31, 2021, and October 31, 2020. This discussion and analysis of financial condition and results of operations should be read in conjunction with the consolidated financial statements and related notes in this Annual Report, which are prepared in accordance with IFRS, as issued by the IASB, and are stated in United States dollars.

------

**Operating Results:**

The following table sets forth certain selected financial information of our Company.

**Selected statement of operation and deficit information**

---

| |
|:---|
| Administration |
| Professional and other fees and salaries |
| Travel and entertainment |
| Recovery of reserve for litigation costs/stale dated payables) |
| Stock compensation expense |
| Interest expense |
| Amortization expense |
| Accretion expense |
| (Gain) Loss on conversion of bridge loans |
| (Gain) on revaluation of derivatives |
| Loss (Gain) on extinguishment of debt |
| Financing costs |
| Foreign exchange loss (gain) |
| (Loss) for the year |
| (Loss) per share - basic and diluted |

---

**Selected balance sheet information**

---

| |
|:---|
| &nbsp;&nbsp;Working capital (deficiency) |
| &nbsp;&nbsp;Other Assets |
| &nbsp;&nbsp;Total Assets |
| &nbsp;&nbsp;Long term liabilities |
| &nbsp;&nbsp;Shareholders' equity (deficiency) |

---

------

**Fiscal 2022 Compared to Fiscal 2021**

a) Administration costs were $185,366 in 2022 versus $155,504 in 2021. These costs include rent and occupancy costs of $50,907 (2021: $15,536, the Company reported sublet income for a portion of its office space in 2022 and 2021; in 2021 the Company also received Federal Government Covid 19 related rent subsidies); office insurance costs of $1,696 (2021: $753; the Company did not renew its D&O insurance coverage after 2020), investor relations, listings and filing fees of $64,769 (2021: $53,029), other general and administrative expenses of $59,938 (2021: $86,168).

b) Professional and other fees and salaries costs were $647,710 in 2022 versus $424,485 in 2021. The components of these total costs include legal and audit related expenses of $110,933 in 2022 (2021: $107,554), 3<sup>rd</sup> party consulting fees were $69,563 in 2022 (2021: $132,793), staff salaries and benefits were $467,214 in 2022 (2021: $184,138).

The CFO has received $40,615 of management fees in 2022 (2021: $25,376). The CEO of the Company has received $92,902 of compensation in 2022 (2021: $81,826).

c) Travel and entertainment expenses were $59,504 in 2022 (2021: $24,903). We limited travel expenses in 2021 as part of a broader effort to reduce the Company's operating expenses; corporate travel has resumed in 2022.

d) In 2022, the Company awarded 2,025,000 million stock options to consultants. (2021: 9.5 million stock options issued to directors, officers and consultants); the related expense of $41,484 was calculated using the Black Scholes option-pricing model (2021: $360,044).

e) Interest expense was $469,425 in 2022 versus $495,809 in 2021. This represents the actual interest expense obligations incurred by the Company based on the stated interest rates on the convertible debenture notes.

f) Amortization expense was $29,755 in 2022 consisting of $3,877 relating to patents and $25,878 relating to Capital Assets (2021: $36,033 consisting of $8,000 relating to patents and $28,033 relating to Capital Assets).

g) Financing costs were $13,233 in 2022 versus $84,478 in 2021. These expenses relate to costs associated with the convertible debenture financings which the Company completed in 2022 and 2021; there were fewer such financings in 2022.

h) The gain on foreign exchange reported in 2022 was $176,477 versus a loss of $222,553 in 2021. This included the exchange relating to the translation of $CDN denominated transactions during the year and to Canadian denominated assets and liabilities at fiscal quarter and year ends. It also included the foreign exchange relating to the initiation, renewal, conversion, and repayment of convertible debentures transactions during the fiscal years. The Canadian dollar, relative to the US dollar was $0.7509 at October 31, 2019, $0.7596 at October 31, 2020, $0.7956 at October 31, 2021 and $0.7327 at October 31, 2022.

i) The other expenses reported relate to the convertible debentures. These expenses are all non-cash expenses and compare as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **Change** |
| &nbsp;&nbsp;Accretion expense | $1179603 | $1169921 | $9682 |
| &nbsp;&nbsp;Loss (gain) on conversion of convertible debentures | 94326 | (9506) | 103832 |
| &nbsp;&nbsp;Loss (gain) on revaluation of derivatives liabilities | (409607) | (2547192) | 2137585 |
| &nbsp;&nbsp;Loss (gain) on extinguishment/repayment of convertible debentures | 200650 | 1018928 | (818278) |
| &nbsp;&nbsp;Net expense | $1064972 | $(367849) | $1432821 |

---

------

**Fiscal 2021 Compared to Fiscal 2020**

a) Administration costs were $155,504 in 2021 versus $154,007 in 2020. These costs include rent and occupancy costs of $15,536 (2020: $37,153 - the Company reported sublet income for a portion of its office space in 2020 and 2019) office insurance costs of $753 (2020: $2,024); investor relations, listings and filing fees of $53,029 (2020: $49,537); other general and administrative expenses of $86,186 (2020: $49,702); and a loss on settlement of accounts payable of nil (2020: $15,591).

b) Professional and other fees and salaries costs were $424,485 versus $462,124 in 2020. The components of these total costs included legal and audit related expenses of $116,425 (2020: $148,926), third party consulting fees of $123,922 (2020: $138,123), and staff salaries and benefits of $184,138 (2020: $175,075).

Our CFO, Dan Amadori, has received $25,376 of cash compensation in 2021, nil in 2020. Our CEO, Joseph Fuda, has received $81,826 of cash compensation in 2021 which amount is reported in staff salaries and benefits; he received $17,517 in 2020.

The Board of Directors has awarded Messrs. Fuda and Amadori additional common stock options in November 2020 and again in October 2021 as additional consideration for services rendered to the Company - no option grants were made in 2020.

Travel and entertainment expenses were $24,903 in 2021 ($23,903 in 2020). There has been minimal corporate travel since March 2020 as a result of the COVID-19 pandemic.

There were 9,500,000 stock options awarded in 2021 and nil in 2020. The stock option expense in 2021, calculated using the Black Scholes option pricing model, was $360,044.

Interest expense was $495,809 in 2021 versus $441,369 in 2020. This represents the actual interest expense obligations incurred by the Company based on the stated interest rates on its convertible debenture notes.

Amortization expense was $36,033 in 2021 consisting of $8,000 relating to patents and $28,033 relating to capital assets ($35,838 in 2020 consisting of $8,123 relating to patents and $27,735 relating to capital assets).

Financing costs were $84,478 in 2021 versus $35,500 in 2020. These expenses relate to costs associated with the convertible debenture financings which the Company completed in 2021 and 2020.

The loss on foreign exchange reported in 2021 was $222,553 versus a loss of $1,447 in 2020. This included the exchange relating to the translation of $CDN denominated transactions during the year and to Canadian denominated assets and liabilities at fiscal quarter and year ends. It also included the foreign exchange relating to the initiation, renewal, conversion and repayment of convertible debenture transactions. The Canadian dollar has fluctuated from $0.7506 at October 31, 2020 to $0.7956 at October 31, 2021 relative to the US dollar.

The other expenses reported relate to the convertible debentures. These expenses are all non-cash expenses and compare as follows:

---

| |
|:---|
| &nbsp;&nbsp;Accretion expense |
| &nbsp;&nbsp;Loss (Gain) on conversion of debentures |
| &nbsp;&nbsp;Gain on revaluation of derivatives |
| &nbsp;&nbsp;Loss (Gain) on extinguishment of debentures |
| &nbsp;&nbsp;Net Expense |

---

------

**Unaudited Quarterly Financial Information**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Three months ended** | **Working capital** | **Capital assets at** |  |  | **Shareholders'** |
| **(unaudited)** | **(deficiency)** | **Net Book Value** | **Other Assets** | **Total Assets** | **equity (deficit)** |
|  | $| $| $| $| $|
| January 31, 2021 | (4694513) | 42364 | 9877 | 124318 | (4698923) |
| April 30, 2021 | (7214609) | 38170 | 7877 | 253940 | (7318323) |
| July 31, 2021 | (4876595) | 31283 | 5877 | 223528 | (4887324) |
| October 31, 2021 | (3452924) | 26012 | 3877 | 225293 | (3471278) |
| January 31, 2022 | (4371708) | 18816 | 1877 | 148789 | (4368574) |
| April 30, 2022 | (3939361) | 11630 |  | 93372 | (3790399) |
| July 31, 2022 | (5421607) | 4445 |  | 97504 | (5463523) |
| October 31, 2022 | (4722878) | 48092 |  | 99519 | (4748000) |

---

---

| | | |
|:---|:---|:---|
| **Three months ended** |  |  |
| **(unaudited)** | **Revenues** | **Loss per share** |
|  | $| $|
| January 31, 2021 |  |  |
| April 30, 2021 |  |  |
| July 31, 2021 |  |  |
| October 31, 2021 |  |  |
| January 31, 2022 |  |  |
| April 30, 2022 |  |  |
| July 31, 2022 |  |  |
| October 31, 2022 |  | 0.01 |

---

**B. Liquidity and Capital Resources:**

**Liquidity**

We have not yet realized commercial revenues from the exploitation of our technology platforms. We currently do not have positive cash flow from operations and will not realize positive cash flow until we license or directly produce and sell products utilizing our technology platforms.

We currently have no lines of credit available. We have relied on obtaining equity financing from investors through private placements, through the exercise of common stock options by officers and directors, and through bridge loans that the Company has secured in order to meet our cash flow needs until we can generate sustainable revenues. At October 31, 2022 we had a working capital deficiency of $4,722,878 (2021: $3,452,924) including cash on hand of $33,227 (2021: $171,397). Since October 31, 2022 we have raised an additional $143,000 of bridge loan financing and $36,635 of financing from private placements. We have granted to our directors, officers, other employees and consultants a number of options to purchase shares at prices that are at or above market price on the date of grant. None of the optionees has any obligation to exercise their options and there can be no guarantee that we will realize any funds from these options.

In 2023, we plan to continue to raise financing as required and we anticipate that we may report initial revenues from our development partners. In our opinion, despite the current working capital deficiency, in consideration of the future financing endeavours, business plan and existing cash resources, we expect the Company to have sufficient financial resources to fund the Company's planned operations through fiscal 2023.

We incurred $nil capital expenditures in 2022, $5,271 in 2021.

------

**C. Research and Development:**

Under IFRS, research costs are expensed in the period incurred. Development expenses are expensed as incurred unless they meet the criteria for deferral and amortization under IFRS, which criteria is the translation of research findings or other knowledge into a plan for the technology prior to commercial production or use.

**D. Trend Information:** 

The market applications for "smart" sensors are expanding; there are potential applications that could be utilized in virtually every industry vertical.

Our prospects for commercial revenues are dependent upon the successful completion of milestones in the development contracts that we have initiated to date and upon the customers deciding to proceed with commercial orders once these development contracts are successfully completed.

**Off-Balance Sheet Arrangements:** 

We are not party to any off-balance sheet arrangements. In addition, we have no unconsolidated special purpose financing or partnership entities.

**Tabular Disclosure of Contractual Obligations:** 

A summary of our financial commitments as of October 31, 2022 is as below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Payments due by period ($USD)** | **Payments due by period ($USD)** | **Payments due by period ($USD)** |  |
|  | **Total** | **Less than 1** <br>**year** | **1-5 years** | **More than 5<br>years** |
| **Operating lease obligations** | $50799 | $18706 | $32093 |  |
|  | **Payments due by period ($USD)** | **Payments due by period ($USD)** | **Payments due by period ($USD)** |  |
|  | **Total** | **Less than 30<br>days** | **31-90 days<br>past billing<br>date** | **Over 90 days<br>past billing<br>date** |
| **Trade payables** | $287575 | $287575 | $- | $- |
|  | **Payments due by period ($USD)** | **Payments due by period ($USD)** | **Payments due by period ($USD)** |  |
|  | **Total** | **Less than 3<br>months** | **Three to six<br>months** | **Six to twelve<br>months** |
| **Convertible debentures** | $3792064 | $- | $- | $- |
| **Derivative liability** | $641299 | $- | $- | $- |

---

------

**Critical Accounting Policies:** 

Our significant accounting policies are set forth in our consolidated financial statements, which should be read in conjunction with management's discussion of our critical accounting policies and estimates set forth below.

Our consolidated financial statements have been prepared in accordance with IFRS as issued by the IAASB.

We have not yet realized commercial revenues from the exploitation of our technology. Under IFRS, research costs are expensed in the period incurred. Development expenses are expensed as incurred unless they meet the criteria for deferral and amortization under IFRS which is the translation of research findings or other knowledge into a plan for the technology prior to commercial production or use. As at October 31, 2022, the Company capitalized nil of development costs and capitalized nil as intangible assets under IFRS.

Management is required to make estimates and assumptions which can affect the reported balances. In determining estimates of net recoverable amounts and net realizable values, or whether there has been a permanent impairment in value, we rely on assumptions regarding applicable industry performance and prospects, as well as general business and economic conditions that prevail and are expected to prevail. Assumptions underlying asset valuations are limited by the availability of reliable comparable data and the uncertainty of predictions concerning future events.

**Contingencies:** 

(1) We have agreed to indemnify our directors and officers and certain of our employees in accordance with our Bylaws. We maintain insurance policies that may provide coverage against certain claims.

(2) The Company may be subject to litigation, claims and governmental and regulatory proceedings arising in the ordinary course of business. In such cases, the Company would accrue a loss contingency for these matters when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated.

(3) **Legal matter: Litigation with Steven Van Fleet**

We have previously reported on the litigation matter, which commenced in 2018, relating to Mr. Van Fleet, the former President of MAST.

In 2021, the Supreme Court of the State of New York, County of Dutchess ultimately dismissed all of Mr. Van Fleet's claims, found that he was liable to Micromem and MAST on their counterclaims and ordered an inquest to determine damages. The inquest was held between June 3 - 7, 2021.

On June 16<sup>th</sup>, 2021, the court ordered that Micromem, and MAST had established damages of $765,579.35, the full amount that had been requested. Additionally, the court awarded costs and statutory prejudgement interest from May 9, 2017. On June 29<sup>th</sup>, 2021, the court entered a judgement ("Judgement") in favor of Micromem and MAST and against Mr. Van Fleet in the amount of $1,051,739.83.

With respect to the Company's efforts to collect on that Judgement, a settlement ("Settlement") was reached during October 2021. Pursuant to the Settlement, the Company received an initial one-time payment and is entitled to additional monthly payments over a period of up to six years. The Company will record those payments as and when they are received. The total amount to be received by the Company if Mr. Van Fleet makes all the required payments under the terms of the Settlement will be less than the amount of the Judgement obtained by the Company, but if Mr. Van Fleet does not comply with the terms of the Settlement, it also provides the Company a means of enforcing a larger judgement against Mr. Van Fleet that is substantially in line with the Judgement.

------

**Translation of Foreign Currencies:**

Our functional and reporting currency is the United States dollar. Accounts recorded in foreign currency have been converted to United States dollars as follows: Monetary assets and liabilities are translated at exchange rates at the consolidated balance sheet dates; non-monetary assets are translated using the historical rate of exchange in effect at the translation dates; revenues and expenses are translated using the three month average rate of exchange per quarter, which rate approximates the rate of exchange prevailing at the transaction dates; and gains and losses resulting from the translation are included in the determination of net loss for the period.

**ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES**

**A. Directors and Executive Officers**

The Directors and Executive Officers of Micromem as at February 21, 2022 are set forth below:

---

| | | |
|:---|:---|:---|
| Name | Age | Position |
| Joseph Fuda | 62 | President, Chief Executive Officer and Director |
| Dan Amadori | 71 | Chief Financial Officer |
| Oliver Nepomuceno | 55 | Director |
| Alex Dey | 79 | Director |

---

**Joseph Fuda** has been President, Chief Executive Officer and Director since February 13, 2002. Previously he served as Manager of Strategic Alliances for Micromem since February 2001. Prior thereto, he served as a consultant to Micromem since November 2000. Prior thereto he served as a Vice-President and a Director of IPO Capital Corp since April 1999. He was a director of Leader Capital Corp. until June 2007 and also served as a director of Echo Energy Canada Inc, and of Echo Power Generational Inc until June 2004.

**Dan Amadori** has served as Chief Financial Officer of Micromem since June 2004. From January 2018 to December 9, 2020, he served as a member of the Board of Directors and as Chair of the Audit Committee of Nerium Biotechnology Inc. He served as a Director and Chair of the Governance Committee of Invesque Inc. from 2015 through May 2019. He served as Chair of the Board of Kingsway Arms Retirement Residences Inc from August 2011 through May 2015 . Prior to 2010 he served as an officer - director of other public companies including HyDrive Technologies Inc., Luxell Technologies Inc., XGen Ventures Inc., Ontex Resources Ltd and Leader Capital Corp. He is President of Lamerac Financial Corp., a financial advisory firm, and has held that position since October 1988. Mr. Amadori is a Chartered Professional Accountant and holds an MBA from the Ivey School of Business. He received his ICD.D designation from the Rotman School of Business in 2010.

**Oliver Nepomuceno** has served as a director of Micromem since June 26, 2006. He is a resident of Switzerland and continues to serve as a financial advisor and is located in Switzerland. He actively assists corporations in the development of new business opportunities in new markets.

**Alex Dey** is a retired businessman and was elected as a director on September 24, 2010. He was the sole proprietor of Alex Dey, Chartered Accountants until July 31, 2004.

There are no arrangements or understandings between any director and any other person pursuant to which the director was selected as a director or executive officer. Each director holds office until the next annual meeting of shareholders or until his or her successor is elected or appointed, unless his or her office is earlier vacated according to the provisions of our By-laws or the *Business Corporations Act* (Ontario).

------

**B. Compensation**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Annual** |  |  | **Long-Term** |  |
|  | **Compensation** |  |  | **Compensation** |  |
|  |  |  |  | **Awards** |  |
|  | **Fiscal** | **Salary** | **Bonus** | **Other Annual** | **Securities** |
| &nbsp;&nbsp;Name and | **Year** | **(US$)** | **(US$)** | **Compensation** | **Under Options** |
| &nbsp;&nbsp;Principal Position |  |  |  | **(US$)** | **Granted (#)** |
| &nbsp;&nbsp;Joseph Fuda | 2020 | 17517 |  |  |  |
| &nbsp;&nbsp;Chief Executive Officer | 2021 | 81826 |  | 86420 | 1900000(1) |
|  | 2022 | 92902 |  |  |  |
| &nbsp;&nbsp;Dan Amadori | 2020 |  |  |  |  |
| &nbsp;&nbsp;Chief Financial Officer | 2021 | 25375 |  | 86420 | 1900000(1) |
|  | 2022 | 40615 |  |  |  |
| &nbsp;&nbsp;Oliver Nepomuceno | 2020 |  |  |  |  |
| &nbsp;&nbsp;Director | 2021 |  |  | 27330 | 600000(2) |
|  | 2021 |  |  |  |  |
| &nbsp;&nbsp;Alex Dey | 2020 |  |  |  |  |
| &nbsp;&nbsp;Director | 2021 |  |  | 27330 | 600000(2) |
|  | 2021 |  |  |  |  |

---

**Notes:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Includes 1,500,000 options issued on November 13, 2020 at a strike price of $0.05 per share and 400,000 options issued on October 8, 2021 at a strike price of $0.07 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Includes 500,000 options issued on November 13, 2020 at a strike price of $0.05 per share and 100,000 options issued on October 8, 2021 at a strike price of $0.07 per share.

Options are offered to directors, executive officers, and employees to purchase our common shares at an exercise price equal to or above the market price for the common shares at the date that the options are granted. These options are approved by the Compensation Committee. None of the directors have agreements that provide for benefits. No stock options were granted to directors or officers in 2022. In 2021 5,000,000 options were granted to directors and officers. The weighted average exercise price was $0.06 per share. No stock options were granted in 2020.

**C. Board Practices:** 

All matters pertaining to our financing, contractual arrangements and Management and Director compensation are approved by the Board of Directors. The members of the Board of Directors are appointed to a one-year term at our Annual General Meeting or until such time as the next Annual General Meeting is held.

Our Board of Directors meets on an as required basis during the fiscal year. Our Board of Directors did not meet in person in 2022. The Board was convened informally as of each quarter end.

Our Audit Committee met regularly during fiscal 2022 for the purpose of approving and recommending to the Board the quarterly financial statements and our yearend financial statements. In addition, our Audit Committee receives regular periodic reports from management.

------

Our Compensation Committee met as part of our audit committee meetings in 2022; it receives regular reports from management. Our Compensation Committee approves management and director compensation and all stock option grants for recommendation to the Board of Directors.

**Audit Committee** 

The Board of Directors has appointed an Audit Committee consisting of two independent directors. The members of the Audit Committee are Alex Dey (Chairman) and Oliver Nepomuceno, each of whom serves in such capacity until the Board of Directors' next annual meeting. The Audit Committee is responsible for the integrity of our internal accounting and control systems. The committee receives and reviews our financial statements and makes recommendations thereon to the Board of Directors prior to its approval by the full Board of Directors. The Audit Committee communicates directly with our external auditors in order to discuss audit and related matters whenever appropriate. The Audit Committee met formally in January, February, March, June, September, and October 2022.

**Compensation Committee**

The Board of Directors has appointed a Compensation Committee which meets on executive compensation matters as and when required. Our Compensation Committee includes Oliver Nepomuceno and Alex Dey as outside directors. The Compensation Committee did not meet separately in 2022 as both members also serve on the Audit Committee.

**Disclosure Committee**

The Board of Directors has appointed a Disclosure Committee whose primary responsibility is to ensure timely and accurate disclosure of all relevant information in accordance with the various securities regulations. Our Disclosure Committee includes Joseph Fuda, the Company's CEO, and Alex Dey, an outside director.

**D. Employees**

We have four employees, one of which serves in a management capacity and three of which serve in an administrative capacity. This includes Mr. Fuda, the Chief Executive Officer and President, and three support staff, all of whom work from our executive offices in Toronto, Canada. Additionally, we had two engineering students on staff temporarily employed full-time from May and June 2021 to August 31, 2022. Mr. Amadori, our CFO, provides services through his management company. All research and development is outsourced to third parties. We consider our relations with our employees to be satisfactory.

------

**E.** **Share Ownership**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**NAME** | **SHARES**<br>**OWNED** | **OPTIONS HELD** | **OPTION**<br>**EXERCISE**<br>**PRICE** | **EXPIRATION**<br>**DATE** | **% OF TOTAL** <sup>1</sup> |
| &nbsp;&nbsp;Joseph Fuda<br>Chief Executive<br>Officer and Director | 1824335 | 250000<br>1500000<br>400000 | $0.10<br>$0.05<br>$0.07 | 06/29/2023<br>11/13/2025<br>10/08/2026 | 0.85%<br>(3974335) |
| &nbsp;&nbsp;Dan Amadori<br>Chief Financial<br>Officer | 873857<sup>2</sup> <br>| 250000<br>1500000<br>400000 | $0.10<br>$0.05<br>$0.07 | 06/29/2023<br>11/13/2025<br>10/08/2026 | 0.65 %<br>(3023857) |
| &nbsp;&nbsp;Oliver Nepomuceno<br>Director | 1078572 <br>| 100000<br>500000<br>100000 | $0.10<br>$0.05<br>$0.07 | 06/29/2023<br>11/13/2025<br>10/08/2026 | 0.38%<br>(1778572) |
| &nbsp;&nbsp;Alex Dey<br>Director | 899795<sup>3</sup> | 100000<br>500000<br>100000 | $0.10<br>$0.05<br>$0.07 | 06/29/2023<br>11/13/2025<br>10/08/2026 | 0.34%<br>(1599795) |

---

---

| |
|:---|
| <sup>1</sup> Calculated based on shares owned plus options held as a percentage total of shares outstanding as of October 31, 2022, plus options held. |
| <sup>2</sup> 215,716 shares are held by a corporation controlled by Mr. Amadori. |
| <sup>3</sup> 254,863 shares are held by a corporation wholly owned by Mr. Dey. |

---

**F. Disclosure of a Registrant's Actions to Recover Erroneously Awarded Compensation.**

Not Applicable.

**ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS**

**A. Major Shareholders:** 

No shareholder holds greater than 5% of the common shares outstanding. As of the date of this Annual Report approximately 56% of the issued and outstanding common shares are held by Canadian investors; approximately 42% of the issued and outstanding shares are held by U.S. investors; and approximately 2% are held by investors outside of Canada and the U.S.

**B. Related Party Transactions:** 

The Company reports the following related party transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Management and consulting fees:

Included in professional fees, other fees and salaries as reported are management fees and consulting fees paid or payable to individuals (or Companies controlled by such individuals) who served as officers, directors, and employees of the Company. The total compensation paid to such parties is summarized as follows:

------

---

| | | | |
|:---|:---|:---|:---|
|  | 2022 | 2021 | 2020 |
| &nbsp;&nbsp;Cash Compensation | $133517 | $107201 | $17517 |
| &nbsp;&nbsp;Stock based compensation |  | 227500 |  |
|  | $133517 | $334701 | $17517 |

---

The cash compensation paid in 2022 included $40,615 to our CFO, Dan Amadori (2021: $25,736) and $92,902 to our CEO, Joseph Fuda (2021: $81,826). The cash compensation paid in 2020 was to our CEO. In 2020, Mr. Fuda and Mr. Amadori each elected to cancel 650,000 stock options previously awarded to them in August 2018.

**C. Interests of Experts and Counsel.**

Not applicable.

**ITEM 8. FINANCIAL INFORMATION**

**A. Consolidated Statements and Other Financial Information**

Our consolidated financial statements for the years ended October 31, 2022, 2021 and 2020 have been prepared in accordance with IFRS as issued by the IASB.

We have never paid a dividend on our securities. We do not anticipate paying dividends in the foreseeable future.

**B. Significant Changes**

Significant Changes since October 31, 2022 are as presented in Note 23 to the Company's Consolidated Financial Statements. See "Item 18 - Financial Statements".

**ITEM 9. THE OFFER AND LISTING**

Our common shares are traded in the United States and are quoted on the OTCQB. The common shares are quoted under the symbol MMTIF. Our common shares are traded in Canada on the CSE under the symbol MRM.

The table below sets forth the high and low sales prices for common shares in U.S. Dollars as quoted on the OTCBB for the periods specified. Our fiscal year end is October 31.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Period** | &nbsp;&nbsp;**High** | &nbsp;&nbsp;**Low** |
| &nbsp;&nbsp;**Last six months:** |  |  |
| &nbsp;&nbsp;January 2023 | &nbsp;&nbsp;0.05 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;December 2022 | &nbsp;&nbsp;0.05 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;November 2022 | &nbsp;&nbsp;0.05 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;October 2022 | &nbsp;&nbsp;0.05 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;September 2022 | &nbsp;&nbsp;0.04 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;August 2022 | &nbsp;&nbsp;0.06 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;**Last eight quarters:** |  |  |
| &nbsp;&nbsp;Q4 2022 | &nbsp;&nbsp;0.06 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;Q3 2022 | &nbsp;&nbsp;0.08 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;Q2 2022 | &nbsp;&nbsp;0.07 | &nbsp;&nbsp;0.04 |
| &nbsp;&nbsp;Q1 2022 | &nbsp;&nbsp;0.12 | &nbsp;&nbsp;0.04 |
| &nbsp;&nbsp;Q4 2021 | &nbsp;&nbsp;0.10 | &nbsp;&nbsp;0.05 |
| &nbsp;&nbsp;Q3 2021 | &nbsp;&nbsp;0.17 | &nbsp;&nbsp;0.07 |
| &nbsp;&nbsp;Q2 2021 | &nbsp;&nbsp;0.22 | &nbsp;&nbsp;0.05 |
| &nbsp;&nbsp;Q1 2021 | &nbsp;&nbsp;0.17 | &nbsp;&nbsp;0.02 |
| &nbsp;&nbsp;**Last five years:** |  |  |
| &nbsp;&nbsp;2022: | &nbsp;&nbsp;0.12 | &nbsp;&nbsp;0.03 |
| &nbsp;&nbsp;2021: | &nbsp;&nbsp;0.22 | &nbsp;&nbsp;0.04 |
| &nbsp;&nbsp;2020: | &nbsp;&nbsp;0.13 | &nbsp;&nbsp;0.01 |
| &nbsp;&nbsp;2019 | &nbsp;&nbsp;0.13 | &nbsp;&nbsp;0.01 |
| &nbsp;&nbsp;2018 | &nbsp;&nbsp;0.28 | &nbsp;&nbsp;0.02 |

---

------

On January 31, 2023, the last reported sale price for our common shares on the OTCQB was $0.03 per share.

**ITEM 10. ADDITIONAL INFORMATION**

**A. Share Capital** 

Our authorized capital consists of an unlimited number of common shares, of which 467,607,678 shares were issued and outstanding as of October 31, 2022, and 2,000,000 special, redeemable, voting preference shares, referred to herein as special shares, none of which were outstanding, as of October 31, 2022.

Additionally, the Company has 11,725,000 stock options outstanding with a weighted average exercise price of $0.06 per share (2021: 11,700,000 options outstanding with a weighted average exercise price of $0.06 per share).

**B. Memorandum and Articles of Incorporation**

**Articles of Incorporation**

**Incorporation Details and Objects of Micromem Technologies Inc.**

Micromem Technologies Inc. was incorporated under the laws of the Province of Ontario, Canada, on October 21, 1985 as Mine Lake Minerals Inc. We subsequently changed our name to Avanti Capital Corp. by filing Articles of Incorporation of Amendment on June 23, 1988 and to AvantiCorp International Inc. on April 30, 1992 before becoming Micromem Technologies Inc. on January 14, 1999. The Articles of Incorporation of Incorporation place no restrictions on the nature of the business to be carried on by Micromem.

**Summary of Directors Powers and Authorities**

The rights, duties, powers and authorities of our Board of Directors are set out in the Articles of Incorporation and By-laws and the statutory provisions of the *Business Corporations Act* (Ontario). The following is a selected summary of the Articles of Incorporation, By-laws and applicable provisions of the Business Corporations Act (Ontario) as they relate to selected rights, duties, powers and authorities of our Board of Directors.

The Articles of Incorporation provide for a minimum of three and a maximum of 12 directors. The Business Corporations Act (Ontario) prescribes that an offering corporation must have a minimum of three directors, at least twenty five percent (25%), or if they are less than 4, at least one of whom are Canadian residents and at least one third of whom are not officers or employees of us or our affiliates. The Board of Directors may, between annual shareholders meetings, appoint one or more additional directors to serve until the next annual shareholders meeting provided that the number of directors so added may not exceed by one-third (1/3) the number of directors required to have been elected at the last annual meeting of shareholders.

The Chairman of the Board of Directors or any one director may call a meeting upon the provision of forty-eight hours notice to each director in the manner prescribed in our By-laws. Any such notice shall include the items of business to be considered at the meeting. A majority of the directors constitute a quorum provided that half of those directors present are Canadian residents. Business cannot be transacted without a quorum. A quorum of directors may vote on any matter of business properly brought before the meeting provided that where a director is a party to a material contract or proposed material contract or has a material interest in the matter to be considered, such director must disclose his or her interest at the earliest possible date, request the conflict be noted in the minutes of the meeting, and with a few limited exceptions enumerated in the By-laws, refrain from voting on the matter in which the director has a material interest. There is no limitation on the Board of Directors to vote on matters of their remuneration provided such remuneration is disclosed in the financial statements and annual shareholder proxy materials.

------

The Board of Directors has broad borrowing powers and may, without authorization from the shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• borrow money on the credit of Micromem:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issue, re-issue, sell or pledge debt obligations of Micromem;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• subject to restrictions respecting financial assistance prescribed in the Business Corporations Act (Ontario), give a guarantee on behalf of Micromem to secure the performance of an obligation of any person; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• mortgage, hypothecate, pledge or otherwise create a security interest in all or any property of Micromem, owned or subsequently acquired, to secure any obligation of Micromem.

A person is qualified to be or stand for election as a director provided such person is at least 18 years of age, is not a bankrupt and is not found to be of unsound mind by a court in Canada or elsewhere. There is no requirement for a director to hold common shares.

**Securities of Micromem**

Holders of our common shares will be entitled to receive notice of, attend and vote at all meetings of the shareholders of Micromem. Each common share carries one vote at such meetings. In the event of the voluntary or involuntary liquidation, dissolution or winding-up of Micromem, after payment of all outstanding debts, the remaining assets of Micromem available for distribution will be distributed to the holders of our common shares. Dividends may be declared and paid on our common shares in such amounts and at such times as the directors shall determine in their discretion in accordance with the Business Corporations Act (Ontario). There are no pre-emptive rights, conversion rights, redemption provisions or sinking fund provisions attaching to the common shares. Common shares are not liable to further calls or to assessment by Micromem; provided, however, that pursuant to the provisions of the Business Corporations Act (Ontario), Micromem has a lien on any common share registered in the name of a shareholder or the shareholder's legal representative for a debt owed by the shareholder to Micromem.

Holders of special shares are entitled to receive notice of, attend and vote at all meetings of the shareholders of Micromem. Each special share carries one vote at such meetings. In the event of the voluntary or involuntary liquidation, dissolution or winding-up of Micromem, after payment of all outstanding debts, the holders of the special shares shall be entitled to receive, before any distribution of any part of the assets of Micromem among the holders of any other shares, the amount paid up on the special shares. The special shares are redeemable at the option of Micromem for the amount paid up on the shares. Dividends may not be declared or paid on the special shares and transfer of the Special Shares is restricted without the approval of the Directors of Micromem and the prior written consent of the Ontario Securities Commission. The number of special shares that may be issued and outstanding at any time is limited to 500,000. There are no pre-emptive rights, conversion rights or sinking fund provisions attaching to the special shares. Special shares are not liable to further calls or to assessment by Micromem; provided, however, that pursuant to the provisions of the Business Corporations Act (Ontario), Micromem has a lien on any special shares registered in the name of a shareholder or the shareholder's legal representative for a debt owed by the shareholder.

**Rights and Privileges of Shareholders**

Only the registered holders of our common shares and special preference shares on the record date are entitled to receive notice of and vote at annual and special meetings of shareholders. Where the items of business affect the rights of shareholders other than the holders of common shares, a special majority of two-thirds of the votes cast by the affected shareholders at the meeting called for such purpose is required to approve the item of business. Beneficial holders of common shares and special shares are also entitled to receive proxy materials in respect of meetings of shareholders in accordance with Canadian Securities Administrators National Instrument 54-101, provided that such proxies are limited in scope to instructing the registered shareholder (usually a brokerage house) on how to vote on behalf of the beneficial shareholder. There are no restrictions on the number of shares that may be held by non-residents other than restrictions set out in the *Investment Canada Act* (Canada). See "Additional Information - D. Exchange Controls".

------

There are no provisions in the By-laws regarding public disclosure of individual shareholdings. Notwithstanding this, applicable Canadian securities legislation requires certain public disclosure of persons owning or acquiring common shares in excess of 10% of a corporation's issued and outstanding share capital.

**C. Material Contracts**

None

**D. Exchange Controls**

As of the date hereof, we are not aware of any governmental laws, decrees or regulations in Canada that restrict the export or import of capital, including, but not limited to, foreign exchange controls, or that affect the remittance of dividends or other payments to nonresident holders of our common shares.

We are not aware of any limitations under the laws of Canada or the Province of Ontario, or in the Articles of Incorporation or any other of our constituent documents on the right of nonresidents of Canada or persons who are not Canadian citizens to hold and/or vote common shares.

**E. Taxation** 

**Certain Canadian Income Tax Consequences** 

This discussion under this heading summarizes the principal Canadian federal income tax consequences of acquiring, holding and disposing of common shares for a shareholder who is not a resident of Canada but is a resident of the United States and who will acquire and hold a common share as capital property for the purposes of the Income Tax Canada, also referred to as the Canadian Tax Act. This summary does not apply to a shareholder who carries on business in Canada through a permanent establishment situated in Canada or performs independent personal services in Canada through a fixed base in Canada if the shareholder is effectively connected with such permanent establishment or fixed base. This summary is based on the provisions of the Canadian Tax Act and the regulations there under and on an understanding of the administrative practices of Canada Customs & Revenue Agency, and takes into account all specific proposals to amend the Canadian Tax Act or regulations made by the Minister of Finance of Canada as of the date hereof. It has been assumed that there will be no other relevant amendments of any governing law although no assurance can be given in this respect. This discussion is general only and is not a substitute for independent advice from a shareholder's own Canadian and US tax advisors.

The provisions of the Canadian Tax Act are subject to income tax treaties to which Canada is a party, including the Canada-United States Income Tax Convention (1980), as amended.

Dividends on common shares and Other Income

Under the Canadian Tax Act, a non-resident of Canada is generally subject to Canadian withholding tax at the rate of 25 percent on dividends paid or deemed to have been paid to him or her by a corporation resident in Canada. We are responsible for the withholding of tax at the source. The Canada-United States Income Tax Convention (1980) limits the rate to 15 percent if the shareholder is a resident of the United States and the dividends are beneficially owned by and paid to such shareholder, and to 5 percent if the shareholder is also a corporation that beneficially owns at least 10 percent of the voting stock of the payor corporation.

The amount of a stock dividend (for tax purposes) would generally be equal to the amount of our paid up or stated capital and increased by reason of the payment of such dividend. We will furnish additional tax information to shareholders in the event of such a dividend. Interest paid or deemed to be paid on our debt securities held by non-Canadian residents may also be subject to Canadian withholding tax, depending upon the terms and provisions of such securities and any applicable tax treaty.

The Canada-United States Income Tax Convention (1980) generally exempts from Canadian income tax dividends paid to a religious, scientific, literary, educational, or charitable organization or to an organization constituted and operated exclusively to administer a pension, retirement or employee benefit fund or plan, if the organization is a resident of the United States and is exempt from income tax under the laws of the United States.

------

Dispositions of Common Shares

Under the Canadian Tax Act, a non-resident of Canada is subject to Canadian tax on taxable capital gains, and may deduct allowable capital losses, realized on a disposition of "taxable Canadian property". common shares will constitute taxable Canadian property of a shareholder at a particular time if the shareholder used the shares in carrying on business in Canada, or if at any time in the five years immediately preceding the disposition 25 percent or more of the issued shares of any class or series in the capital stock of Micromem belonged to one or more persons in a group comprising the shareholder and persons with whom the shareholder did not deal at "arm's length" and in certain other circumstances.

The Canada-United States Income Tax Convention (1980) relieves United States residents from liability for Canadian tax on capital gains derived on a disposition of shares unless:

the value of the shares is derived principally from "real property" in Canada, including the right to explore for or exploit natural resources and rights to amounts computed by reference to production, the shareholder was resident in Canada for 120 months during any period of 20 consecutive years preceding, and at any time during the 10 years immediately preceding, the disposition and the shares were owned by them when they ceased to be resident in Canada, or the shares formed part of the business property of a "permanent establishment" that the holder has or had in Canada within the 12 months preceding the disposition.

**Certain United States Federal Income Tax Consequences** 

The following is a general summary of certain U.S. federal income tax considerations applicable to a U.S. Holder (as defined below) arising from and relating to the acquisition, ownership and disposition of the common shares.

This summary is for general information purposes only and does not purport to be a complete analysis or listing of all potential U.S. federal income tax considerations that may apply to a U.S. Holder as a result of the acquisition, ownership and disposition of the common shares. In addition, this summary does not take into account the individual facts and circumstances of any particular U.S. Holder that may affect the U.S. federal income tax consequences to such U.S. Holder, including specific tax consequences to a U.S. Holder under an applicable tax treaty. Accordingly, this summary is not intended to be, and should not be construed as, legal or U.S. federal income tax advice with respect to any particular U.S. Holder. This summary does not address the U.S. federal net investment income, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local, and non-U.S. tax consequences to U.S. Holders of the acquisition, ownership, and disposition of common shares. In addition, except as specifically set forth below, this summary does not discuss applicable tax reporting requirements. Each U.S. Holder should consult its own tax advisor regarding the U.S. federal, U.S. federal net investment income, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local, and non-U.S. tax consequences relating to the acquisition, ownership and disposition of common shares.

No opinion from legal counsel or ruling from the Internal Revenue Service (the "IRS") has been requested, or will be obtained, regarding the U.S. federal income tax considerations applicable to U.S. Holders as discussed in this summary. This summary is not binding on the IRS, and the IRS is not precluded from taking a position that is different from, and contrary to, the positions taken in this summary. In addition, because the authorities on which this summary is based are subject to various interpretations, the IRS and the U.S. courts could disagree with one or more of the positions taken in this summary.

**Scope of this Summary**

Authorities

This summary is based on the Internal Revenue Code of 1986, as amended (the "Code"), Treasury Regulations (whether final, temporary, or proposed) promulgated under the Code, published rulings of the IRS, published administrative positions of the IRS, the Convention Between Canada and the United States of America with Respect to Taxes on Income and on Capital, signed September 26, 1980, as amended, and U.S. court decisions, that are in effect and available, as of the date of this document. Any of the authorities on which this summary is based could be changed in a material and adverse manner at any time, and any such change could be applied retroactively. This summary does not discuss the potential effects, whether adverse or beneficial, of any proposed legislation that, if enacted, could be applied on a retroactive or prospective basis.

------

U.S. Holders

For purposes of this summary, the term "U.S. Holder" means a beneficial owner of common shares that is for U.S. federal income tax purposes:

* a citizen or individual resident of the United States;

* a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) organized under the laws of the United States, any state thereof or the District of Columbia;

* an estate whose income is subject to U.S. federal income taxation regardless of its source; or

* a trust that (1) is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons for all substantial decisions or (2) has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person.

U.S. Holders Subject to Special U.S. Federal Income Tax Rules Not Addressed

This summary does not address the U.S. federal income tax considerations applicable to U.S. Holders that are subject to special provisions under the Code, including U.S. Holders that: (a) are tax-exempt organizations, qualified retirement plans, individual retirement accounts, or other tax-deferred accounts; (b) are financial institutions, underwriters, insurance companies, real estate investment trusts, or regulated investment companies; (c) are brokers or dealers in securities or currencies or are traders in securities that elect to apply a mark-to-market accounting method; (d) have a "functional currency" other than the U.S. dollar; (e) own common shares as part of a straddle, hedging transaction, conversion transaction, constructive sale, or other integrated transaction; (f) acquired common shares in connection with the exercise of employee stock options or otherwise as compensation for services; (g) hold common shares other than as a capital asset within the meaning of Section 1221 of the Code (generally, property held for investment purposes); (h) are subject to the alternative minimum tax; (i) are partnerships and other pass-through entities (and investors in such partnerships and entities); (j) are S corporations (and shareholders therein); (k) are subject to special tax accounting rules; (l) own, have owned or will own (directly, indirectly, or by attribution) 10% or more of the total combined voting power or value of our outstanding shares; (m) are U.S. expatriates or former long-term residents of the U.S.; or (n) hold common shares in connection with a trade or business, permanent establishment, or fixed base outside the United States or are otherwise subject to taxing jurisdictions other than, or in addition to, the United States. U.S. Holders that are subject to special provisions under the Code, including U.S. Holders described immediately above, should consult their own tax advisors regarding the U.S. federal, U.S. federal net investment income, U.S. federal alternative minimum, U.S. federal estate and gift, U.S. state and local, and non-U.S. tax consequences relating to the acquisition, ownership and disposition of common shares.

If an entity or arrangement that is classified as a partnership (or other pass-through entity) for U.S. federal income tax purposes holds common shares, the U.S. federal income tax consequences to such entity or arrangement and the owners of such entity or arrangement generally will depend on the activities of such entity or arrangement and the status of such partners (or other owners). This summary does not address the tax consequences to any such entity or arrangement or partner (or other owner). Partners (or other owners) of entities or arrangements that are classified as partnerships for U.S. federal income tax purposes should consult their own tax advisor regarding the U.S. federal income tax consequences arising from and relating to the acquisition, ownership, and disposition of common shares.

**Passive Foreign Investment Company Rules**

If we are considered a "passive foreign investment company" within the meaning of Section 1297 of the Code (a "PFIC") at any time during a U.S. Holder's holding period, the following sections will generally describe the potentially adverse U.S. federal income tax consequences to U.S. Holders of the acquisition, ownership, and disposition of common shares.

------

We believe that we were classified as a PFIC for our most recently completed tax year, and based on current business plans and financial expectations, we expect that we may be a PFIC for our current tax year and subsequent tax years. No opinion of legal counsel or ruling from the IRS concerning our status as a PFIC has been obtained or is currently planned to be requested. The determination of whether any corporation was, or will be, a PFIC for a tax year depends, in part, on the application of complex U.S. federal income tax rules, which are subject to differing interpretations. In addition, whether any corporation will be a PFIC for any tax year depends on the assets and income of such corporation over the course of each such tax year and, as a result, our PFIC status for the current year and future years cannot be predicted with certainty as of the date of this document. Accordingly, there can be no assurance that the IRS will not challenge any PFIC determination made by us. Each U.S. Holder should consult its own tax advisor regarding our status as a PFIC and the PFIC status of each of our non-U.S. subsidiaries.

In any year in which we are classified as a PFIC, a U.S. Holder will be required to file an annual report with the IRS containing such information as Treasury Regulations and/or other IRS guidance may require. In addition to penalties, a failure to satisfy such reporting requirements may result in an extension of the time period during which the IRS can assess a tax. U.S. Holders should consult their own tax advisors regarding the requirements of filing such information returns under these rules, including the requirement to file an IRS Form 8621 annually.

We generally will be a PFIC for any tax year in which (a) 75% or more of our gross income for such tax year is passive income (the "PFIC income test") or (b) 50% or more of the value of our assets either produce passive income or are held for the production of passive income, based on the quarterly average of the fair market value of such assets (the "PFIC asset test"). "Gross income" generally includes sales revenues less the cost of goods sold, plus income from investments and from incidental or outside operations or sources, and "passive income" generally includes, for example, dividends, interest, certain rents and royalties, certain gains from the sale of stock and securities, and certain gains from commodities transactions.

For purposes of the PFIC income test and PFIC asset test described above, if we own, directly or indirectly, 25% or more of the total value of the outstanding shares of another corporation, we will be treated as if it (a) held a proportionate share of the assets of such other corporation and (b) received directly a proportionate share of the income of such other corporation. In addition, for purposes of the PFIC income test and PFIC asset test described above, "passive income" does not include any interest, dividends, rents, or royalties that are received or accrued by us from a "related person" (as defined in Section 954(d)(3) of the Code), to the extent such items are properly allocable to the income of such related person that is not passive income.

Under certain attribution rules, if we are a PFIC, U.S. Holders will be deemed to own their proportionate share of any of our subsidiaries which are also PFICs (each, a "Subsidiary PFIC"), and will generally be subject to U.S. federal income tax as discussed below under the heading "*Default PFIC Rules Under Section 1291 of the Code*" discussed below on their proportionate share of any (i) distribution on the shares of a Subsidiary PFIC and (ii) disposition or deemed disposition of shares of a Subsidiary PFIC, both as if such U.S. Holders directly held the shares of such Subsidiary PFIC. Accordingly, U.S. Holders should be aware that they could be subject to tax under the PFIC rules even if no distributions are received and no redemptions or other dispositions of common shares are made. In addition, U.S. Holders may be subject to U.S. federal income tax on any indirect gain realized on the stock of a Subsidiary PFIC on the sale or disposition of common shares.

Default PFIC Rules Under Section 1291 of the Code

If we are a PFIC, the U.S. federal income tax consequences to a U.S. Holder of the purchase of common shares and the acquisition, ownership, and disposition of common shares will depend on whether such U.S. Holder makes a "qualified electing fund" or "QEF" election under Section 1295 of the Code (a "QEF Election") or makes a mark-to-market election under Section 1296 of the Code (a "Mark-to-Market Election") with respect to the common shares. A U.S. Holder that does not make either a QEF Election or a Mark-to-Market Election (a "Non-Electing U.S. Holder") will be subject to tax as described below.

A Non-Electing U.S. Holder will be subject to the rules of Section 1291 of the Code with respect to (a) any gain recognized on the sale or other taxable disposition of common shares and (b) any excess distribution received on the common shares. A distribution generally will be an "excess distribution" to the extent that such distribution (together with all other distributions received in the current tax year) exceeds 125% of the average distributions received during the three preceding tax years (or during a U.S. Holder's holding period for the common shares, if shorter).

------

Under Section 1291 of the Code, any gain recognized on the sale or other taxable disposition of common shares of a PFIC (including an indirect disposition of shares of a Subsidiary PFIC), and any excess distribution received on such common shares (or a distribution by a Subsidiary PFIC to its shareholder that is deemed to be received by a U.S. Holder) must be ratably allocated to each day in a Non-Electing U.S. Holder's holding period for the common shares. The amount of any such gain or excess distribution allocated to the tax year of disposition or distribution of the excess distribution and to years before the entity became a PFIC, if any, would be taxed as ordinary income (and not eligible for certain preferential tax rates, as discussed below). The amounts allocated to any other tax year would be subject to U.S. federal income tax at the highest tax rate applicable to ordinary income in each such year, and an interest charge would be imposed on the tax liability for each such year, calculated as if such tax liability had been due in each such year. A Non-Electing U.S. Holder that is not a corporation must treat any such interest paid as "personal interest," which is not deductible.

If we are a PFIC for any tax year during which a Non-Electing U.S. Holder holds common shares, we will continue to be treated as a PFIC with respect to such Non-Electing U.S. Holder, regardless of whether we cease to be a PFIC in one or more subsequent tax years. If we cease to be a PFIC, a Non-Electing U.S. Holder may terminate this deemed PFIC status with respect to common shares by electing to recognize gain (which will be taxed under the rules of Section 1291 of the Code as discussed above) as if such common shares were sold on the last day of the last tax year for which we were a PFIC.

QEF Election

A U.S. Holder that makes a QEF Election for the first tax year in which its holding period of its common shares begins generally will not be subject to the rules of Section 1291 of the Code discussed above with respect to its common shares. However, a U.S. Holder that makes a QEF Election will be subject to U.S. federal income tax on such U.S. Holder's pro rata share of (a) our net capital gain, which will be taxed as long-term capital gain to such U.S. Holder, and (b) our ordinary earnings, which will be taxed as ordinary income to such U.S. Holder. Generally, "net capital gain" is the excess of (a) net long-term capital gain over (b) net short-term capital loss, and "ordinary earnings" are the excess of (a) "earnings and profits" over (b) net capital gain. A U.S. Holder that makes a QEF Election will be subject to U.S. federal income tax on such amounts for each tax year in which we are a PFIC, regardless of whether such amounts are actually distributed to such U.S. Holder by us. However, for any tax year in which we are a PFIC and have no net income or gain, U.S. Holders that have made a QEF Election would not have any income inclusions as a result of the QEF Election. If a U.S. Holder that made a QEF Election has an income inclusion, such a U.S. Holder may, subject to certain limitations, elect to defer payment of current U.S. federal income tax on such amounts, subject to an interest charge. If such U.S. Holder is not a corporation, any such interest paid will be treated as "personal interest," which is not deductible.

A U.S. Holder that makes a timely and effective QEF Election generally (a) may receive a tax-free distribution from us to the extent that such distribution represents "earnings and profits" that were previously included in income by the U.S. Holder because of such QEF Election and (b) will adjust such U.S. Holder's tax basis in the common shares to reflect the amount included in income or allowed as a tax-free distribution because of such QEF Election. In addition, a U.S. Holder that makes a QEF Election generally will recognize capital gain or loss on the sale or other taxable disposition of common shares.

The procedure for making a QEF Election, and the U.S. federal income tax consequences of making a QEF Election, will depend on whether such QEF Election is timely. A QEF Election will be treated as "timely" for purposes of avoiding the default PFIC rules discussed above if such QEF Election is made for the first year in the U.S. Holder's holding period for the common shares in which we were a PFIC. A U.S. Holder may make a timely QEF Election by filing the appropriate QEF Election documents at the time such U.S. Holder files a U.S. federal income tax return for such year. If a U.S. Holder owns PFIC stock indirectly through another PFIC, separate QEF Elections must be made for the PFIC in which the U.S. Holder is a direct shareholder and the Subsidiary PFIC for the QEF rules to apply to both PFICs.

------

A QEF Election will apply to the tax year for which such QEF Election is made and to all subsequent tax years, unless such QEF Election is invalidated or terminated or the IRS consents to revocation of such QEF Election. If a U.S. Holder makes a QEF Election and, in a subsequent tax year, we cease to be a PFIC, the QEF Election will remain in effect (although it will not be applicable) during those tax years in which we were not a PFIC. Accordingly, if we become a PFIC in another subsequent tax year, the QEF Election will be effective and the U.S. Holder will be subject to the QEF rules described above during any subsequent tax year in which we qualify as a PFIC.

U.S. Holders should be aware that there can be no assurances that we will satisfy the record keeping requirements that apply to a QEF, or that we will supply U.S. Holders with a PFIC Annual Information Statement or other information that such U.S. Holders are required to report under the QEF rules, in the event that we are a PFIC. Thus, U.S. Holders may not be able to make a QEF Election with respect to their common shares. Each U.S. Holder should consult its own tax advisors regarding the availability of, and procedure for making, a QEF Election.

A U.S. Holder makes a QEF Election by attaching a completed IRS Form 8621, including a PFIC Annual Information Statement, to a timely filed U.S. federal income tax return. However, if we do not provide the required information with regard to us or any Subsidiary PFICs, U.S. Holders will not be able to make a QEF Election for such entity and will continue to be subject to the rules of Section 1291 of the Code discussed above that apply to Non-Electing U.S. Holders with respect to the taxation of gains and excess distributions.

Mark-to-Market Election

A U.S. Holder may make a Mark-to-Market Election with respect to common shares only if the common shares are marketable stock. The common shares generally will be "marketable stock" if the common shares are regularly traded on (a) a national securities exchange that is registered with the SEC, (b) the national market system established pursuant to Section 11A of the U.S. Exchange Act or (c) a foreign securities exchange that is regulated or supervised by a governmental authority of the country in which the market is located, provided that (i) such foreign exchange has trading volume, listing, financial disclosure, and other requirements and the laws of the country in which such foreign exchange is located, together with the rules of such foreign exchange, ensure that such requirements are actually enforced and (ii) the rules of such foreign exchange ensure active trading of listed stocks. If such stock is traded on such a qualified exchange or other market, such stock generally will be considered "regularly traded" for any calendar year during which such stock is traded, other than in *de minimis* quantities, on at least 15 days during each calendar quarter. U.S. Holders should consult their own tax advisors regarding the marketable stock rules.

A U.S. Holder that makes a Mark-to-Market Election with respect to its common shares generally will not be subject to the rules of Section 1291 of the Code discussed above with respect to such common shares. However, if a U.S. Holder does not make a Mark-to-Market Election beginning in the first tax year of such U.S. Holder's holding period for the common shares and such U.S. Holder has not made a timely QEF Election, the rules of Section 1291 of the Code discussed above will apply to certain dispositions of, and distributions on, the common shares.

A U.S. Holder that makes a timely and effective Mark-to-Market Election will include in ordinary income, for each tax year in which we are a PFIC, an amount equal to the excess, if any, of (a) the fair market value of the common shares, as of the close of such tax year over (b) such U.S. Holder's tax basis in the common shares. A U.S. Holder that makes a Mark-to-Market Election will be allowed a deduction in an amount equal to the excess, if any, of (i) such U.S. Holder's adjusted tax basis in the common shares, over (ii) the fair market value of such common shares (but only to the extent of the net amount of previously included income as a result of the Mark-to-Market Election for prior tax years).

A U.S. Holder that makes a timely and effective Mark-to-Market Election generally also will adjust such U.S. Holder's tax basis in the common shares to reflect the amount included in gross income or allowed as a deduction because of such Mark-to-Market Election. In addition, upon a sale or other taxable disposition of common shares, a U.S. Holder that makes a Mark-to-Market Election will recognize ordinary income or ordinary loss (not to exceed the excess, if any, of (a) the amount included in ordinary income because of such Mark-to-Market Election for prior tax years over (b) the amount allowed as a deduction because of such Mark-to-Market Election for prior tax years).

A U.S. Holder makes a Mark-to-Market Election by attaching a completed IRS Form 8621 to a timely filed U.S. federal income tax return. A timely Mark-to-Market Election applies to the tax year in which such Mark-to-Market Election is made and to each subsequent tax year, unless the common shares cease to be "marketable stock" or the IRS consents to revocation of such election. Each U.S. Holder should consult its own tax advisor regarding the availability of, and procedure for making, a Mark-to-Market Election.

------

Although a U.S. Holder may be eligible to make a Mark-to-Market Election with respect to the common shares, no such election may be made with respect to the stock of any Subsidiary PFIC that a U.S. Holder is treated as owning because such stock is not marketable. Hence, the Mark-to-Market Election will not be effective to eliminate the interest charge and other income inclusion rules described above with respect to deemed dispositions of Subsidiary PFIC stock or distributions from a Subsidiary PFIC to its shareholder.

Other PFIC Rules

Under Section 1291(f) of the Code, the IRS has issued proposed Treasury Regulations that, subject to certain exceptions, would cause a U.S. Holder that had not made a timely QEF Election to recognize gain (but not loss) upon certain transfers of common shares that would otherwise be tax-deferred (e.g., gifts and exchanges pursuant to corporate reorganizations). However, the specific U.S. federal income tax consequences to a U.S. Holder may vary based on the manner in which common shares are transferred.

If finalized in their current form, the proposed Treasury Regulations applicable to PFICs would be effective for transactions occurring on or after April 1, 1992. Because the proposed Treasury Regulations have not yet been adopted in final form, they are not currently effective, and there is no assurance that they will be adopted in the form and with the effective date proposed. Nevertheless, the IRS has announced that, in the absence of final Treasury Regulations, taxpayers may apply reasonable interpretations of the Code provisions applicable to PFICs and that it considers the rules set forth in the proposed Treasury Regulations to be reasonable interpretations of those Code provisions. The PFIC rules are complex, and the implementation of certain aspects of the PFIC rules requires the issuance of Treasury Regulations which in many instances have not been promulgated and which, when promulgated, may have retroactive effect. U.S. Holders should consult their own tax advisors about the potential applicability of the proposed Treasury Regulations.

Certain additional adverse rules will apply with respect to a U.S. Holder if we are a PFIC, regardless of whether such U.S. Holder makes a QEF Election. For example under Section 1298(b)(6) of the Code, a U.S. Holder that uses common shares as security for a loan will, except as may be provided in Treasury Regulations, be treated as having made a taxable disposition of such common shares.

In addition, a U.S. Holder who acquires common shares from a decedent will not receive a "step up" in tax basis of such common shares to fair market value.

Special rules also apply to the amount of foreign tax credit that a U.S. Holder may claim on a distribution from a PFIC. Subject to such special rules, foreign taxes paid with respect to any distribution in respect of stock in a PFIC are generally eligible for the foreign tax credit. The rules relating to distributions by a PFIC and their eligibility for the foreign tax credit are complicated, and a U.S. Holder should consult with their own tax advisor regarding the availability of the foreign tax credit with respect to distributions by a PFIC.

The PFIC rules are complex, and each U.S. Holder should consult its own tax advisor regarding the PFIC rules (including the applicability and advisability of a QEF Election and Mark-to-Market Election) and how the PFIC rules may affect the U.S. federal income tax consequences of the acquisition, ownership, and disposition of common shares.

**General Rules Applicable to the Acquisition, Ownership, and Disposition of Common Shares**

The following discussion describes the general rules applicable to the ownership and disposition of the common shares but is subject in its entirety to the special rules described above under the heading "*Passive Foreign Investment Company Rules*."

Distributions on Common Shares

We do not anticipate paying dividends with respect to the common shares in the foreseeable future. A U.S. Holder that receives a distribution, including a constructive distribution, with respect to a common share will be required to include the amount of such distribution in gross income as a dividend (without reduction for any Canadian income tax withheld from such distribution) to the extent of our current and accumulated "earnings and profits", as computed under U.S. federal income tax principles. A dividend generally will be taxed to a U.S. Holder at ordinary income tax rates we are a PFIC for the tax year of such distribution or the preceding tax year. To the extent that a distribution exceeds our current and accumulated "earnings and profits", such distribution will be treated first as a tax-free return of capital to the extent of a U.S. Holder's tax basis in the common shares and thereafter as gain from the sale or exchange of such common shares (see "*Sale or Other Taxable Disposition of Common Shares*" below). However, we may not maintain the calculations of earnings and profits in accordance with U.S. federal income tax principles, and each U.S. Holder may be required to assume that any distribution by us with respect to the common shares will constitute ordinary dividend income. Dividends received on common shares generally will not be eligible for the "dividends received deduction" generally applicable to corporations. Subject to applicable limitations and provided we are eligible for the benefits of the Convention Between Canada and the United States of America with Respect to Taxes on Income and on Capital, signed September 26, 1980, as amended, or the common shares are readily tradable on a United States securities market, dividends paid by us to non-corporate U.S. Holders, including individuals, generally will be eligible for the preferential tax rates applicable to long-term capital gains for dividends, provided certain holding period and other conditions are satisfied, including that we not be classified as a PFIC in the tax year of distribution or in the preceding tax year. The dividend rules are complex, and each U.S. Holder should consult its own tax advisor regarding the application of such rules.

------

Sale or Other Taxable Disposition of common shares

Upon the sale or other taxable disposition of common shares, a U.S. Holder generally will recognize capital gain or loss in an amount equal to the difference between (a) the amount of cash plus the fair market value of any property received and (b) such U.S. Holder's tax basis in such common shares sold or otherwise disposed of. Gain or loss recognized on such sale or other taxable disposition generally will be long-term capital gain or loss if, at the time of the sale or other taxable disposition, the common shares have been held for more than one year. Preferential tax rates may apply to long-term capital gain of a U.S. Holder that is an individual, estate, or trust. There are no preferential tax rates for long-term capital gain of a U.S. Holder that is a corporation. Deductions for capital losses are subject to significant limitations under the Code.

**Additional Tax Considerations**

Receipt of Foreign Currency

The amount of any distribution paid to a U.S. Holder in foreign currency or on the sale, exchange or other taxable disposition of common shares generally will be equal to the U.S. dollar value of such foreign currency based on the exchange rate applicable on the date of receipt (regardless of whether such foreign currency is converted into U.S. dollars at that time). If the foreign currency received is not converted into U.S. dollars on the date of receipt, a U.S. Holder will have a tax basis in the foreign currency equal to its U.S. dollar value on the date of receipt. Any U.S. Holder who receives payment in foreign currency and engages in a subsequent conversion or other disposition of the foreign currency may have a foreign currency exchange gain or loss that would be treated as ordinary income or loss, and generally will be U.S. source income or loss for foreign tax credit purposes. Different rules apply to U.S. Holders who use the accrual method of tax accounting. Each U.S. Holder should consult its own U.S. tax advisor regarding the U.S. federal income tax consequences of receiving, owning, and disposing of foreign currency.

Foreign Tax Credit

Dividends paid on the common shares will be treated as foreign-source income, and generally will be treated as "passive category income" or "general category income" for U.S. foreign tax credit purposes. The Code applies various complex limitations on the amount of foreign taxes that may be claimed as a credit by U.S. taxpayers. In addition, Treasury Regulations that apply to taxes paid or accrued (the "**Foreign Tax Credit Regulations**") impose additional requirements for Canadian withholding taxes to be eligible for a foreign tax credit, and there can be no assurance that those requirements will be satisfied.

Subject to the PFIC rules and the Foreign Tax Credit Regulations discussed above, a U.S. Holder that pays (whether directly or through withholding) Canadian income tax with respect to dividends paid on the common shares generally will be entitled, at the election of such U.S. Holder, to receive either a deduction or a credit for such Canadian income tax paid. Generally, a credit will reduce a U.S. Holder's U.S. federal income tax liability on a dollar-for-dollar basis, whereas a deduction will reduce a U.S. Holder's income subject to U.S. federal income tax. This election is made on a year-by-year basis and applies to all foreign taxes paid or accrued (whether directly or through withholding) by a U.S. Holder during a year. The foreign tax credit rules are complex and involve the application of rules that depend on a U.S. Holder's particular circumstances. Accordingly, each U.S. Holder should consult its own tax advisor regarding the foreign tax credit rules.

------

Information Reporting; Backup Withholding Tax

Under U.S. federal income tax laws certain categories of U.S. Holders must file information returns with respect to their investment in, or involvement in, a foreign corporation. For example, U.S. return disclosure obligations (and related penalties) are imposed on U.S. Holders that hold certain specified foreign financial assets in excess of certain threshold amounts. The definition of specified foreign financial assets includes not only financial accounts maintained in foreign financial institutions, but also, unless held in accounts maintained by a financial institution, any stock or security issued by a non-U.S. person. U. S. Holders may be subject to these reporting requirements unless their common shares are held in an account at certain financial institutions. Penalties for failure to file certain of these information returns are substantial. U.S. Holders should consult their own tax advisors regarding the requirements of filing information returns, including the requirement to file IRS Form 8938.

Payments made within the U.S., or by a U.S. payor or U.S. middleman, of dividends on, and proceeds arising from the sale or other taxable disposition of the common shares generally may be subject to information reporting and backup withholding tax, currently at the rate of 24%, if a U.S. Holder (a) fails to furnish its correct U.S. taxpayer identification number (generally on Form W-9), (b) furnishes an incorrect U.S. taxpayer identification number, (c) is notified by the IRS that such U.S. Holder has previously failed to properly report items subject to backup withholding tax, or (d) fails to certify, under penalty of perjury, that it has furnished its correct U.S. taxpayer identification number and that the IRS has not notified such U.S. Holder that it is subject to backup withholding tax. However, certain exempt persons, such as U.S. Holders that are corporations, generally are excluded from these information reporting and backup withholding tax rules. Any amounts withheld under the U.S. backup withholding tax rules will be allowed as a credit against a U.S. Holder's U.S. federal income tax liability, if any, or will be refunded, if such U.S. Holder furnishes required information to the IRS in a timely manner.

The discussion of reporting requirements set forth above is not intended to constitute a complete description of all reporting requirements that may apply to a U.S. Holder. A failure to satisfy certain reporting requirements may result in an extension of the time period during which the IRS can assess a tax and, under certain circumstances, such an extension may apply to assessments of amounts unrelated to any unsatisfied reporting requirement. Each U.S. Holder should consult its own tax advisors regarding the information reporting and backup withholding rules.

**THE ABOVE SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSIDERATIONS APPLICABLE TO U.S. HOLDERS WITH RESPECT TO THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF COMMON SHARES. U.S. HOLDERS SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO THE TAX CONSIDERATIONS APPLICABLE TO THEM IN THEIR OWN PARTICULAR CIRCUMSTANCES.**

**F. Dividends and Paying Agents** 

Not applicable.

**G. Statement by Experts** 

Not applicable.

**H. Documents on Display** 

We have filed the documents referred to herein and other information with the SEC, the Ontario Securities Commission and the Alberta Securities Commission. You may inspect and copy such material at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of such material from the SEC at prescribed rates by writing to the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference rooms.

------

The SEC maintains an Internet website at www.sec.gov that contains reports, proxy statements, information statements and other material that are filed through the SEC's Electronic Data Gathering, Analysis and Retrieval ("EDGAR") system. Documents filed with the Ontario Securities Commission and the Alberta Securities Commission can be accessed through an Internet website at www.sedar.com that contains reports, proxy statements, information statements and other material that are filed through the System for Electronic Document Analysis and Retrieval ("SEDAR").

Additional information is also available on our website at www.micromeminc.com. Such information on our website is not part of this Form 20-F.

**I. Subsidiary Information**

Not Applicable.

**J. Annual Report to Security Holders**

Not Applicable.

**ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in interest rates and foreign currency exchange rates. We do not hold or issue financial instruments for trading purposes. See Note 20 to our consolidated financial statements for our quantitative and qualitative disclosures about market risk.

**ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES** 

Not Applicable.

**PART II** 

**ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES**

None.

**ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS**

None.

**ITEM 15. CONTROLS AND PROCEDURES**

<u>Disclosure Controls and Procedures</u>

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of October 31, 2022. Based on management's evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of October 31, 2022, our disclosure controls and procedures were effective in that they were designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in our reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Exchange Act Rule 13a-15(e) also states that disclosure controls and procedures are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

------

Management's Annual Report on Internal Control over Financial Reporting

Micromem's Board of Directors and executive management are responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of its published consolidated financial statements.

All internal control systems no matter how well designed have inherent limitations. Therefore, even those systems determined to be effective may not prevent or detect misstatements and can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our Chief Executive Officer and Chief Financial Officer assessed the effectiveness of Micromem's internal control over financial reporting as of October 31, 2022. In making this assessment, they used the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment the Chief Executive Officer and Chief Financial Officer have concluded that, as of October 31, 2022 our internal control over financial reporting were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of 17 CFR 240.13a-15 or 240.15d-15 that occurred during the period covered by this Annual Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**ITEM 16. [Reserved]**

Not applicable.

**ITEM 16A**. **Audit Committee Financial Expert**

Our Board of Directors has determined that a member of the Board of Directors, Alex Dey, is an audit committee financial expert and that he is independent, as defined in the Marketplace Rules of the Nasdaq Stock Market.

**ITEM 16B**. **Code of Ethics**

We have adopted a Code of Ethics to impose certain policies relating to ethical conduct on all of our Directors and employees, including our Chief Executive Officer, Chief Financial Officer, principal accounting officer and persons performing similar functions. We undertake to provide a copy of our Code of Ethics to any holder of our securities upon request, without charge.

**ITEM 16C. Principal Accountant Fees and Services**

The following table presents fees for professional audit services rendered by our auditors for the audit of our consolidated financial statements for the years ended October 31, 2022 and 2021, and fees billed for other services rendered by our auditors including our offerings of securities and tax services.

------

---

| | | |
|:---|:---|:---|
|  | **Fiscal 2022** | **Fiscal 2021** |
| Audit Fees | $80000 | $70000 |
| Audit Related Fees | $- |  |
| Tax Fees | $5000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4000 |
| All Other Fees |  |  |

---

Audit Fees

In 2022 we incurred $80,000 and in 2021 we incurred $70,000, in audit fees to MNP LLP.

Audit Related Fees

In 2022 we paid $nil in audit-related fees.

Tax Fees

We paid $5,000 in 2022 and $4,000 in 2021, of tax-related fees for services to Chiampou Travis LLP.

All Other Fees

None

Pre-approval policies

The Audit Committee assesses and pre-approves all audit and non-audit services.

**ITEM 16D. Exemptions from the Listing Standards for Audit Committees**

Not applicable.

**ITEM 16E. Purchases of Equity by the Issuer and Affiliated Purchasers.**

None.

**ITEM 16F. Change in Registrants Certifying Accountant.** 

Not Applicable.

**ITEM 16G. Corporate Governance** 

Not applicable.

**ITEM 16H. Mine Safety Disclosure** 

Not applicable.

**ITEM 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections** 

Not applicable.

------

**PART III**

**ITEM 17. Financial Statements**

See Item 18.

**ITEM 18. Financial Statements** 

The Consolidated Financial Statements and schedules appear on pages F-2 through F-23 of this Annual Report and are incorporated herein by reference. Our audited financial statements as prepared by our management and approved by the Board of Directors include:

Report of Independent Registered Public Accounting Firm (PCAOB ID: 1930)

Consolidated Financial Statements:

Consolidated Statements of Financial Position

Consolidated Statements of Operations and Comprehensive Income (Loss)

Consolidated Statements of Changes in Equity

Consolidated Statements of Cash Flows

Notes to the Consolidated Financial Statements

All the above statements are available on the Company's website at www.micromeminc.com or under the Company's profile on SEDAR at www.sedar.com.

------

![](form20fxz001.jpg)

**Micromem Technologies Inc.**

**Consolidated Financial Statements**

**For the years ended October 31, 2022 and 2021**

(Expressed in United States Dollars)

------

**Micromem Technologies Inc.**

**Consolidated Financial Statements**

**For the years ended October 31, 2022 and 2021**

(Expressed in United States Dollars)

**Contents**

---

| | |
|:---|:---|
| [Report of Independent Registered Public Accounting Firm](#page3_integixAnchor)(PCAOB ID: 1930) | [1](#page3_integixAnchor) |
| Consolidated Financial Statements: |  |
| &nbsp;&nbsp;&nbsp;[Consolidated Statements of Financial Position](#consolidatedStatementsOfFinancialPosition_integixAnchor) | [2](#consolidatedStatementsOfFinancialPosition_integixAnchor) |
| &nbsp;&nbsp;&nbsp;[Consolidated Statements of Operations and Comprehensive Income (Loss)](#consolidatedStatementsOfOperationsAndComprehensiveLoss_integixAnchor) | [3](#consolidatedStatementsOfOperationsAndComprehensiveLoss_integixAnchor) |
| &nbsp;&nbsp;&nbsp;[Consolidated Statements of Changes in Equity](#consolidatedStatementsOfChangesInEquity_integixAnchor) | [4](#consolidatedStatementsOfChangesInEquity_integixAnchor) |
| &nbsp;&nbsp;&nbsp;[Consolidated Statements of Cash Flows](#consolidatedStatementsOfCashFlows_integixAnchor) | [5](#consolidatedStatementsOfCashFlows_integixAnchor) |
| &nbsp;&nbsp;&nbsp;[Notes to the Consolidated Financial Statements](#notesToConsolidatedFinancialStatements_integixAnchor) | [6](#notesToConsolidatedFinancialStatements_integixAnchor) |

---

------

---

| |
|:---|
| ![](form20fxz002.jpg) |
| **Report of Independent Registered Public Accounting Firm** |

---

To the Board of Directors and Stockholders of Micromem Technologies Inc.

**Opinion on the Consolidated Financial Statements**

We have audited the accompanying consolidated statements of financial position of Micromem Technologies Inc. (the "Company") as of October 31, 2022 and 2021, and the related consolidated statements of operations and comprehensive loss, changes in equity, and cash flows for each of the years in the three-year period ended October 31, 2022, and the related notes (collectively referred to as the consolidated financial statements).

In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of October 31, 2022 and 2021, and its financial performance and its consolidated cash flows for each of the years in the three-year period ended October 31, 2022, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

**Material Uncertainty Related to Going Concern**

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. This matter is also described in the "Critical Audit Matters" section of our report.

**Basis for Opinion**

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matters**

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

---

| | |
|:---|:---|
| **MNP LLP** |  |
| 1 Adelaide Street East, Suite 1900, Toronto ON, M5C 2V9 | 1.877.251.2922 T: 416.596.1711 F: 416.596.7894 |

---

------

![](form20fxz003.jpg)

**Going Concern**

*Critical Audit Matter Description*

As described in Note 2, the Company's operations are mainly funded with debt financing, which is dependent upon many external factors and may be difficult to raise when required. The Company may not have sufficient cash to fund its operations, and therefore, will require additional funding, which if not raised, may result in the delay, postponement or curtailment of some or all its activities. Management has prepared future cash flow forecasts, which involves judgement and estimation of key variables, such as planned capital expenditures, revenue, production volumes and market conditions. Future economic conditions, including the impact of the global COVID-19 pandemic and effects of key events subsequent to the year end, such as debt financing, also impacted management's judgements and estimates. We identified the Company's ability to continue as a going concern as a critical audit matter because auditing the Company's going concern assessment is complex and involves a high degree of auditor judgment to assess the reasonableness of the cash flow forecasts, planned refinancing actions and other assumptions used in the Company's going concern analysis. The Company's ability to execute the planned refinancing actions are especially judgmental given that the global financial markets and economic conditions have been, and continue to be, volatile as a result of the COVID-19 pandemic. This matter is also described in the "Material Uncertainty Related to Going Concern" section of our report.

*Audit Response*

We responded to this matter by performing procedures over management's assessment of the Company's ability to continue as a going concern. Our audit work in relation to this included, but was not restricted to, the following:

* We evaluated the cash flow forecasts prepared by management and evaluated the integrity and arithmetical accuracy of the model.

* We evaluated the key assumptions used in the model to estimate future cash flows for a reasonable period of time, not exceeding 12 months from the date of the Statements of Financial Position, by comparing assumptions used by management against historical performance, budgets, economic and industry indicators and publicly available information.

* We evaluated the key assumptions pertaining to estimated cash flows from operating activities and expected cash flows from financing activities, comparing these to available market data, underlying agreements, private placement raises and subsequent events thereafter.

* We assessed the adequacy of the going concern and COVID-19 disclosures included in Note 2 of the consolidated financial statements and consider these to appropriately reflect the assessments that management has performed.

**Valuation of Financial Instruments**

*Critical Audit Matter Description*

As described in Note 11 to the consolidated financial statements, for the year ended October 31, 2022, the Company has various convertible debentures some of which result in the recognition of derivative liabilities or equity components. Management measured the fair value of the embedded derivative liability and the fair value of host loans using the valuation techniques that require management to make several assumptions related to the inputs into those models. Auditing management's fair value determinations was challenging due to the complexity of accounting for the instruments, the related valuation models and the inputs into those models, which are highly sensitive to changes, such as volatility, risk free rates, variable conversion prices and discount rate.

*Audit Response*

We responded to this matter by performing procedures over valuation of debt instruments. Our audit work in relation to this included, but was not restricted to:

* We obtained and reviewed management's analysis of the financial instruments, including the assessment of the accounting for the financial instruments and the valuation methodology.
 

* We obtained signed copies of all agreements, including renewals, conversions and any new issuances and confirmed the balances and terms for a sample of the financial instruments.

---

| | |
|:---|:---|
| *1 Adelaide Street East, Suite 1900, Toronto, Ontario, M5C 2V9*<br> *1.877.251.2922 T: 416.596.1711 F: 416.596.7894 MNP.ca* | ![](form20fxz003.jpg) |

---

------

* We obtained support for cash receipts related to a sample of newly issued financial instruments and cash disbursements related to a sample of repayments, and, for a sample of conversions, obtained support such as conversion notices and share issuances as confirmed with the transfer agent.
 

* We involved internal professionals with specialized skills and knowledge to assist in developing an independent implied interest rate range for a similar liability without a convertible feature and to assess the prepayment option embedded in the loans.
 

* We tested the mathematical accuracy of the valuation model and agreed certain inputs including volatility, risk free rates, variable conversion rates and discount rate to underlying source information.

---

| | |
|:---|:---|
|  | ![](form20fxz004.jpg) |
| Toronto, Ontario | Chartered Professional Accountants |
| February 15, 2023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Licensed Public Accountants |
| We have served as the Company's auditor since 2017 |  |

---

---

| | |
|:---|:---|
| *1 Adelaide Street East, Suite 1900, Toronto, Ontario, M5C 2V9*<br> *1.877.251.2922 T: 416.596.1711 F: 416.596.7894 MNP.ca* | ![](form20fxz003.jpg) |

---

------

**Micromem Technologies Inc.**

**Consolidated Statements of Financial Position As at October 31, 2022 and October 31, 2021** 

(Expressed in United States dollars)

---

| | | | |
|:---|:---|:---|:---|
|  | <br>**Notes** | **As at**<br>**October 31, 2022** | **As at**<br>**October 31, 2021** |
| **Assets** |  |  |  |
| Current |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash | 20 | $33227 | $171397 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other receivables |  | 18200 | 24007 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets |  | 51427 | 195404 |
| Property and equipment | 6 | 48092 | 26012 |
| Patents | 7 | - | 3877 |
| &nbsp;&nbsp;&nbsp;**Total assets** |  | $99519 | $225293 |
| **Liabilities** |  |  |  |
| Current |  |  |  |
| &nbsp;&nbsp;&nbsp;Trade payables and other liabilities | 18(b), 20(c) | $287575 | $343850 |
| &nbsp;&nbsp;&nbsp;Current lease liability | 8 | 15366 | 24788 |
| &nbsp;&nbsp;&nbsp;Debenture payable | 11 | 38001 | 40207 |
| &nbsp;&nbsp;&nbsp;Convertible debentures | 1020 | 3792064 | 2452402 |
| &nbsp;&nbsp;&nbsp;Derivative liabilities | 1020 | 641299 | 787081 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities |  | 4774305 | 3648328 |
| &nbsp;&nbsp;&nbsp;Non-current lease liability | 8 | 29418 |  |
| &nbsp;&nbsp;&nbsp;Long-term loan | 9 | 43796 | 48243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** |  | 4847519 | 3696571 |
| **Shareholders' Deficiency** |  |  |  |
| &nbsp;&nbsp;&nbsp;Share capital | 12 | 87784725 | 86815836 |
| &nbsp;&nbsp;&nbsp;Contributed surplus |  | 27459730 | 28197382 |
| &nbsp;&nbsp;&nbsp;Equity component of convertible debentures | 10 | 793140 | 14004 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit |  | (120785595) | (118498500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total shareholders' deficiency** |  | (4748000) | (3471278) |
| &nbsp;&nbsp;&nbsp;**Total liabilities and shareholders' deficiency** |  | $99519 | $225293 |
| Going concern | 2 |  |  |
| Contingencies | 19 |  |  |
| Subsequent events | 23 |  |  |

---

The accompanying notes are an integral part of these consolidated financial statements.

Approved on behalf of the Board of Directors: <br> <u> *"Joseph Fuda"* </u> <u> *"Alex Dey"* </u> <br> Director Director

F - 2

------

**Micromem Technologies Inc.**

**Consolidated Statements of Operations and Comprehensive Loss For the years ended October 31, 2022, 2021, and 2020** 

(Expressed in United States dollars)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Years ended October 31,** | **Years ended October 31,** | **Years ended October 31,** |
|  | <br>&nbsp;&nbsp;&nbsp;&nbsp;**Notes** | **2022** | **2021** | **2020** |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative | 16(a) | $185366 | $155504 | $154007 |
| &nbsp;&nbsp;&nbsp;Professional, other fees and salaries | 16(b) | 647710 | 424485 | 462124 |
| &nbsp;&nbsp;&nbsp;Recovery of reserve for litigation costs |  |  |  | (205788) |
| &nbsp;&nbsp;&nbsp;Statute barred payables | 17(b) |  | (422982) |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 13 | 41484 | 360044 |  |
| &nbsp;&nbsp;&nbsp;Travel and entertainment |  | 59504 | 24903 | 23903 |
| &nbsp;&nbsp;&nbsp;Amortization of property and equipment | 6 | 25878 | 28033 | 27735 |
| &nbsp;&nbsp;&nbsp;Amortization of patents | 7 | 3877 | 8000 | 8123 |
| &nbsp;&nbsp;&nbsp;Foreign exchange loss (gain) | 20(a) | (176477) | 222553 | 1447 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total operating expenses** |  | 787342 | 800540 | 471551 |
| **Other expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Accretion expense | 10 | 1179603 | 1169921 | 1099818 |
| &nbsp;&nbsp;&nbsp;Interest expense on convertible debt | 10 | 469425 | 495809 | 441369 |
| &nbsp;&nbsp;&nbsp;Other finance expenses | 810 | 13233 | 84478 | 35500 |
| &nbsp;&nbsp;&nbsp;Loss (gain) on revaluation of derivative liabilities | 10 | (409607) | (2547192) | (771920) |
| &nbsp;&nbsp;&nbsp;Loss (gain) on conversion of convertible debentures | 10 | 94326 | (9506) | 96484 |
| &nbsp;&nbsp;&nbsp;Loss (gain) on repayment of convertible debentures | 10 | (47877) |  |  |
| &nbsp;&nbsp;&nbsp;Loss (gain) on extinguishment of convertible debentures | 10 | 200650 | 1018928 | (127409) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total other expenses** |  | 1499753 | 212438 | 773842 |
| Loss before income tax provision |  | (2287095) | (1012978) | (1245393) |
| Income tax provision | 15 | - | - | - |
| **Net loss and comprehensive loss** |  | $(2287095) | $(1012978) | $(1245393) |
| **Weighted average number of outstanding shares, basic and diluted** | 14 | 451177796 | 422613046 | 377380476 |
| **Loss per share, basic and diluted** | 14 | $(0.01) | $- | $- |

---

The accompanying notes are an integral part of these consolidated financial statements.

F - 3

------

**Micromem Technologies Inc.**

**Consolidated Statements of Changes in Equity**

**For the years ended October 31, 2022, 2021, and 2020** 

(Expressed in United States dollars)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | <br>**Notes** | <br>**Number** <br>**of shares** | <br>**Share**<br>**capital** | <br>**Contributed**<br>**surplus** | **Equity**<br>**component of**<br>**convertible**<br>**debentures** | <br>**Accumulated**<br>**deficit** | <br>**Total** |
| **Balance at November 1, 2019** |  | 346952721 | $84153696 | $27757639 | $50147 | $(116240129) | $(4278647) |
| &nbsp;&nbsp;&nbsp;Private placements of shares for cash | 12 | 10996994 | 425789 |  |  |  | 425789 |
| &nbsp;&nbsp;&nbsp;Convertible debentures converted into common shares | 10 | 44237644 | 859331 |  |  |  | 859331 |
| &nbsp;&nbsp;&nbsp;Expiry of convertible debenture conversion option | 10 |  |  | 52947 | (52947) |  |  |
| &nbsp;&nbsp;&nbsp;Renewal of convertible debentures | 10 |  |  |  | 26752 |  | 26752 |
| &nbsp;&nbsp;&nbsp;Shares issued on settlement of accounts payable | 12 | 365094 | 24826 |  |  |  | 24826 |
| &nbsp;&nbsp;&nbsp;Net loss |  | - | - | - | - | (1245393) | (1245393) |
| **Balance at October 31, 2020** |  | 402552453 | $85463642 | $27810586 | $23952 | $(117485522) | $(4187342) |
| &nbsp;&nbsp;&nbsp;Private placements of shares for cash | 12 | 17573429 | 840564 |  |  |  | 840564 |
| &nbsp;&nbsp;&nbsp;Convertible debentures converted into common shares | 10 | 15611852 | 511630 |  |  |  | 511630 |
| &nbsp;&nbsp;&nbsp;Expiry of convertible debenture conversion option | 10 |  |  | 26752 | (26752) |  |  |
| &nbsp;&nbsp;&nbsp;Renewal of convertible debentures | 10 |  |  |  | 16804 |  | 16804 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 13 |  |  | 360044 |  |  | 360044 |
| &nbsp;&nbsp;&nbsp;Net loss |  | - | - | - | - | (1012978) | (1012978) |
| **Balance at October 31, 2021** |  | 435737734 | $86815836 | $28197382 | $14004 | $(118498500) | $(3471278) |
| &nbsp;&nbsp;&nbsp;Private placements of shares for cash | 12 | 5012450 | 207588 |  |  |  | 207588 |
| &nbsp;&nbsp;&nbsp;Share issuance costs | 12 |  | (25591) |  |  |  | (25591) |
| &nbsp;&nbsp;&nbsp;Convertible debentures converted into common shares | 10 | 26443820 | 764432 |  |  |  | 764432 |
| &nbsp;&nbsp;&nbsp;Shares issued on settlement of accounts payable | 12 | 413674 | 22460 |  |  |  | 22460 |
| &nbsp;&nbsp;&nbsp;Expiry of convertible debenture conversion option | 10 |  |  | 1258388 | (1258388) |  |  |
| &nbsp;&nbsp;&nbsp;Renewal of convertible debentures | 10 |  |  | (2037524) | 2037524 |  |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 13 |  |  | 41484 |  |  | 41484 |
| &nbsp;&nbsp;&nbsp;Net loss |  | - | - | - | - | (2287095) | (2287095) |
| **Balance at October 31, 2022** |  | 467607678 | 87784725 | 27459730 | 793140 | (120785595) | (4748000) |

---

The accompanying notes are an integral part of these consolidated financial statements.

F - 4

------

**Micromem Technologies Inc.**

**Consolidated Statements of Cash Flows**

**For the years ended October 31, 2022, 2021, and 2020** 

(Expressed in United States dollars)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | | **Years ended October 31,** | **Years ended October 31,** | **Years ended October 31,** |
|  | <br>**Notes** | **2022** | **2021** | **2020** |
| **Operating activities** |  |  |  |  |
| Net loss |  | $(2287095) | $(1012978) | $(1245393) |
| Items not affecting cash: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Statute barred payables |  |  | (422982) |  |
| &nbsp;&nbsp;&nbsp;Amortization of property and equipment | 6 | 25878 | 28033 | 27735 |
| &nbsp;&nbsp;&nbsp;Amortization of patents | 7 | 3877 | 8000 | 8123 |
| &nbsp;&nbsp;&nbsp;Accretion expense | 1017 | 1179603 | 1169921 | 1099818 |
| &nbsp;&nbsp;&nbsp;Accrued interest on convertible debentures | 17 | 368280 | 605507 | 306839 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 13 | 41484 | 360044 |  |
| &nbsp;&nbsp;&nbsp;Loss (gain) on conversion of convertible debentures | 1017 | 94326 | (9506) | 96484 |
| &nbsp;&nbsp;&nbsp;Loss (gain) on repayment of convertible debentures | 1017 | (47877) |  |  |
| &nbsp;&nbsp;&nbsp;Loss (gain) on revaluation of derivative liabilities | 1017 | (409607) | (2547192) | (771920) |
| &nbsp;&nbsp;&nbsp;Loss (gain) on extinguishment of convertible debentures | 1017 | 200650 | 1018928 | (127409) |
| &nbsp;&nbsp;&nbsp;Shares issued for financing costs |  |  |  | 7500 |
| &nbsp;&nbsp;&nbsp;Foreign exchange loss (gain) | 20 | (136336) | 421937 | 78004 |
|  |  | (966817) | (380288) | (520219) |
| Net changes in non-cash working capital: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Decrease in prepaid expenses and other receivables |  | 5807 | 1414 | (10670) |
| &nbsp;&nbsp;&nbsp;Decrease in trade payables and other liabilities |  | (36021) | (383892) | (229683) |
| Cash flows used in operating activities |  | (997031) | (762766) | (760572) |
| **Investing activity** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | 5 | - | (5271) | - |
| Cash flows used in investing activity |  |  | (5271) |  |
| **Financing activities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Principal payments on lease liability | 8 | (25317) | (27282) | (11422) |
| &nbsp;&nbsp;&nbsp;Proceeds from long-term loan |  |  | 17974 | 30269 |
| &nbsp;&nbsp;&nbsp;Private placements of shares for cash | 12 | 207588 | 840564 | 425789 |
| &nbsp;&nbsp;&nbsp;Share issuance costs |  | (25591) |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible debentures | 17 | 765671 | 510000 | 612279 |
| &nbsp;&nbsp;&nbsp;Repayments of convertible debentures | 17 | (63490) | (593301) | (150920) |
| Cash flows provided by financing activities |  | 858861 | 747955 | 905995 |
| **Net change in cash** |  | (138170) | (20082) | 145423 |
| Cash - beginning of period |  | 171397 | 191479 | 46056 |
| **Cash - end of period** |  | $33227 | $171397 | $191479 |
| **Supplemental cash flow information** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest paid (classified in operating activities) | 10 | $88465 | $87266 | $155690 |
| &nbsp;&nbsp;&nbsp;Interest converted (classified in operating activities) | 10 | $12680 | $196964 | $- |
| &nbsp;&nbsp;&nbsp;Interest paid on non-convertible debt (classified in operating activities) |  | $9604 | $11785 | $8081 |
| &nbsp;&nbsp;&nbsp;Interest paid on lease liability (classified in operating activities) | 8 | $3629 | $9160 | $14081 |
| &nbsp;&nbsp;&nbsp;Carrying amount of convertible debentures converted into common shares | 17 | $764432 | $521136 | $762847 |
| &nbsp;&nbsp;&nbsp;Shares issued on settlement of accounts payable | 12 | $22460 | $- | $24826 |
| &nbsp;&nbsp;&nbsp;ROU asset and lease liability recognized | 8 | $48408 | $- | $- |

---

The accompanying notes are an integral part of these consolidated financial statements.

F - 5

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021 and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**1. Reporting entity and nature of business**

Micromem Technologies Inc. ("Micromem" or the "Company") is incorporated under the laws of the Province of Ontario, Canada. Micromem is a publicly traded company with its head office located at 121 Richmond Street West, Suite 602, Toronto, Ontario, Canada. The Company's common shares are currently listed on the Canadian Securities Exchange under the trading symbol "MRM" and on the Over the Counter Venture Market under the trading symbol "MMTIF".

The Company develops, based upon proprietary technology, customized sensor applications for companies (referred to as "Development Partners") operating internationally in various industry segments. The Company has not generated commercial revenues through October 31, 2022 and is devoting substantially all its efforts to securing commercial revenue opportunities.

**2. Going concern**

These consolidated financial statements have been prepared with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

There are material uncertainties related to conditions and events that cast substantial doubt about the Company's ability to continue as a going concern and ultimately on the appropriateness of the use of the accounting principles applicable to a going concern. During the year ended October 31, 2022, the Company reported a net loss and comprehensive loss of $2,287,095 (2021 - $1,012,978, 2020 - $1,245,393) and negative cash flow from operations of $997,031 (2021 - $762,766, 2020 - $760,572). The Company's working capital deficiency as at October 31, 2022 was $4,722,878 (October 31, 2021 - $3,452,924).

The Company's success depends on the profitable commercialization of its proprietary sensor technology. Based upon its current operating and financial plans, management of the Company believes that it will have sufficient access to financial resources to fund the Company's planned operations through fiscal 2023; however, the ability of the Company to continue as a going concern is dependent upon its ability to secure additional financing and/or to profitably commercialize its technology. There is no assurance that the Company will be successful in the profitable commercialization of its technology, or will be able to secure the necessary additional financing. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. If the going concern assumption was not appropriate for these consolidated financial statements then adjustments could be necessary to the carrying value of assets and liabilities, the reported expenses and the statement of financial position classifications used; in such cases, these adjustments could be material.

The COVID-19 pandemic creates additional risk for the Company if there is a prolonged industry slowdown in those sectors where the Company currently operates including the oil and gas sectors in particular. The Company has encountered delays in the commercial plans for its technology with its primary target customers. It secured a government backed loan of $60,000 CDN ($43,796 USD) as at October 31, 2022 (October 31, 2021 - $60,000 CDN, $48,243 USD) which matures in December 2025 (Note 9). During the year ended October 31, 2022, the Company received government wage subsidies of $nil CDN ($nil USD) (October 31, 2021 - $167,388 CDN, $133,699 USD) (Note 15(b)(i)) and rent subsidies of $nil CDN ($nil USD) (October 31, 2021 - $38,440 CDN, $30,613 USD).

**3. Basis of presentation**

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations issued by the IFRS Interpretations Committee ("IFRIC"). The Company has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

These consolidated financial statements were authorized for issuance and release by the Company's Board of Directors on February 14, 2023.

F - 6

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**3. Basis of presentation (continued)**

(a) Basis of consolidation

These consolidated financial statements include the accounts of Micromem Technologies Inc. and its subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.

The Company's wholly-owned subsidiaries include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| (i) | **Inactive subsidiaries** | **Domiciled in** |
|  | Micromem Applied Sensors Technology Inc. ("MAST") | United States |
|  | 707019 Canada Inc. | Canada |
|  | Memtech International Inc. | Bahamas |
|  | Memtech International (USA) Inc., Pageant Technologies (USA) Inc. | United States |
|  | Pageant Technologies Inc., Micromem Holdings (Barbados) Inc. | Barbados |

---

(b) Basis of measurement

These consolidated financial statements have been prepared on the historical cost basis, except for financial instruments designated at fair value through profit and loss which are measured at their fair value.

(c) Functional and presentation currency

These consolidated financial statements are presented in United States dollars ("USD"), which is the functional currency of the Company and all of its subsidiaries.

(d) Use of estimates and judgments

The preparation of these consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates are reviewed periodically and adjustments are made as appropriate in the reporting period they become known. Items for which actual results may differ materially from these estimates are described in the following section.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Fair value of options and conversion features

The Company makes estimates and utilizes assumptions in determining the fair value for stock options and conversion features based on the application of the Black-Scholes option pricing model or the binomial option pricing model, depending on the circumstances. These pricing models require management to make various assumptions and estimates that are susceptible to uncertainty, including the volatility of the share price, expected dividend yield, expected term, risk-free interest rate, and exercise price in the binomial option pricing model.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Useful lives and recoverability of long-lived assets

Long-lived assets consist of property and equipment and patents. Amortization is dependent upon estimates of useful lives and impairment is dependent upon estimates of recoverable amounts. These are determined through the exercise of judgment and are dependent upon estimates that take into account factors such as economic and market conditions, frequency of use, anticipated changes in laws, and technological improvements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Income taxes

Income taxes and tax exposures recognized in the consolidated financial statements reflect management's best estimate of the outcome based on facts known at the reporting date. When the Company anticipates a future income tax payment based on its estimates, it recognizes a liability. The difference between the expected amount and the final tax outcome has an impact on current and deferred taxes when the Company becomes aware of this difference.

When the Company incurs losses for income tax purposes, it assesses the probability of taxable income being available in the future, based on budgeted forecasts. These forecasts are adjusted for certain non-taxable income and expenses and specific rules on the use of unused credits and tax losses. When the forecasts indicate that sufficient future taxable income will be available to deduct the temporary differences, a deferred tax asset is recognized for all deductible temporary differences.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Going concern assumption

The Company applies judgment in assessing whether material uncertainties exist that would cause doubt as to the whether the Company could continue as a going concern.

F - 7

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**4. Summary of significant accounting policies**

The principal accounting policies applied to the preparation of these consolidated financial statements are set out below:

(a) Foreign currency translation

These consolidated financial statements are presented in USD, which is the functional currency of the Company and all of its subsidiaries. At each reporting date, foreign currency denominated monetary assets and liabilities are translated at year-end exchange rates. Nonmonetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction. Income, expenses, and cash flows, are translated into USD using annual average exchange rates. Exchange differences arising from operating transactions are recorded in operating profit or loss for the period; exchange differences related to financing transactions are recognized in finance income or directly in equity.

(b) Financial instruments

The Company aggregates similar financial instruments into classes based on their nature and characteristics. All financial assets except those classified as fair value through profit or loss are reviewed at each reporting date to determine whether there is any indication of impairment. Financial assets are considered to be impaired when there is objective evidence that the estimated future cash flows of the investment have been affected as a result of one or more events that occurred after the initial recognition.

The Company's accounting policy for each class of financial instruments is as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Fair value through profit or loss

Financial instruments classified as fair value through profit or loss are reported at fair value at each reporting date, and any change in fair value is recognized in net income in the period during which the change occurs. In these consolidated financial statements, cash and derivative liabilities have been classified as fair value through profit or loss.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Other financial assets and financial liabilities

Other financial instruments are carried at amortized cost using the effective interest method. Transaction costs are included in the amount initially recognized. In these consolidated financial statements, trade payables and other liabilities, debenture payable, convertible debentures, and long-term loan have been subsequently measured at amortized cost.

(c) Convertible debentures and derivative liabilities

The Company issues convertible debentures used as bridge loans, which can be converted into common shares at the option of the holder, into a fixed number of shares for a fixed amount of consideration, or into a fixed number of shares for a variable amount of consideration, or into a variable number of shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Initial recognition

For convertible debentures which provide conversion into a fixed number of shares, the liability component is recognized initially at the fair value of a similar, non-convertible liability. The equity component is recognized as the difference between the fair value of the instrument as a whole and the fair value of the liability component. Any directly attributable transaction costs are allocated to the liability and equity components in proportion to their initial carrying amounts.

For convertible debentures which provide conversion into a variable number of shares or into a fixed number of shares for a variable amount of consideration, the conversion option is accounted for as an embedded derivative, which is separated from the host contract. Upon initial recognition, the derivative liability is valued at fair value using a Black Scholes or a binomial pricing model. The carrying amount of the convertible debenture is recognized as the difference between the fair value of the instrument as a whole and the fair value of the derivative liability. Any directly attributable transaction costs are allocated to the derivative liability and host contract in proportion to their initial carrying amounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Modifications and extinguishments

To the extent there are changes to the terms of outstanding convertible debentures, these changes may be recorded as a modification or an extinguishment. A substantial change in the terms of an existing financial liability is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. The terms are substantially different if the discounted present value of the cash flows at the original effective interest rate under the new terms is at least 10% different from the discounted present value of the remaining cash flows of the original financial liability. For a modification that does not result in derecognition, a gain or loss will be recognised in profit or loss for the difference between the original contractual cash flows and the modified cash flows discounted at the original effective interest rate. For a modification that results in derecognition, a gain or loss will be recognised in profit or loss for the difference between the carrying amount of the financial liability extinguished and the fair value of the modified financial liability.

F - 8

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**4. Summary of significant accounting policies (continued)**

(d) Property and equipment

Property and equipment are recorded at cost and are amortized over their estimated useful lives at the following annual rates and methods:

---

| | | |
|:---|:---|:---|
|  | **Method** | **Rate** |
| Computers | Declining balance | &nbsp;&nbsp;&nbsp;&nbsp; 30% |
| Right-of-use asset | Straight-line | lesser of useful life and lease term (three years) |

---

(e) Impairment of long-lived assets

The Company follows the guidelines prescribed in IAS 36 with respect to the measurement for impairment of assets. The carrying amounts of property and equipment and patents are reviewed for impairment when events or changes in circumstances indicate that the carrying amounts may not be recoverable. When the carrying amount exceeds the estimated recoverable amount, the assets are written down to their recoverable amount. The recoverable amount of long-lived assets is the greater of fair value less costs to sell and value in use. Impairment losses are recognized in the consolidated statements of loss and comprehensive loss.

(f) Development costs

Research costs are expensed in the period incurred. Development costs are expensed as incurred unless they meet the criteria for capitalization. Expenditures during the development phase are capitalized if the Company can demonstrate each of the following criteria: (i) the technical feasibility of completing the asset so that it will be available for use or sale, (ii) its intention to complete the asset and use or sell it, (iii) its ability to use or sell the asset, (iv) how the asset will generate probable future economic benefits, (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the asset, and (vi) its ability to measure reliably the expenditure attributable to the asset during its development; otherwise, these costs are expensed as incurred. Costs to be recovered from development partners are recorded to development costs receivable. Payments received from development partners on projects are recorded to income as a recovery of costs incurred and reduce the outstanding receivable. There were no development costs incurred or recovery of such costs in 2022, 2021, or 2020.

(g) Patents

Patents are recorded at cost and are amortized on a straight line basis over their estimated useful lives of 5 years.

(h) Leases

At the inception of a contract, the Company assesses whether a contract is, or contains a lease. A contract is, or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the commencement date of the lease. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. In addition, the right- of-use assets are adjusted for impairment losses, if any. The estimated useful lives and recoverable amounts of right-of-use assets are determined on the same basis as those of property and equipment. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company's incremental borrowing rate currently set at 9%. The lease liability is subsequently measured at amortized cost using the effective interest method. The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases (lease term of 12 months or less) and leases for which the underlying asset is of low value as there are none. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.

(i) Stock-based compensation and other stock-based payments

Where equity instruments are granted to employees, they are recorded at the fair value of the equity instrument granted at the grant date. The grant date fair value is recognized in net income over the vesting period. Where equity instruments are granted to non-employees, they are recorded at the fair value of the goods or services received. When the value of goods or services received in exchange for the stock-based payment cannot be reliably estimated, the fair value is measured by use of a valuation model. The cost recognized for all equity-settled stock-based payments is reflected in contributed surplus, until the instruments are exercised. Upon exercise, shares are issued from treasury and the amount previously reflected in contributed surplus along with any proceeds paid upon exercise, are credited to share capital.

F - 9

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**4. Summary of significant accounting policies (continued)**

(j) Government grants

The Company recognises government grants when there is reasonable assurance of compliance with grant conditions and that the grants will be received. Government grants are recognised in profit or loss on a systematic basis over the periods when the related expenses are incurred and are presented in the consolidated financial statements as a reduction of these expenses. A government grant that becomes receivable as compensation for expenses already incurred is recognised in profit or loss of the period in which it becomes receivable.

(k) Income taxes

The Company accounts for its income taxes using the deferred tax assets and liabilities method. Deferred income tax assets and liabilities are determined based on the difference between the carrying amount and the tax basis of the assets and liabilities. Any change in the net amount of deferred income tax assets and liabilities is included in profit or loss or equity. Deferred income tax assets and liabilities are determined based on enacted or substantively enacted tax rates and laws which are expected to apply to taxable profit for the years in which the assets and liabilities will be recovered or settled. Deferred income tax assets are recognized when it is probable they will be realized. Deferred tax assets and liabilities are not discounted.

(l) Provisions

Provision for risks and expenses are recognized for probable outflows of resources that can be estimated and that result from present obligations resulting from past events. In the case where a potential obligation resulting from past events exists, but where occurrence of the outflow of resources is not probable or the estimate is not reliable, these contingencies are disclosed. Provisions, if any, are measured based on management's best estimates of outcomes on the basis of facts known at the reporting date.

(m) Share capital

Share capital is presented at the fair value of the shares issued or the cash amount received. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.

(n) Earnings or loss per share

The Company presents basic and diluted earnings per share data for its common shares. Basic earnings per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding, for the effects of all potentially dilutive common shares, which comprise stock options and convertible debentures.

**5.** **New accounting standards and pronouncements**

(a) Amendment to IAS 1, Presentation of Financial Statements, Issued but not yet effective

IAS 1 was amended in January 2020 to address inconsistences with how entities apply the standard over classification of current and non-current liabilities. The amendment serves to address whether, in the statement of financial position, debt and other liabilities with an uncertain settlement should be classified as current or non-current. The amendment is effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted. The Company will adopt this amendment as of the effective date, and does not anticipate any material impacts on adoption.

(b) Amendment to IAS 37, Provisions, Contingent Liabilities and Contingent Assets, Issued but not yet effective

IAS 37 was amended in May 2020 to clarify the costs a company should include as the cost of fulfilling a contract when assessing whether a contract is onerous. The amendment is effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted. The Company will adopt the amendment as of the effective date, and does not anticipate any material impacts on adoption.

(c) Amendment to IAS 16, Property, Plant and Equipment, Issued but not yet effective

IAS 16 was amended in May 2020 to prohibit deducting from the cost of an item of property, plant and equipment any proceeds from selling items produced while bringing that asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Instead, an entity recognizes the proceeds from selling such items, and the cost of producing those items, in profit or loss. The amendment is effective for annual reporting periods beginning on or after January 1, 2022. Earlier adoption is permitted. The Company will adopt the amendment as of the effective date, and does not anticipate any material impacts on adoption.

F - 10

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**5. New accounting standards and pronouncements (continued)**

(d) Amendment to IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, Issued but not yet effective

In February 2021, the International Accounting Standards Board ("IASB") issued 'Definition of Accounting Estimates' to help entities distinguish between accounting policies and accounting estimates. The amendment is effective for annual reporting periods beginning on or after January 1, 2023. Earlier adoption is permitted. The Company will adopt the amendment as of the effective date, and is currently assessing the impacts of adoption.

(e) Amendment to IFRS 9, Financial Instruments, Issued but not yet effective

The amendment clarifies the fees an entity includes in assessing the terms of a new or modified financial liability to determine whether to recognize a financial liability. The amendment clarifies that the reference to fees in the 10% test includes only fees paid or received between the borrower and the lender, including fees paid or received by either the borrower or the lender on the other's behalf (ie. finders fees, brokerage commission and legal fees are excluded). The amendment is effective for annual periods beginning on or after January 1, 2022. The Company will adopt the amendment as of the effective date, and does not anticipate any material impacts on adoption.

**6. Property and equipment**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As at**<br>**November 1,**<br>**2021** | <br>**Additions** | <br>**Disposals** | **As at**<br>**October 31,**<br>**2022** |
| **Cost** |  |  |  |  |
| Computers | $18570 | $- | $(11104) | $7466 |
| Right-of-use assets | 74307 | 48408 | (74307) | 48408 |
|  | 92877 | 48408 | (85411) | 55874 |
| **Accumulated amortization** |  |  |  |  |
| Computers | 12824 | 1723 | (10799) | 3748 |
| Right-of-use assets | 54041 | 24155 | (74162) | 4034 |
|  | 66865 | 25878 | (84961) | 7782 |
| **Net book value** | $26012 |  |  | $48092 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As at**<br>**November 1,**<br>**2020** | <br>**Additions** | <br>**Disposals** | **As at**<br>**October 31,**<br>**2021** |
| **Cost** |  |  |  |  |
| Computers | $32040 | $5271 | $(18741) | $18570 |
| Right-of-use assets | 74307 | - | - | 74307 |
|  | 106347 | 5271 | (18741) | 92877 |
| **Accumulated amortization** |  |  |  |  |
| Computers | 30077 | 1013 | (18266) | 12824 |
| Right-of-use assets | 27021 | 27020 | - | 54041 |
|  | 57098 | 28033 | (18266) | 66865 |
| **Net book value** | $49249 |  |  | $26012 |

---

During the year ended October 31, 2022, the Company's lease agreement pertaining to the right-of-use asset as at October 31, 2021 expired and the asset was fully depreciated and derecognized. A new lease agreement was entered into and is therefore recorded as an addition during the year ended October 31, 2022. Refer to Note 8.

F - 11

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**7. Patents**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As at**<br>**November 1,**<br>**2021** | <br>**Additions** | <br>**Disposals** | **As at**<br>**October 31,**<br>**2022** |
| Cost | $681288 | $- | $- | $681288 |
| Accumulated amortization | 677411 | 3877 | - | 681288 |
| **Net book value** | $3877 | $(3877) | $- | $- |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As at**<br>**November 1,**<br>**2020** | <br>**Additions** | <br>**Disposals** | **As at**<br>**October 31,**<br>**2021** |
| Cost | $681288 | $- | $- | $681288 |
| Accumulated amortization | 669411 | 8000 | - | 677411 |
| **Net book value** | $11877 | $(8000) | $- | $3877 |

---

The Company holds several patents in the United States for its Multimodal Fluid Condition Sensor Platform. In prior years, the Company had negotiated with a major automotive company and a Tier 1 manufacturer for the development and commercial exploitation of this patented technology. The Company maintains that there remains significant potential value in its existing patents in terms of potential licensing agreements and royalty fees once it begins to exploit this asset class in the future.

**8. Leases**

(a) Continuity schedule of lease obligation

The lease obligation relates to the use of office space in Toronto, Ontario. The lease agreement in effect for the years ended October 31, 2021 and 2020 was set to expire on July 31, 2022. On May 26, 2022, a new lease agreement was entered into for a term from August 1, 2022 to July 31, 2025 for office space in another location in Toronto, Ontario. The present value of the lease obligation was calculated using a discount rate of 9%.

---

| | |
|:---|:---|
| Balance, November 1, 2019 | $- |
| Adoption of IFRS 16 | 74307 |
| Interest expense | 14081 |
| Lease payments | (25504) |
| Foreign exchange | (10814) |
| Balance, October 31, 2020 | $52070 |
| Interest expense | 9160 |
| Lease payments | (36442) |
| Balance, October 31, 2021 | $24788 |
| New lease agreement | 48408 |
| Interest expense | 3629 |
| Lease payments | (28946) |
| Foreign exchange | (3095) |
| Balance, October 31, 2022 | $44784 |

---

(b) Maturity analysis of lease obligations

The following represents a maturity analysis of the Company's undiscounted contractual lease obligations as at October 31, 2022:

---

| | |
|:---|:---|
|  | **CDN** |
| Less than one year | $25532 |
| Between one and five years | $43804 |

---

F - 12

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**9. Long-term loan**

As at October 31, 2022 the Company has obtained a $60,000 CDN ($43,796 USD) (October 31, 2021 - $60,000 CDN, $48,243 USD) interest-free loan from the Government of Canada under the Canada Emergency Business Account ("CEBA") program to cover its operating costs. The term loan matures on December 31, 2025. Repaying the balance of the loan on or before December 31, 2023 will result in a loan forgiveness of $20,000 CDN ($14,599 USD). Effective January 1, 2024, any outstanding balance on the term loan shall bear interest at a rate of 5% per annum. As the Company does not yet know whether they will be able to meet the terms of forgiveness, no amount has been recognized to income.

**10. Convertible debentures**

The Company issues three types of convertible debentures: USD denominated convertible debentures with an equity component, Canadian dollar ("CDN") denominated convertible debentures with an embedded derivative due to variable consideration payable upon conversion caused by foreign exchange, and USD denominated convertible debentures with an embedded derivative caused by variable conversion prices.

During the year ended October 31, 2022, the Company incurred $21,000 financing costs (2021 - $84,478, 2020 - $35,500) which primarily consisted of early repayment and administrative fees, of which $nil (2021 - $nil, 2020 - $7,500) was converted into common shares. All loan principal amounts and conversion prices are expressed in original currency and all remaining dollar amounts are expressed in USD.

(a) Current period information presented in the consolidated financial statements

**Convertible debentures outstanding as at October 31, 2022:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **USD**<br>**(equity**<br>**component)** | <br>**CDN (embedded**<br>**derivative)** | <br>**USD (embedded**<br>**derivative)** | <br>**Total** |
| **Loan principal outstanding** | $1205144 | $2321755 | $347700 |  |
| **Terms of loan** |  |  |  |  |
| Annual stated interest rate | 12% - 24% | 12% - 24% | 2% - 4% |  |
| Effective annual interest rate | 24% | 22 - 131% | 24% - 5803% |  |
| Conversion price to common shares | $0.03 - $0.07 | $0.05 - $0.08 | (i) - (ii) |  |
| Remaining life (in months) | 0 - 6 | 0 - 10 | 0 - 11 |  |
| **Consolidated Statement of Financial Position** |  |  |  |  |
| Carrying value of loan principal | $1203478 | $1661742 | $130424 | $2995644 |
| Interest payable | 380360 | 389617 | 26443 | 796420 |
| Convertible debentures | $1583838 | $2051359 | $156867 | $3792064 |
| Derivative liabilities | $- | $439194 | $202105 | $641299 |
| Equity component of convertible debentures | $793140 | $- | $- | $793140 |

---

**For the year ended October 31, 2022:**<br>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **USD**<br>**(equity**<br>**component)** | <br>**CDN (embedded**<br>**derivative)** | <br>**USD (embedded**<br>**derivative)** | <br>**Total** |
| **Consolidated Statement of Operations and Comprehensive Loss** |  |  |  |  |
| Accretion expense | $28000 | $1086385 | $65218 | $1179603 |
| Interest expense | $230058 | $232211 | $7156 | $469425 |
| (Gain) loss on revaluation of derivative liabilities | $- | $(379736) | $(29871) | $(409607) |
| (Gain) loss on conversion of convertible debentures | $- | $- | $94326 | $94326 |
| (Gain) loss on repayment of convertible debentures | $- | $(661) | $(47216) | $(47877) |
| (Gain) loss on extinguishment of convertible debentures | $(28007) | $99078 | $129579 | $200650 |
| **Consolidated Statement of Changes in Equity** |  |  |  |  |
| Amount of principal converted to common shares | $- | $- | $712100 |  |
| Amount of interest converted to common shares | $- | $- | $12680 |  |
| Number of common shares issued on conversion of convertible debentures |  |  | 26443820 | 26443820 |

---

F - 13

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**10. Convertible debentures (continued)**

(a) Current period information presented in the consolidated financial statements

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Consolidated Statement of Cash Flows** |  |  |  |  |
| Amount of principal repaid in cash | $- | $7490.0 | $56000 | $63490.0 |
| Amount of interest repaid in cash | $14941 | $73524.0 | $- | $88465.0 |

---

(i) Conversion price defined as 75% multiplied by the average of the lowest 3 closing stock prices for the 10 trading days prior to conversion date.

(ii) Conversion price defined as 75% multiplied by the lowest stock price for the 20 trading days prior to conversion date.

(b) Comparative information presented in the consolidated financial statements

**Convertible debentures outstanding as at October 31, 2021:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **USD**<br>**(equity**<br>**component)** | <br>**CDN (embedded**<br>**derivative)** | <br>**USD (embedded**<br>**derivative)** | <br>**Total** |
| **Loan principal outstanding** | $1037782 | $1989187 | $468600 |  |
| **Terms of loan** |  |  |  |  |
| Annual stated interest rate | 12% - 24% | 12% - 24% | 2% - 10% |  |
| Effective annual interest rate | 24.00% | 13% - 28735624% | 0% - 5525% |  |
| Conversion price to common shares | $0.03 - $0.07 | $0.05 - $0.08 | (i) - (ii) |  |
| Remaining life (in months) | 0 - 6 | 0 - 6 | 0 - 10 |  |
| **Consolidated Statement of Financial Position** |  |  |  |  |
| Carrying value of loan principal | $1036124 | $609924 | $172166 | $1818214 |
| Interest payable | 332605 | 269455 | 32128 | 634188 |
| Convertible debentures | $1368729 | $879379 | $204294 | $2452402 |
| Derivative liabilities | $- | $557322 | $229759 | $787081 |
| Equity component of convertible debentures | $14004 | $- | $- | $14004 |

---

(i) Conversion price defined as 75% multiplied by the average of the lowest 3 closing stock prices for the 10 trading days prior to conversion date.

(ii) Conversion price defined as 75% multiplied by the lowest stock price for the 20 trading days prior to conversion date.

**For the year ended October 31, 2021:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **USD**<br>**(equity**<br>**component)** | <br>**CDN (embedded**<br>**derivative)** | <br>**USD (embedded**<br>**derivative)** | <br>**Total** |
| **Consolidated Statement of Operations and Comprehensive Loss** |  |  |  |  |
| Accretion expense | $28001 | $1003613 | $138307 | $1169921 |
| Interest expense | $236519 | $226520 | $32770 | $495809 |
| (Gain) loss on revaluation of derivative liabilities | $- | $(2718409) | $171217 | $(2547192) |
| (Gain) loss on conversion of convertible debentures | $- | $(47356) | $37850 | $(9506) |
| (Gain) loss on extinguishment of convertible debentures | $- | $1360536 | $(341608) | $1018928 |
| **Consolidated Statement of Changes in Equity** |  |  |  |  |
| Amount of principal converted to common shares | $- | $100000 | $284000 |  |
| Amount of interest converted to common shares | $30200 | $160064 | $6700 |  |
| Number of common shares issued on conversion of convertible debentures | 1118519 | 7744774 | 6748559 | 15611852 |

---

F - 14

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**10. Convertible debentures (continued)**

(b) Comparative information presented in the consolidated financial statements

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Consolidated Statement of Cash Flows** |  |  |  |  |
| Amount of principal repaid in cash | $205100.0 | $31492.0 | $364370.0 | $600962.0 |
| Amount of interest repaid in cash | $25101.0 | $36052.0 | $26113.0 | $87266.0 |

---

**For the year ended October 31, 2020:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **USD**<br>**(equity**<br>**component)** | <br>**CDN (embedded**<br>**derivative)** | <br>**USD (embedded**<br>**derivative)** | <br>**Total** |
| **Consolidated Statement of Operations and Comprehensive Loss** |  |  |  |  |
| Accretion expense | $37934 | $723641 | $338244 | $1099818 |
| Interest expense | $194091 | $215923 | $31355 | $441369 |
| (Gain) loss on revaluation of derivative liabilities | $- | $(590625) | $(179295) | $(769920) |
| (Gain) loss on conversion of convertible debentures | $- | $- | $96484 | $96484 |
| (Gain) loss on extinguishment of convertible debentures | $- | $(10919) | $(116490) | $(127409) |
| **Consolidated Statement of Changes in Equity** |  |  |  |  |
| Amount of principal converted to common shares | $20000 | $35000 | $553000 | $608000 |
| Amount of interest converted to common shares | $447 | $1168 | $27046 | $28661 |
| Number of common shares issued on conversion of convertible | 511175 | 731440 | 42995029 | 44237644 |
| **Consolidated Statement of Cash Flows** |  |  |  |  |
| Amount of principal repaid in cash | $- | $93721 | $80000 | $173721 |
| Amount of interest repaid in cash | $60918 | $93005 | $1767 | $155690 |

---

(c) Fair value of derivative liabilities outstanding

The fair value of the derivative liabilities is determined in accordance with the Black-Scholes or binomial option-pricing models, depending on the circumstances. The underlying assumptions are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **As at** | **As at** | |
|  | **October 31,** | **October 31,** | |
|  | **2022** | **2022** | **As at**<br>**October 31,**<br>**2021** |
| Share price | $0.03 | $0.03 | &nbsp;&nbsp;&nbsp;$0.05 |
| Exercise price | $0.02 - $0.07 | $0.02 - $0.07 | &nbsp;&nbsp;&nbsp;&nbsp;$0.03 - $0.07 |
| Volatility factor (based on historical volatility) | 140% | - 232% | &nbsp;&nbsp;&nbsp;32% - 133% |
| Risk free interest rate | 3.09% | - 4.28% | &nbsp;&nbsp;&nbsp;0.17% - 0.55% |
| Expected life of conversion features (in months) | 0 - 11 | 0 - 11 | &nbsp;&nbsp;&nbsp;0 - 10 |
| Expected dividend yield | 0% | 0% | &nbsp;&nbsp;&nbsp;0% |
| CDN to USD exchange rate (as applicable) | 0.7299 | 0.7299 | &nbsp;&nbsp;&nbsp;0.8041 |
| Call value | $0.00 | - $0.02 | &nbsp;&nbsp;&nbsp;$0.01 - $0.04 |

---

Volatility was estimated using the historical volatility of the Company's stock prices for common shares.

**11. Debenture payable**

This debenture was issued on March 17, 2020 with an original maturity date of June 17, 2020 with a principal amount of $51,500 CAD. On June 17, 2020, December 17, 2020, June 17, 2021, December 17, 2021, June 17, 2022, and December 17, 2022, the debenture was extended for six month intervals. The most recent extension on December 17, 2022, extended the debenture to June 17, 2023. The debenture bears interest at a rate of 24% and is unsecured. Interest expense on this debenture of $9,604 USD has been recognized during the year ended October 31, 2022 (2021 - $7,261 USD, 2020 - $4,840 USD).

F - 15

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**12. Share capital**

(a) Authorized and outstanding shares

The Company has two classes of shares as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Special redeemable voting preference shares - 2,000,000 authorized, nil issued and outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Common shares without par value - an unlimited number authorized. The holders of the common shares are entitled to receive dividends which may be declared from time to time, and are entitled to one vote per share at shareholder meetings of the Company. All common shares are ranked equally with regards to the Company's residual assets.

(b) Private placements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) In 2022, the Company completed 9 private placements with investors consisting of common shares with no warrants, pursuant to prospectus and registration exemptions set forth in applicable securities law. The Company received net proceeds of $181,997 and issued a total of 5,012,450 common shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) In 2021, the Company completed 37 private placements with investors consisting of common shares with no warrants, pursuant to prospectus and registration exemptions set forth in applicable securities law. The Company received net proceeds of $840,564 and issued a total of 17,573,429 common shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) In 2020, the Company completed three private placements with investors consisting of common shares with no warrants, pursuant to prospectus and registration exemptions set forth in applicable securities law. The Company received net proceeds of $425,789 and issued a total of 10,996,994 common shares.

(c) Accounts payable settled in common shares

During the year ended October 31, 2022, $22,460 (2021 - $nil, 2020 - $24,826) of accounts payable was settled in exchange for 413,674 (2021 - nil, 2020 - 365,094) common shares. There was no gain or loss recognized upon settlement.

**13. Stock options**

(a) Stock option plan

Until September 8, 2020, under the Company's fixed stock option plan (the "Plan"), the Company could grant up to 18,840,000 shares of common stock to directors, officers, employees or consultants of the Company and its subsidiaries. The exercise price of each option is equal to or greater than the market price of the Company's shares on the date of grant unless otherwise permitted by applicable securities regulations. An option's maximum term under the Plan is 10 years. Stock options are fully vested upon issuance by the Company unless the Board of Directors stipulates otherwise by Directors' resolution.

The Company held its most recent Annual General Meeting of Shareholders on September 8, 2020. The authorized limit for stock options in the Company's plan was increased from 18.84 million options to 27.5 million options at the meeting.

(b) Summary of changes

---

| | | |
|:---|:---|:---|
|  | <br>**Number of options** | **Weighted average**<br>**exercise price** |
| **Outstanding at October 31, 2019** | 5730000 | $0.25 |
| Cancelled | (2040000) | 0.25 |
| Expired | (1490000) | 0.46 |
| **Outstanding at October 31, 2020** | 2200000 | $0.10 |
| Granted | 9500000 | 0.06 |
| **Outstanding at October 31, 2021** | 11700000 | $0.06 |
| Granted | 2025000 | 0.07 |
| Expired | (2000000) | 0.07 |
| **Outstanding at October 31, 2022** | 11725000 | $0.06 |

---

F - 16

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**13. Stock options (continued)**

(c) Stock options outstanding at October 31, 2022

There were nil options issued to directors and officers during the year ended October 31, 2022 (2021 - 9,500,000 options issued, 2020 - nil). Of the options granted, 525,000 options have vested, 500,000 options will vest by January 11, 2023, 500,000 options will vest by April 11, 2023, and the remaining 500,000 options will vest by July 11, 2023.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Weighted average** | **Weighted average** |
| <br>**Date of issue** | <br>**Expiry date** | <br>**Number of**<br>**options** | <br>**Exercise price** | **Remaining**<br>**contractual life** |
| June 29, 2018 | June 29, 2023 | 2200000 | 0.10 | 0.7 |
| November 13, 2020 | November 13, 2025 | 6500000 | 0.05 | 3.0 |
| October 8, 2021 | October 8, 2026 | 1000000 | 0.07 | 3.9 |
| December 15, 2021 | December 15, 2023 | 25000 | 0.07 | 1.1 |
| October 11, 2022 | October 11, 2023 | 2000000 | 0.07 | 0.9 |
| **Outstanding at October 31, 2022** |  | 11725000 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.06 | 2.3 |

---

Of the total options outstanding, 10,225,000 are exercisable as at October 31, 2022 (2021 - 11,700,000).

(d) Fair value of options issued during the year

The fair value of the stock options issued has been determined in accordance with the Black Scholes option-pricing model. Volatility was estimated using the historical volatility of the Company's stock prices for its common shares. The underlying assumptions are as follows:

---

| | | |
|:---|:---|:---|
|  | **2022** | **2021** |
| Share price at grant date | $0.03 - $0.05 | &nbsp;&nbsp;&nbsp;$0.05 |
| Exercise price | $0.07 | $0.05 - $0.07 |
| Volatility factor | 212% - 272% | 148% - 180% |
| Risk free interest rate | 0.97% - 4.33% | &nbsp;&nbsp;&nbsp;0.75% |
| Expected life of options in years | 1 - 2 | 5 |
| Expected divided yield | 0% | &nbsp;&nbsp;&nbsp;0% |
| Forfeiture rate | 0% | &nbsp;&nbsp;&nbsp;0% |
| Weighted average Black Scholes value at grant date | $0.02 - $0.03 | $0.05 - $0.06 |

---

During the year ended October 31, 2022, the Company recorded an expense of $41,484 respectively to the issuance of these stock options (2021 - $360,044).

**14. Loss per share**

Basic and diluted loss per share are calculated using the following numerators and denominators:

---

| | | | |
|:---|:---|:---|:---|
| **Numerator** | **2022** | **2021** | **2020** |
| Net loss attributable to common shareholders and used in computation of basic and diluted loss per share | $(2287095) | $(1012978) | (1245393) |
| **Denominator** |  |  |  |
| Weighted average number of common shares for computation of basic and diluted loss per share | 451177796 | 422613046 | 377380476 |

---

For the years ended October 31, 2022, 2021 and 2020, all stock options and conversion features were anti-dilutive and, therefore, are excluded from the calculation of diluted loss per share.

F - 17

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**15. Income taxes**

(a) The Company has non-capital losses of approximately $32 million available to reduce future taxable income, the benefit of which has not been recognized in these consolidated financial statements. As at October 31, 2022, the tax losses expire as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Canada** | **United States** | **Total** |
| 2026.0 | $1743280 | $- | $1743280 |
| 2027.0 | 1465962 |  | 1465962 |
| 2028.0 |  |  |  |
| 2029.0 | 1502416 | 143721 | 1646137 |
| 2030.0 | 2027152 | 1880897 | 3908049 |
| 2031.0 | 1221296 | 18526 | 1239822 |
| 2032.0 | 1353513 | 325793 | 1679306 |
| 2033.0 | 1640591 | 157463 | 1798054 |
| 2034.0 | 2373379 | 679089 | 3052468 |
| 2035.0 | 2682124 | 570901 | 3253025 |
| 2036.0 | 3147625 | 441019 | 3588644 |
| 2037.0 | 2519765 | 232714 | 2752479 |
| 2038.0 | 1703454 | 317 | 1703771 |
| 2039.0 | 1523813 |  | 1523813 |
| 2040.0 | 513301 |  | 513301 |
| 2041.0 | 889381 |  | 889381 |
| 2042.0 | 1262336 | - | 1262336 |
|  | $27569388 | $4450440 | $32019828 |

---

(b) In addition, the Company has available capital loss carryforwards of approximately $1.2 million to reduce future taxable capital gains, the benefit of which has not been recognized in these consolidated financial statements. Capital losses carry forward indefinitely.

(c) Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Non-capital losses and other | $8485255 | $8924982 | $8232346 |
| Capital losses | 162275 | 178808 | 166316 |
| Property, equipment, patents and deferred costs | 1639306 | 1794285 | 1666788 |
|  | $10286836 | $10898075 | $10065450 |
| Deferred tax asset not recognized | (10286836) | (10898075) | (10065450) |
|  | $- | $- | $- |

---

As at October 31, 2022 and 2021, the Company assessed that it is not probable that sufficient taxable profit will be available to use deferred income tax assets based on operating losses in prior years; therefore, there are no balances carried in the consolidated statements of financial position for such assets.

(d) The reconciliation of income tax attributed to continuing operations computed at the statutory tax rates to income tax expense is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Loss before income taxes | $(2287095) | $(1012987) | $(1245393) |
| Statutory tax rate | 26.5% | 26.5% | 26.5% |
| Expected income tax recovery | $(606080) | $(268439) | $(330029) |
| Accretion expense and loss (gain) on convertible debentures and derivative liabilities | 269531 | (97480) |  |
| Stock-based compensation | 10992 | 95412 |  |
| Non-deductible (non-taxable) expenses and other items | (3780) | 82530 | 143550 |
| Effect of exchange rate on deferred tax assets carried forward and other | 940577 | (644649) | 38037 |
| Change in deferred tax assets not recognized | (611240) | 832626 | 148442 |
|  | $- | $- | $- |

---

F - 18

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**16. Operating expenses**

(a) General and administration

The components of general and administration expenses are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| General and administration | $59938 | $86186 | $49702 |
| Rent and occupancy | 50907 | 15536 | 37153 |
| Office insurance | 1696 | 753 | 2024 |
| Investor relations, listing and filing fees | 64769 | 53029 | 49537 |
| Telephone | 8056 | - | 15591 |
|  | $185366 | $155504 | $154007 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Rent subsidy

The Government of Canada announced the Canada Emergency Rent Subsidy (CERS) to support eligible businesses by covering part of their commercial rent or property expenses. For the year ended October 31, 2022, the Company recognized $nil (2021 - $38,440 CDN ($30,613 USD)) (2020 - $nil) of rent subsidy under this program, which has been recorded as a reduction of rent and occupancy expenses in the consolidated statements of operations and comprehensive loss. This program ran from September 27, 2020 to October 23, 2021.

(b) Professional, other fees and salaries

The components of professional, other fees and salaries expenses are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Professional fees | $110933 | $107554 | $148926 |
| Consulting fees | 69563 | 132793 | 138123 |
| Salaries and benefits | 467214 | 184138 | 175075 |
|  | $647710 | $424485 | $462124 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Wage subsidy

The Canada Emergency Wage Subsidy (CEWS) was announced by the Government of Canada on March 27, 2020 to enable companies negatively impacted by COVID-19 to re-hire workers. Under this program, qualifying business can receive a subsidy for a portion of their employees' wages. For the year ended October 31, 2022, the Company recognized $nil (2021 - $167,388 CDN ($133,699 USD)) (2020 - $85,455 CDN ($63,792 USD))of wage subsidy under this program, which has been recorded as a reduction of salaries expenses in the consolidated statements of operations and comprehensive loss. This program concluded on October 23, 2021.

**17. Supplemental cash flow information**

The following provides a reconciliation of the cash flows from convertible debentures and derivative liabilities :

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended October 31,** | **Years ended October 31,** | **Years ended October 31,** |
|  | **2022** | **2021** | **2020** |
| **Balance - beginning of period** | $3239483 | $3615080 | $3364499 |
| Cash flows from financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible debentures | 765671 | 510000 | 612279 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of convertible debentures | (63490) | (593301) | (150920) |
| Non-cash changes: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion expense | 1179603 | 1169921 | 1099818 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest on convertible debentures | 368280 | 408543 | 285679 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on repayment of convertible debentures | (47877) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on conversion of convertible debentures | 94326 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on revaluation of derivative liabilities | (409607) | (2547192) | (771920) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on extinguishment of debt | 200650 | 1018928 | (127409) |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible debentures converted into common shares | (764432) | (521136) | (762847) |
| &nbsp;&nbsp;&nbsp;&nbsp;Renewal of convertible debentures |  | (16804) | (26752) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss | (129244) | 195444 | 92653 |
| **Balance - end of period** | $4433363 | $3239483 | $3615080 |

---

F - 19

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**18**. **Key management compensation and related party transactions**

The Company reports the following related party transactions:

(a) Key management compensation

Key management personnel are persons responsible for planning, directing and controlling activities of the Company, including officers and directors. Compensation paid or payable to these individuals (or companies controlled by such individuals) are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2022** | **2021** | **2020** |
| Professional, other fees, and salaries | $133517 | $107201 | $17517 |
| Stock-based compensation |  | 227500 |  |
|  | $133517 | $334701 | $17517 |

---

During the year ended October 31, 2022, key management were not awarded any options. During the year ended October 31, 2021, the Company awarded 5 million stock options to key management as part of the total 9.5 million stock options issued (2020 - nil).

(b) Trade payables and other liabilities

In 2021, the Company reversed certain amounts totalling $422,982 due to the payables being statute barred. These balances carried forward from prior years and the Company derecognized these balances during the year ended October 31, 2021. Included in accounts payable is $5,650 CDN (USD - $4,139) payable to a corporation controlled by an officer of the Company as at October 31, 2022 (2021 - $nil).

(c) Convertible debentures

In January 2018, the CEO of the Company subscribed for a convertible debenture of $150,000 CDN ($114,086 USD). As at October 31, 2022, $nil CDN ($nil USD) (October 31, 2021 - $9,483 CDN, $7,657 USD) in loan principal remains outstanding.

**19. Contingencies**

(a) The Company has agreed to indemnify its directors and officers and certain of its employees in accordance with the Company's by-laws. The Company maintains insurance policies that may provide coverage against certain claims.

(b) The Company has previously reported on the lawsuit filed by Mr. Steven Van Fleet against Micromem, the Company's response to the lawsuit and its counterclaims against Mr. Van Fleet.

On April 29, 2021 the matter was resolved in Micromem's favor when the Court dismissed Mr. Van Fleet's claims and ruled that he was liable to the Company and to MAST on their counterclaims. On June 16, 2021, the Court ruled that Micromem and MAST had established damages totaling $765,579 representing the full amount that had been requested; furthermore, the Court awarded costs and statutory prejudgment interest from May 9, 2017. On June 29, 2021 the Court entered a judgement in favor of Micromem and MAST for a total amount of $1,051,739.

With respect to the Company's efforts to collect on that Judgement, a settlement ("Settlement") was reached during October 2021. Pursuant to the Settlement, the Company received an initial one-time payment and is entitled to additional monthly payments over a period of up to six years. The Company will record those payments as and when they are received. The total amount to be received by the Company if Mr. Van Fleet makes all the required payments under the terms of the Settlement will be less than the amount of the Judgement obtained by the Company, but if Mr. Van Fleet does not comply with the terms of the Settlement, it also provides the Company a means of enforcing a larger judgement against Mr. Van Fleet that is substantially in line with the Judgement. Mr. Van Fleet has made the prescribed monthly payments each month since October 2021.

The Company is now pursuing collection of the judgement award. It will report the rcovery of this contingent asset as funds are received. In the year ended October 31, 2022 the Company has recorded a recovery of $9,040 received in the period as a reduction of legal expenses (year ended October 31, 2021 - $40,000).

F - 20

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**20. Financial risk management**

(a) Currency risk

Currency risk is the risk that the fair value of, or future cash flows from, the Company's financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to currency risk to the extent that it incurs expenses and issues convertible debentures denominated in Canadian dollars (CDN). The Company manages currency risk by monitoring the Canadian dollar position of these monetary financial instruments on a periodic basis throughout the course of the reporting period.

As at October 31, 2022, and October 31, 2021, balances that are denominated in CDN are as follows:

---

| | | |
|:---|:---|:---|
|  | **As at**<br>**October 31,**<br>**2022**<br>**CDN** | **As at**<br>**October 31,**<br>**2021**<br>**CDN** |
| Cash | $15715 | $55950 |
| Other receivables | $13832 | $7422 |
| Trade payables and other liabilities | $393978 | $425549 |
| Convertible debentures | $2810362 | $1093684 |
| Debenture payable | $51500 | $51500 |
| Derivative liabilities | $601696 | $693143 |
| Long-term loan | $60000 | $60000 |

---

A 10% strengthening of the US dollar against the CDN would decrease net loss and comprehensive loss by $257,995 as at October 31, 2022 (October 31, 2021 - decrease net loss and comprehensive loss by $166,047). A 10% weakening of the USD against the CDN would have the opposite effect of the same magnitude.

(b) Interest rate risk

Interest rate risk is the risk that the fair value of, or future cash flows from, the Company's financial instruments will significantly fluctuate due to changes in market interest rates. The Company is exposed to interest rate risk on its interest-bearing convertible debentures. This exposure is limited due to the short-term nature of the convertible debentures.

(c) Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company's policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company's management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. With the exception of the long-term loan, all financial liabilities are due within 1 year as at October 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Trade payables

The following represents an analysis of the maturity of trade payables:

---

| | | |
|:---|:---|:---|
|  | **As at**<br>**October 31,**<br>**2022** | **As at**<br>**October 31,**<br>**2021** |
| Less than 30 days past billing date | $287575 | $384057 |
| 31 to 90 days past billing date |  |  |
| Over 90 days past billing date | - | - |
|  | $287575 | $384057 |

---

F - 21

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**20. Financial risk management (continued)**

(c) Liquidity risk (continued)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Convertible debentures and derivative liabilities

The following represents an analysis of the maturity of the convertible debentures and derivative liabilities:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **As at October 31,** | **As at October 31,** | **As at October 31,** | **As at October 31,** | **As at October 31,** | **As at October 31,** |
|  | **2022** | **2022** | **2022** | **2021** | **2021** | **2021** |
|  | | | Debenture | | | |
|  | Convertible<br>debentures | Derivative<br>liabilities | payable | Convertible<br>debentures | Derivative<br>liabilities | Debenture<br>payable |
| Less than three months | $2440840 | $162380 | $- | $1609762 | $238802 | $- |
| Three to six months | 1204783 | 257933 |  | 842451 | 414602 |  |
| Six to twelve months | 146441 | 220986 | 38001 | 189 | 133677 | 40207 |
|  | $3792064 | $641299 | $38001 | $2452402 | $787081 | $40207 |

---

(d) Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash. The maximum exposure to credit risk is the carrying value of these financial assets, which amounted to $33,227 as at October 31, 2022 (October 31, 2021 - $171,397). The Company reduces its credit risk by assessing the credit quality of counterparties, taking into account their financial position, past experience and other factors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Cash

The Company held cash of $33,227 at October 31, 2022 (October 31, 2021 - $171,397). The cash is held with central banks and financial institution counterparties that are highly rated. The Company has assessed no significant change in credit risk and an insignificant loss allowance.

**21. Fair value hierarchy**

Assets and liabilities recorded at fair value in the consolidated statements of financial position are classified using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

Level 1 - valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. There are no assets or liabilities in this category in these consolidated financial statements.

Level 2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. In these consolidated financial statements, derivative liabilities are included in this category.

Level 3 - valuation techniques using the inputs for the asset or liability that are not based on observable market data. There are no assets or liabilities in this category in these consolidated financial statements.

The Company's policy for determining when transfers between levels of fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer. During the years ended October 31, 2022 and 2021, there were no transfers between levels.

**22. Capital risk management**

The Company's objectives when managing capital are to (i) maintain its ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders, (ii) ensure it has sufficient cash resources to further develop and market its technologies and (iii) maintain its ongoing operations. The Company defines its capital as its net assets, i.e. total assets less total liabilities. In order to secure the additional capital necessary to pursue these objectives, the Company may attempt to raise additional funds through the issuance of equity or convertible debentures or by securing strategic partners. The Company is not subject to externally imposed capital requirements and there has been no change with respect to the overall capital risk management strategy during the year ended October 31, 2022.

F - 22

------

Micromem Technologies Inc.

**Notes to Consolidated Financial Statements**

**For the years ended October 31, 2022, 2021, and 2020**

(Expressed in United States dollars, unless otherwise noted)

------

**23. Subsequent events**

Subsequent to October 31, 2022:

(a) The Company secured two (2) private placements with investors consisting of common shares with no warrants pursuant to prospectuses and registrations set forth in applicable securities law. It realized net proceeds of $50,000 CDN ($36,635 USD) and issued a total of 1,000,000 common shares.

(b) The Company secured $143,000 USD in convertible debentures with a 12 month term and conversion features which become effective six months after initiation date.

(c) The Company converted $172,584 USD of convertible debentures and accrued interest through the issuance of 7,307,524 common shares.

(d) The Company repaid $5,000 USD of interest accrued on a convertible debenture.

(e) The Company extended convertible debentures that were within 3 months of maturity date from October 31, 2022 for an additional (6) months.

F - 23

------

**ITEM 19. Exhibits**

The following exhibits are filed as part of this Annual Report:

---

| | |
|:---|:---|
| [Exhibit No. 1.1](http://www.sec.gov/Archives/edgar/data/1085921/000092242300000060/0000922423-00-000060.txt) | [Articles of Incorporation of Micromem Technologies Inc. and amendments thereto in effect as of January 11, 2000, (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on January 11, 2000).](http://www.sec.gov/Archives/edgar/data/1085921/000092242300000060/0000922423-00-000060.txt) |
| [Exhibit No. 1.2](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_2.htm) | [Articles of Incorporation of Amendment of Micromem Technologies Inc. dated as of October 17, 2001 amending the Articles of Incorporation of Micromem Technologies Inc. to increase the number of directors to a minimum of three and a maximum of ten (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on March 26, 2003).](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_2.htm) |
| [Exhibit No. 1.3](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_3.htm) | [Articles of Incorporation of Amendment of Micromem Technologies Inc. dated as of June 24, 2002 amending the Articles of Incorporation of Micromem Technologies Inc. to increase the number of directors to a minimum of 3 and a maximum of 12 (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on March 26, 2003).](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_3.htm) |
| [Exhibit No. 1.5](http://www.sec.gov/Archives/edgar/data/1085921/000092242300000060/0000922423-00-000060.txt) | [By-Laws of Micromem Technologies Inc. in effect as of January 11, 2002, (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on January 11, 2000).](http://www.sec.gov/Archives/edgar/data/1085921/000092242300000060/0000922423-00-000060.txt) |
| [Exhibit No. 1.6](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_5.htm) | [Amendment to the By-Laws of Micromem Technologies Inc. approved by shareholders on June 29, 2000, deleting the requirement from the By-Laws that the President shall be appointed from amongst the directors (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on March 26, 2003).](http://www.sec.gov/Archives/edgar/data/1085921/000089979703000135/exhibit_5.htm) |
| [Exhibit No. 1.7](http://www.sec.gov/Archives/edgar/data/1085921/000106299321001832/exhibit1-7.htm) | [Amendment to the By-Laws of Micromem Technologies Inc. approved by shareholders on September 8, 2020 (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on February 22, 2021)](http://www.sec.gov/Archives/edgar/data/1085921/000106299321001832/exhibit1-7.htm) |

---

------

---

| | |
|:---|:---|
| [Exhibit No. 4.1](http://www.sec.gov/Archives/edgar/data/1085921/000106299321001832/exhibit4-1.htm) | [2020 Stock Option Plan, as amended and approved by shareholders on September 8, 2020 (Incorporated herein by reference to the Company's Form 20-F filed with the Commission on February 22, 2021)](http://www.sec.gov/Archives/edgar/data/1085921/000106299321001832/exhibit4-1.htm) |
| [Exhibit No. 8.1](http://www.sec.gov/Archives/edgar/data/1085921/000120445910000377/exhibit8-1.htm) | [List of Subsidiaries (Incorporated by reference to the Company's Annual Report on Form 20-F filed with the Commission on March 1, 2010)](http://www.sec.gov/Archives/edgar/data/1085921/000120445910000377/exhibit8-1.htm) |
| [Exhibit No. 12.1](exhibit12-1.htm) | [Officer's Certification pursuant to Section 302 of the Sarbanes Oxley Act, 2002 (filed herewith).](exhibit12-1.htm) |
| [Exhibit No. 12.2](exhibit12-2.htm) | [Officer's Certification pursuant to Section 302 of the Sarbanes Oxley Act, 2002 (filed herewith).](exhibit12-2.htm) |
| [Exhibit No. 13.1](exhibit13-1.htm) | [Officer's Certification pursuant to Section 906 of the Sarbanes Oxley Act, 2002 (filed herewith).](exhibit13-1.htm) |
| [Exhibit No. 13.2](exhibit13-2.htm) | [Officer's Certification pursuant to Section 906 of the Sarbanes Oxley Act, 2002 (filed herewith).](exhibit13-2.htm) |
| [Exhibit No. 15.1](exhibit15-1.htm) | [Consent of MNP LLP (filed herewith)](exhibit15-1.htm) |
| Exhibit No. 101.INS | Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
| [Exhibit No. 101.SCH](mmtif-20221031.xsd) | [Inline XBRL Taxonomy Extension Schema Document](mmtif-20221031.xsd) |
| [Exhibit No. 101.CAL](mmtif-20221031_cal.xml) | [Inline XBLR Taxonomy Extension Calculation Linkbase Document](mmtif-20221031_cal.xml) |
| [Exhibit No. 101.DEF](mmtif-20221031_def.xml) | [Inline XBRL Taxonomy Extension Definition Linkbase Document](mmtif-20221031_def.xml) |
| [Exhibit No. 101.LAB](mmtif-20221031_lab.xml) | [Inline XBRL Taxonomy Extension Label Linkbase Document](mmtif-20221031_lab.xml) |
| [Exhibit No. 101.PRE](mmtif-20221031_pre.xml) | [Inline XBRL Taxonomy Extension Presentation Linkbase Document](mmtif-20221031_pre.xml) |
| Exhibit No. 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

**SIGNATURES**

The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form 20-F on its behalf.

---

| | |
|:---|:---|
| **MICROMEM TECHNOLOGIES INC.** | **MICROMEM TECHNOLOGIES INC.** |
| By: | /s/ Joseph Fuda |
| Name: | Joseph Fuda |
| Title: | Chief Executive Officer |
| By: | /s/ Dan Amadori |
| Name: | Dan Amadori |
| Title: | Chief Financial Officer |

---

Dated: February 24, 2023

------

## Exhibit 12.1

------

Exhibit 12.1

**SECTION 302 CERTIFICATION** 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER** 

I, Joseph Fuda, certify that:

1. I have reviewed this annual report on Form 20-F of Micromem Technologies Inc. for the Fiscal Year Ended October 31, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

------

Exhibit 12.1

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: February 24, 2023 | /s/ Joseph Fuda |
|  | Joseph Fuda |
|  | Chief Executive Officer |
|  | (Principal executive officer) |

---

------

## Exhibit 12.2

------

Exhibit 12.2

**SECTION 302 CERTIFICATION** 

**CERTIFICATION OF CHIEF FINANCIAL OFFICER** 

I, Dan Amadori, certify that:

1. I have reviewed this annual report on Form 20-F of Micromem Technologies Inc. for the Fiscal Year Ended October 31, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

------

Exhibit 12.2

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: February 24, 2023 | /s/ Dan Amadori  |
|  | Dan Amadori |
|  | Chief Financial Officer |
|  | (Principal financial officer) |

---

------

## Exhibit 13.1

------

Exhibit 13.1

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Annual Report of Micromem Technologies Inc. (the "Company") on Form 20-F for the Fiscal Year Ended October 31, 2022 (the "Report"), I, Joseph Fuda, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, based on my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | |
|:---|:---|
| Date: February 24, 2023 | /s/ Joseph Fuda |
|  | Joseph Fuda |
|  | Chief Executive Officer |
|  | (Principal executive officer) |

---

------

## Exhibit 13.2

------

Exhibit 13.2

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Annual Report of Micromem Technologies Inc. (the "Company") on Form 20-F for the Fiscal Year Ended October 31, 2022 (the "Report"), I, Dan Amadori, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, based on my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | |
|:---|:---|
| Date: February 24, 2023 | /s/ Dan Amadori |
|  | Dan Amadori |
|  | Chief Financial Officer |
|  | (Principal financial officer) |

---

------

## Exhibit 15.1

------

![](exhibit15-1xu001.jpg)

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the inclusion in the Annual Report on Form 20-F of our auditor's report dated February 15, 2023 relating to the consolidated financial statements of Micromem Technologies Inc. (the "Company") consisting of the consolidated statements of financial position as at October 31, 2022 and 2021 and the related consolidated statements of operations and comprehensive loss, changes in equity and cash flows for each of the years in the three year period ended October 31, 2022, which appears in this Form 20-F for the year ended October 31, 2022 as filed with the United States Securities Exchange Commission.

We also consent to the incorporation by reference of such report in the Company's Registration Statement on Form S-8 (File No. 333-203466).

**Signed:**

**Toronto, Ontario**

February 24, 2023

---

| | |
|:---|:---|
| **MNP LLP** |  |
| 1 Adelaide Street East, Suite 1900, Toronto ON, M5C 2V9 | 1.877.251.2922 T: 416.596.1711 F: 416.596.7894 |

---

------